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Introduction 
In this thesis, six studies are presented in which different aspects of the treatment of 
patients with chronic fatigue syndrome (CFS) were investigated. In this introductory 
chapter, some of the literature on this syndrome is reviewed and a cognitive-behavioural 
model of CFS is introduced. This model forms the basis for cognitive behaviour therapy 
(CBT), an evidence based treatment for CFS. The different elements of this mode of 
treatment are explained in detail and the controversies and unresolved issues surrounding 
CBT for CFS are discussed. Some of these unresolved issues are addressed in this thesis.  
Also, an attempt is made to further develop this form of treatment by testing the 
effectiveness of a new type of intervention. The chapter ends with a description of the 
research centre where the studies were undertaken.  
 
Chronic fatigue syndrome 
For most people, fatigue is a ‘normal’ and sometimes pleasant state that is experienced 
regularly. However, fatigue becomes a symptom when it is severe, chronic and interfering 
with daily live. In certain instances we then speak of CFS. CFS is characterized by severe 
fatigue lasting longer than six months and leading to a substantial reduction of activities. A 
somatic explanation for the fatigue is lacking.1 Most patients have, aside from fatigue, 
additional symptoms. According to the US Center for Disease Control criteria for CFS1 2 a 
patient must report four out of eight additional symptoms: unrefreshing sleep, post-
exertional malaise, headache, muscle pain, multi-joint pain, sore throat, tender lymph nodes 
and concentration and memory impairment. Although some suggest that CFS is a ‘modern 
disease’, reports about patients with CFS-like symptoms date back to the end of the 19th 
century.3 4  
The prevalence of CFS in the Netherlands is estimated to be between 30,000 to 40,000 
patients.5 The prognosis of CFS without treatment in adults is not favourable. A recent 
review showed that only 5% of the patients show spontaneous recovery.6  In adolescents 
with CFS the prognosis is much better.7  
 
What causes CFS?  
The aetiology of CFS is still unknown. It is probable that CFS is multi-factorially 
determined. A distinction between factors that predispose someone for CFS, factors that 
precipitate CFS, and factors that perpetuate the symptoms has proven to be fruitful.8 
Research into the factors that predispose someone for CFS has shown that physical 
inactivity, being female, and early adverse experiences (i.e. physical or emotional neglect 
or abuse) are risk factors for developing CFS.8 9 There is also some evidence that a genetic 
disposition exists for CFS.8  
Different somatic and psychological stressors, like an operation, infection or loss of a loved 
one, can precipitate CFS. They can all act as triggers of the symptoms of CFS.  
Psychological processes seem to be the main factors in perpetuating CFS once the 
symptoms have been established. 8 10 11  
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Although until now no consistent somatic impairment has been found in CFS, a recent and 
promising line of research investigated possible neurobiological abnormalities that are 
associated with CFS. The activity patterns in specific areas of the brain were shown to be 
different in patients with CFS when they were performing the same tasks as healthy 
controls. In a study of de Lange et al12 areas in the brain that play a role in the emotional 
response to making an error showed less activity, suggesting some kind of motivational 
impairment in CFS. Other research showed that more areas in the brain were activated 
when CFS patients performed a complex cognitive task while their actual performance did 
not differ from healthy controls. The level of activity in the brain of CFS patients was 
associated with the reported severity of mental fatigue.13 14 There are also two studies that 
show that patients with CFS have less grey matter. In one of those studies, the amount of 
grey matter was negatively correlated with the level of physical activity.15 16 Furthermore, 
changes in functioning of the Hypothalamopituitary-adrenal (HPA) axis and serotonergic 
transmitter systems have been found.8 To what extent these abnormalities reflect the 
consequences of CFS, are the biological correlates of the perpetuating factors, or are related 
to the aetiology of CFS is not yet clear.  
 
A cognitive behavioural model of perpetuating factors of CFS 
Vercoulen et al11 developed a statistically tested model of the psychological factors that 
perpetuate fatigue and disabilities in CFS (see Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Model of perpetuating cognitions and behaviour of CFS.28 
 
 
Cognitions and behaviour are the maintaining factors in CFS. A low self-efficacy 
negatively influences the fatigue. The conviction that the symptoms have a somatic cause 
lowers the physical activity, which in turn increases the fatigue and leads to disabilities. 
Body consciousness or a strong focus on bodily symptoms also has a negative influence on 
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the level of fatigue and disabilities. A more recent study showed a perceived lack of social 
support and more negative social interactions in CFS patients. A lack of social support was 
identified as a factor that has to be added to the model of perpetuating factors of CFS.17   
 
The treatment of CFS 
Different treatment modes have been applied to CFS. In a systematic review, Whiting et 
al18 concluded that behavioural interventions have shown the most promising results. A 
recent update19 again showed that behavioural interventions appeared to reduce symptoms 
and improve the level of functioning when tested in randomized controlled trials (RCT).   
Cognitive behaviour therapy (CBT) and graded exercise therapy (GET) are the most 
frequently used behavioural interventions for CFS. Both interventions involve a gradual 
exposure to activity. In GET, the gradual build up of physical exercise is a central element. 
In CBT, there are also interventions specifically aimed at changing CFS related beliefs and 
perceptions. Five RCT’s have tested GET. Depending on the outcome variable used, GET 
results in a significant reduction of symptoms and disabilities in 18 to 63 per cent of the 
patients.20 A higher success rate (69%) was reported by Powell et al21 who combined GET 
with an educational intervention that explained both the reasons for ill health and the 
rationale for GET. Of the eight trials that tested the effects of CBT for CFS, six reported a 
positive effect of the intervention.19 After CBT, between 50 to 70 percent of the patients 
report a significant reduction of symptoms, disabilities or both.18 19 22   
 
Cognitive behaviour therapy for CFS 
There are different CBT protocols for CFS.23 24 All protocols aim at a change in fatigue 
related cognitions and a gradual increase of activity. These interventions should lead to a 
decrease of the severe fatigue and disabilities. It is (often implicitly) assumed that other 
symptoms, such as pain, difficulty concentrating, or forgetfulness will also decrease if 
patients become less fatigued. However, this is still a matter of discussion and the fact that 
the reduction of fatigue is the main focus of CBT while less attention is given to other 
symptoms is sometimes criticized.  
The protocol that is used in the studies of this thesis is based on the model of perpetuating 
factors of Vercoulen et al.11 The protocol was tested in two RCT ‘s, one in adults25 and one 
in adolescents.22 The treatment starts with the establishment of goals. In this phase, the 
model of perpetuating factors is explained to the patient and individualized to her situation 
(the female pronoun is used to denote both female and male patient). When the patient is 
invited to formulate the treatment goals, it is emphasized that recovery of CFS is possible. 
Recovery means that a patient no longer suffers from CFS, is no longer chronically and 
severely fatigued, and can resume her normal activities as a result of the therapy. This is 
different from the other CBT protocols in which, rather than recovery, the reduction of 
symptoms and disabilities is seen as the highest attainable goal of treatment.  
A disruption of circadian rhythms as a consequence of changes in the sleep-wake cycle in 
response to the severe fatigue (e.g. sleeping during the day) is thought to be one of the 
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perpetuating factors in CFS. Therefore, after formulating the goals of the treatment, the 
patient learns to regulate her sleep-wake pattern, which means that she goes to bed at the 
same time everyday, gets up at the same time, and does not sleep or lies down during the 
day.  
In the protocol of Bleijenberg et al26 the pattern of physical activity determines the type of 
interventions that are used after the regulation of the sleep-wake cycle. An actometer, a 
motion sensing device that can quantify physical activity, is used to assess the activity 
pattern.27 Two types of activity patterns are distinguished: relatively active and passive.  
The relatively active pattern is characterised by bursts of activity followed by periods of 
rest. Patients with a relatively active pattern have cognitions that enhance their symptoms. 
Examples of these cognitions are non-acceptance of symptoms and cognitions that lead to 
peaks of activity, such as wanting to do too much or making too many demands on  ones 
self in light of current symptoms.  Relatively active patients first have to attain a base level 
of activity and subsequently gradually increase their activity level.  By means of a 
systematic program, they first increase their physical activity (walking of cycling), and then 
they gradually resume work and other activities of daily life. To do this successfully, the 
cognitions that enhance the symptoms and maintain the peaks of activity have to be 
systematically challenged. Patients with a passive activity pattern are characterised by an 
extremely low physical activity level and activity impeding cognitions. After entering 
treatment, they immediately start with a graded physical activity program followed by a 
systematic increase of mental, social and work related activities. It is assumed that the 
gradual resumption of mental activities will decrease the self-reported mental impairments. 
This has however never been empirically tested. When patients follow the graded activity 
program, the activity impeding cognitions are changed because patients stop avoiding 
activities.  
For all patients, specific cognitive behavioural interventions are used. These interventions 
are aimed at decreasing the focusing on bodily symptoms, changing the way patients  
communicate with others about CFS and changing their attitude when dealing with the 
reaction of others to their symptoms. An important intervention for decreasing the focus of 
bodily symptoms is, no longer talk about the symptoms in therapy, but to talk about the 
ways in which to change the perpetuating behaviour and cognitions. When patients start 
with CBT they have to agree to stop all medical assessments aimed at finding the ‘cause’ of 
the fatigue. This also helps to decrease the focus on physical functioning. Finally, specific 
interventions are used to normalise the perception of signals of the body and to learn to give 
them less attention.28  During treatment, it is stressed that patients have to learn to cope 
with a limited understanding of their symptoms by (a part of) their social environment. It is 
important that the patient takes responsibility for changing her situation, even if her 
environment is less supportive. At the same time, an attempt to increase the social support 
of a patient is made by educating the spouse, or other important proxy’s, and colleagues 
about CFS in ways in which they can support the patient. Throughout the treatment, the 
focus of communication is on the resumption of activities (like work) and the reduction of 
Introduction 
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symptoms.  The therapy ends with interventions aimed at the prevention of relapses. 
Bleijenberg et al26 describe the treatment protocol in more detail.  
CBT for adolescents for CFS is comparable to that of adults, however, the parents of the 
adolescent are involved in the therapy, and the treatment is shorter as a positive outcome 
can be reached more quickly than in adults.22  
 
Research into CBT for CFS: outline of this thesis       
Although there is substantial evidence that CBT is an effective treatment for CFS, there are 
a number of controversies surrounding this mode of treatment. Some seem related to the 
unwillingness of certain researchers and patient advocacy groups to accept that cognitions 
and behaviour play an important role in the perpetuation of CFS symptoms. Others are 
related to legitimate concerns about the effectiveness and scope of CBT.  This thesis aims 
to address some of these unresolved issues surrounding CBT. Additionally, the thesis aims 
to further the development of CBT.  
 
The effect of CBT on pain symptoms  
Although chronic fatigue is an important symptom of CFS, it is not the only one. Most 
patients also complain of chronic pain.29 30 Four of the eight additional symptom criteria of 
the CDC definition of CFS are pain symptoms: headache, muscle pain, multi joint pain and 
a sore throat. The pain symptoms lead to significant disabilities in patients.31  
The question addressed in chapter 2 is whether CBT for CFS is also effective for pain 
symptoms. To answer this question, data of two previous studies testing the effectiveness of 
CBT for CFS in adults32 and adolescents22 were re-analysed. Also, the mechanisms of the 
change in pain symptoms and the predictive value of the pain symptoms for the outcome of 
CBT for CFS were studied.  
 
The effect of CBT on neuropsychological test performance and self reported cognitive 
impairments 
Most patients who are chronically fatigued also complain about difficulty concentrating and 
forgetfulness. As already mentioned, it is assumed that these symptoms will decrease 
following CBT but that has never been investigated systematically. The role of the 
impairments in cognitive functioning in CFS is unclear. Although a majority of patients 
complain about their mental functioning, their performance on neuropsychological tests that 
objectively measures mental capacities often shows no impairment.33 There is a 
discrepancy between subjective cognitive functioning and objective neuropsychological test 
performance (see also Vercoulen et al34). This discrepancy is not limited to cognitive 
impairments but also occurs in sleep disorders and the perception of pain.35 36 Furthermore, 
research also showed that the mental functioning of CFS patients is negatively influenced 
by a focus on bodily symptoms.37  All these findings suggest that there is a disorder in the 
perception of  bodily symptoms and mental functioning in CFS and not in the objective 
cognitive performance or bodily functioning. If this is true, one would expect that following 
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CBT the perception of the patient’s own functioning will change rather than her 
performance on neuropsychological tests. In chapter 3, the question is addressed to what 
extent the self-reported cognitive impairments decreased and neuropsychological test 
performance increased following CBT for CFS.    
 
The change in the experience of fatigue following CBT 
For most people, fatigue is a pleasant and normal phenomenon after a period of activity. 
CFS patients not only report severe fatigue, the perceived quality of their fatigue is often 
very different from that of healthy people. For patients with CFS, fatigue has a profound 
negative connotation. An important goal of the treatment is to make the perception of the 
fatigue comparable to that of a healthy person, meaning that the patient experiences the 
fatigue as something normal, without persistent negative connotations. The scales used to 
assess fatigue mostly measure fatigue severity and not the subjective quality of the fatigue. 
We developed an adjective checklist, the Fatigue Quality List, to assess the experience of 
the fatigue. The psychometric properties of this list and the effect of CBT on the experience 
of fatigue were investigated. That study is reported in chapter 4.  
 
Rehabilitation versus recovery 
The majority of the studies that investigate the effects of CBT for CFS report a change in 
symptoms and disabilities. However, the nature of this change following treatment is 
controversial. Some suggest that patients learn to adapt to a chronic condition. Patients 
learn to manage their chronic condition better, will report less symptoms and disabilities, 
but remain impaired by CFS.38 Others think that a full recovery from CFS is possible and 
that recovery should be the goal of CBT.39 In the protocol used in the studies of this thesis, 
recovery is explicitly stated as the goal of treatment.   
The question what the tenable goal is for CBT for CFS, adaptation or recovery, is not only 
an interesting research question but also one of clinical importance. If recovery is the goal 
of treatment, a therapist will select other interventions than when the goal is to cope better 
with chronic symptoms. Furthermore, the communication of the aim of the treatment by the 
therapist is in itself a cognitive intervention that can facilitate a behavioural change. 
Chapter 5 will report on a study in which we measured the proportion of the patients that 
are (fully) recovered following CBT using different measures and definitions of recovery. 
 
Long term effects of CBT for CFS 
Several trials have shown a positive effect of CBT for CFS directly following treatment. 
Less is known about the long term effects of CBT. In other disorders for which CBT is an 
effective treatment, large discrepancies occur between short and long term effects. In 
affective disorders for example, a high relapse rate is common after a positive outcome 
directly following treatment with CBT.40 There is only one study that systematically studied 
the long term outcome of CBT for CFS.  This study of Deale et al38 showed that CBT can 
produce lasting benefits in adult CFS patients five years after the treatment. We 
Introduction 
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investigated the long term outcome of CBT for CFS in adolescents. A previous study of our 
research group had already shown that CBT has a positive effect in adolescent CFS patients 
directly following treatment.22 All patients who participated in the trial were contacted for a 
follow-up assessment to see if the positive effects of CBT were maintained. Furthermore, 
we tried to predict treatment outcome from the baseline assessment. The study is described 
in chapter 6.    
 
The efficacy of self instructions based on CBT in the treatment of CFS     
CBT for CFS is an intensive treatment. It consists of 16 individual sessions in a period of 8 
months.26 Licensed cognitive behavioural therapists need additional training and 
supervision to learn to treat CFS patients effectively. The current treatment capacity for 
CBT for CFS in the Netherlands is limited; yet it is unlikely that intensive treatment is 
necessary for all CFS patients. If a less intense form of CBT for CFS is available, treatment 
capacity will increase and it will become possible to better tailor the intervention to the 
specific needs of the CFS patient. We developed a minimal intervention based on the CBT 
protocol for CFS. It consisted of a self help booklet supported by two-weekly email contact 
with a CBT therapist. The efficacy of this minimal intervention was tested in a RCT where 
the effects of the self help booklet supported by email contact were compared with a 
waiting list condition. The objective of the study was twofold: first, we wanted to test the 
effectiveness of the minimal intervention in reducing CFS symptoms and second, we 
wanted to identify those patients for whom a minimal intervention sufficed. In chapter 7 the 
results of this study are reported.   
 
In the final chapter (chapter 8) the results of the aforementioned studies are discussed in 
light of the existing literature on CBT for CFS. The clinical implications of the findings 
will be formulated and possible directions for future research will be mentioned.   
 
Expert Centre Chronic Fatigue 
All studies reported on in this dissertation were performed at the Expert Centre Chronic 
Fatigue of the Radboud University Nijmegen Medical Centre (www.umcn.nl/ 
chronicfatigue). The expert centre started in 1990 as the result of collaboration between the 
departments of Internal Medicine, Virology and Medical Psychology. Possible somatic and 
psychological determinants and consequences of CFS were studied systematically. This 
resulted in a model of perpetuating factors of CFS, which formed the basis for the 
development of the protocol of CBT for CFS. Several intervention studies testing CBT for 
CBS have been performed.22 25 32 41 The expert centre implemented CBT for CFS in clinical 
routine and treated over 200 CFS patients in 2006.  Current research focuses on the 
neurobiological correlates of CFS, the process of change (and somatic correlates of this 
change) during CBT for CFS and the development and implementation of a model of 
stepped care for CFS.   
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The expertise of the Expert Centre Chronic Fatigue is not limited to CFS but extends to 
chronic fatigue in other conditions, such as cancer42, neuromuscular disorders43 44 and 
rheumatoid arthritis. A RCT has shown that CBT is effective in treating fatigue in disease-
free cancer patients45 and a trial testing the effectiveness of CBT in treating chronic fatigue 
in neuromuscular disorders is in preparation.  
 
REFERENCES 
1. Fukuda K, Straus SE, Hickie I, Sharpe  MC, Dobbins JG,  Komaroff A. The chronic fatigue syndrome: a 
comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. 
Ann Intern Med 1994; 121: 953-9. 
2. Reeves WCC,  Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. Identification of ambiguities 
in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC 
Health Serv Res 2003; 31: 25.  
3. Wessely S, Hotoph M, Sharpe M. Chronic fatigue and its syndromes. Oxford: Oxford University Press, 
1998.   
4. Bleijenberg, G. De ene vermoeidheid is de andere niet. Oratie. Katholieke Universiteit Nijmegen, 2003.  
5. Gezondheidsraad. Het chronische-vermoeidheidssyndroom [Health council. Chronic fatigue syndrome]. Den 
Haag: gezondheidsraad, 2005, publicatie nr 2005/02.  
6. Cairns R, Hotoph M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup 
Med-C 2005;  55: 20-31.  
7. Rimes KA, Goodman R, Hotoph M, Wessely S. Incidence, prognosis, and risk factors for fatigue and 
chronic fatigue syndrome in adolescents: a prospective community study. Pediatrics 2007; 119: 603-9. 
8. Prins JB, Van der Meer JWM, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006; 376: 346-355.  
9. Heim C, Wagner D, Maloney E, Papanicolaou DA, Solomon L, Jones JF, et al. Early adverse experience 
and risk for chronic fatigue syndrome: results from a population based study. Arch Gen Psychiatry 2006; 63: 
1258-1266.  
10. Suraway C, Hackmann A, Hawton K, Sharpe M. Chronic fatigue syndrome: a cognitive approach. Behav 
Res Ther 1995; 33: 535-544.  
11. Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, Jongen PJH, Hommes OR, et al. The 
persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: the development of a model. J 
Psychosom Res 1998; 45: 507–517.   
12. de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Werf SP, van der Meer JWM, et al. Neural 
correlates of the chronic fatigue syndrome- an fMRI study. Brain 2004; 127: 1979-1992. 
13. Lange G, Stefferer J, Cook DB, Bly BM, Christodoulou C, Liu WC, et al. Objective evidence of cognitive 
complaints in chronic fatigue syndrome: A BOLD fMRI study of verbal working memory. NeuroImage 
2005; 26: 513-524. 
14. Cook DB, O’ Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue 
induced by cognition among chronic fatigue syndrome patients and controls. NeuroImage 2007; 36: 108-
122. 
15. Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JWM, Toni I. Gray matter volume 
reduction in the chronic fatigue syndrome.  NeuroImage 2005;  26: 777-781. 
16. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based 
morphometric study of chronic fatigue syndrome. BMC Neurol 2004;  4: 14. 
17. Prins  JB, Bos E, Huibers MJ, Servaes P, van der Werf SP, van der Meer JW, et al. Social support and the 
persistence of complaints in chronic fatigue syndrome. Psychother Psychosom 2004; 73: 174-182. 
18. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment 
and management of chronic fatigue syndrome: a systematic review. J Am Med Assoc 2001;  286: 1360-8. 
Introduction 
 19
19. Chambers D, Bagnall A, Hempel S, Forbes C. Interventions for the treatment, management and 
rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic 
review. J Roy Soc Med 2006;  99: 506-520. 
20. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database of 
Systematic Reviews, 2004, Issue 3. Art no: CD003200. DOI:10.1002/14651858.CD003200.pub2.    
21. Powell P, Bentall RP, Nye FJ, Edwards RHT. Randomised controlled trial of patient education to encourage 
graded exercise in chronic fatigue syndrome.  Brit Med  J  2001;  322: 1-5. 
22. Stulemeijer M, de Jong LWAM,  Fiselier TJW, Hoogveld SWB, Bleijenberg G:  Cognitive behaviour 
therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. Brit Med J 2005;  330: 
7481-6. 
23. Deale A, Chalder T, Wessely SC, Keijsers GPJ, Hoogduin CAL. Protocollaire behandeling van patienten 
met het chonisch vermoeidheidssyndroom: graduele activering en cognitieve therapie [a protocol for the 
treatment of chronic fatigue syndrome: graded activity and cognitive therapy]. In: Protocollaire behandeling 
in the ambulante geestelijke gezondheidszorg. Keijsers GPJ, Van Minnen A, Hoogduin CAL, eds. 
Houten/diegem: Bohn Stafleu van Loghum, 1999.    
24. Bleijenberg G, Bazelmans E, Prins J. Chronisch vermoeidheidssyndroom [chronic fatigue syndrome]. 
Houten/Diegem: Bohn Stafleu Van Loghum, 2001.  
25. Prins JB, Bleijenberg G, Bazelmans E, Elving L, de Boo Th, Severens JL, et al. Cognitive behaviour therapy 
for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet 2001;  357: 841-7. 
26. Bleijenberg G, Prins J, Bazelmans E. Cognitive behavioral therapies; in Jason LA, Fennell PA, Taylor RR 
(eds). Handbook of chronic fatigue syndrome. New York, Wiley & Sons, 2003, pp 493-526. 
27. Van der Werf SP, Prins JB, Vercoulen JHMM, Van der Meer JWM, Bleijenberg G.  Identifying physical 
activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res 2000; 49: 373-
9. 
28. Knoop H, Bleijenberg G. Belemmerende preoccupaties bij patiënten met het chronisch vermoeidheids-
syndroom [preoccupations in chronic fatigue syndrome]. Tijdschrift voor directieve therapie 2005;  25: 205-
217. 
29. Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama, JMD, Van der Meer JWM, Bleijenberg G. 
Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;  38: 383-392. 
30. King C, Jason LA. Improving the diagnostic criteria and procedures for chronic fatigue syndrome. Biol 
Psychol 2005;  68: 87-106. 
31. Meeus M, Nijs J, De Meirleir K. Chronic musculoskeletal pain in patients with the chronic fatigue 
syndrome: a systematic review. Eur J Pain 2007; 11: 377-386.  
32. Knoop H, Bleijenberg G, Gielissen MFM, van der Meer JWM, White PD. Is a full recovery possible after 
cognitive behavioural therapy for chronic fatigue syndrome? Psychother Psychosom 2007;  76:  171-6. 
33. Vercoulen JH, Bazelmans E, Swanink CM, Galama JM, Fennis JF, van der Meer JW, et al. 
Neuropsychological impairment in  chronic fatigue syndrome. J Clin Exp Neuropsychol 1998;  20: 144-56. 
34. Mahurin RK, Claypoole KH, Goldberg JH, Arguelles L, Ashton S, Buchwald D. Cognitive processing in 
monozygotic twins discordant for chronic fatigue syndrome. Neuropsychology 2004; 18: 232-9. 
35. Van der Werf SW, De Vree B, Van der Meer JWM, Bleijenberg G. The relationship between body 
consciousness, somatic symptoms report and information processing speed in chronic fatigue syndrome. 
Neurol Neuropsychology Behav Neurol 2002; 12: 12-15.   
36. Watson NF, Jacobsen C, Goldberg J, Kapur V, Buchwald D. Subjective and objective sleepiness in 
monozygotic twins discordant for chronic fatigue syndrome. Sleep 2004;  27: 973 –7.  
37. Ullrich PM, Afari N, Jacobsen C, Goldberg J, Buchwald D. Cold pressor pain sensitivity in monozygotic 
twins discordant for chronic fatigue syndrome. Pain Med 2007;  8: 216-222.  
38. Deale A, Husain K, Chalder T, Wessely, S. Long-term outcome of cognitive behaviour therapy versus 
relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry 2001; 158:  
2038-2042. 
39. Prins JB, Bleijenberg G, van der Meer JWM.. Chronic fatigue syndrome and myalgic encephalomyelitis. 
Lancet 2002;  359:1699. 
 20
40. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP,  et al. Prevention of 
relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 
2005; 62: 417-422.  
41. Bazelmans E, Prins JB, Lulofs R, van der Meer JWM, Bleijenberg G. Cognitive behaviour group therapy in 
chronic fatigue syndrome: a wait-list controlled study. Psychother Psychosom 2005; 74: 218-224. 
42. Servaes, P. Fatigue in disease-free cancer patients. Thesis. Radboud University Nijmegen, 2003 
http://webdoc.ubn.kun.nl/mono/s/servaes_p/fatiindic.pdf  
43. Schillings M. Fatigue in neuromuscular disorders and chronic fatigue syndrome. A neurophysiological 
approach. Thesis. Radboud University Nijmegen, 2005. http://webdoc.ubn.ru.nl/mono/s/schillingsm 
/fatiinned.pdf 
44. Kalkman JS. From prevalence to predictors of fatigue in neuromuscular disorders. The building of a model. 
Thesis. Radboud University Nijmegen, 2006 http://webdoc.ubn.ru.nl/mono/k/kalkman_j/fromprtop.pdf 
45. Gielissen, MFM, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely 
fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a 
randomized controlled trial. J Clin Oncol 2006;  24: 4882-7. 
 2 
Is cognitive behaviour therapy for chronic fatigue syndrome also 
effective for pain symptoms?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hans Knoop, Maja Stulemeijer, Judith B. Prins, Jos W.M. van der Meer, Gijs Bleijenberg. 
Behaviour Research and Therapy  2007; 45: 2034-2043   
 22
ABSTRACT  
Patients with chronic fatigue syndrome (CFS) frequently report chronic pain symptoms. 
Cognitive behaviour therapy (CBT) for CFS results in a reduction of fatigue, but is not 
aimed at pain symptoms. In this study, we tested the hypothesis that a successful treatment 
of CFS can also lead to a reduction of pain. The second objective was to explore possible 
mechanisms of changes in pain. The third objective was to assess the predictive value of 
pain for treatment outcome. Data from two previous CBT studies were used, one of adult 
CFS patients (n=96) and one of adolescent CFS patients (n=32). Pain severity was assessed 
with a daily self-observation list at baseline and post-treatment. The location of pain in 
adults was assessed with the McGill Pain Questionnaire (MPQ). Patients were divided into 
recovered and non-recovered groups. Recovery was defined as reaching a post-treatment 
level of fatigue within normal range. Recovered adult and adolescent CFS patients reported 
a significant reduction of pain severity compared to non-recovered patients. Recovered 
adult patients also had fewer pain locations following treatment. The decrease in fatigue 
predicted the change in pain severity. In adult patients, a higher pain severity at baseline 
was associated with a negative treatment outcome. 
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe fatigue lasting longer than 6 
months and leading to functional impairment. CFS is neither the result of an organic disease 
or ongoing exertion nor alleviated by rest. According to the Centre for Disease Control 
(CDC) definition of CFS, the patient should have four out of eight additional symptom 
criteria.1 Four of these are pain symptoms, i.e. muscle pain, multi-joint pain, headaches and 
a sore throat. The other four are post-exertional malaise, unrefreshing sleep, concentration 
and/or memory impairments and sensitive lymph nodes. The frequency of pain symptoms 
in CFS differs between studies but is usually high.2 3 4  In the study of Vercoulen et al2, the 
frequency of spontaneously reported pain symptoms ranged from 13% (sore throat) to 71% 
(muscle pain). King and Jason3 systematically assessed complaints and found much higher 
frequencies ranging from 60% for a sore throat to 93%  for headaches and muscle pain. The 
chronic pain symptoms in CFS are disabling and compromise physical and social 
functioning.4  
The aetiology of CFS is unknown, but cognitions and behaviour can perpetuate CFS.5 6 A 
statistically tested model of perpetuating factors in CFS showed that a low sense of control 
of symptoms and a focus on bodily symptoms had a direct causal effect on fatigue.7 
Furthermore, attributing the symptoms of CFS to a somatic cause produced low levels of 
physical activity which in turn had a negative causal effect on fatigue. More recently, it was 
found that a perceived lack of social support can also perpetuate the fatigue.8   
Several controlled trials have found that cognitive behaviour therapy (CBT) aimed at the 
perpetuating factors of CFS leads to a reduction of fatigue and disabilities.9 A recent 
systematic review showed that of the eight CBT trials for CFS that have been performed, 
six reported a positive outcome.10 Most studies used fatigue as an outcome measure.  
There are no interventions in the different treatment protocols for CFS that focus on pain 
symptoms, but it is implicitly assumed that an effective treatment of fatigue will also lead 
to a reduction of pain. Recently, it was shown that adolescents indeed report a decrease of 
muscle pain and headache following CBT for CFS.11 However, the measure used was a 
four-point Likert scale in which the prevalence of pain had to be evaluated retrospectively 
over a period of 6 months. This type of pain assessment is easily influenced by situational 
circumstances and memory biases which can be prevented with the use of a pain diary.12  
To our knowledge, there are no published data pertaining to the effect of CBT for CFS on 
pain in adult patients.  
The first objective of this study was to determine whether an effective treatment of CFS 
with CBT also leads to a significant reduction of pain symptoms when these symptoms are 
evaluated with an appropriate assessment method. CBT is considered effective if a patient 
is recovered, that is reporting a level of fatigue within the range of healthy individuals.13 In 
assessing pain symptoms we looked at pain severity and the location of the pain symptoms.  
The second objective was to investigate the mechanisms of  possible changes in pain 
severity  following CBT. A central feature of CBT for CFS is the gradual increase of 
physical activity. It is possible that the increased activity levels also leads to a decrease of 
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pain. CBT for CFS also aims to modify those cognitions and cognitive processes that 
perpetuate fatigue. The persistent focus on bodily symptoms or body consciousness is one 
of these cognitive processes.7 If this focus is lessened as a consequence of therapy, it is 
likely that this generalises to other symptoms than fatigue, e.g. pain. Finally, CBT for CFS 
leads to a reduced negative affectivity, which could lead to a diminished report of physical 
symptoms (i.e. pain).    
The third objective was to assess the predictive value of pain severity at baseline on the 
outcome of the treatment. Although physical activity has a positive effect on chronic pain in 
the long term14, increase in activity can have a negative influence on pain symptoms in the 
short term. Whiteside et al15 found that CFS patients reported a lower pain threshold 
following physical activity. In their study, the pain threshold of patients was repeatedly 
determined after graded exercise. Since graded activity is an important feature of CBT, this 
could mean that CBT leads to a lower pain threshold. This lower pain threshold might 
hamper the increase in activity level during therapy and could lead to a less favourable 
outcome of CBT. We suspected that this was especially true for those patients who already 
had a high pain severity at the start of the therapy. In determining the predictive value of 
pain for treatment outcome, we controlled for the relationship between pain and physical 
activity 
 
METHODS 
Subjects To answer our research questions, data from two previous CBT studies with 
patients with CFS were used. In the first study, the outcome of CBT for CFS in adults was 
evaluated.16 The effect of CBT on pain symptoms was not determined in this study. Ninety-
six adult patients who met the CDC criteria for CFS participated in the study. They were 
severely fatigued and functionally impaired. Severe fatigue was defined by a cut-off score 
of 35 or higher on the subscale fatigue severity of the checklist individual strength (CIS).2 
Functional impairment was assessed with the sickness impact profile (SIP). The SIP 
consists of eight subscales measuring functional impairments of different domains of 
functioning. The scores on the subscales were added to provide one weighted score of 
general disability. A score of 700 or higher was used as a cut-off score.17 The mean age of 
the adult patients was 37 years (SD= 11.5). Seventy-three patients were women (76%), and 
the median duration of the illness was 48 months (range= 264 months).     
The second study used was a randomised controlled trial testing the effectiveness of CBT 
for adolescents with CFS.11 Patients included in this study were between 10 and 17.2 years 
old. They met the CDC criteria for CFS. In this study, severe fatigue was defined as having 
a score of 40 or higher on the CIS subscale fatigue severity. The cut-off score for 
adolescents is higher than for adults because the mean fatigue severity in healthy 
adolescents is also higher.11 Severe functional impairment was operationalised as having a 
weighted score of 65 or less on the SF-36 Physical Functioning scale. The score on this 
subscale can range from 0 (maximum physical limitations) to 100 (ability to do vigorous 
activity). The CBT group consisted of 35 adolescents with a mean age of 15.6 years (SD= 
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1.3); 31 patients were female (89%) and the median duration of the illness was 16 months 
(range=44 months). Three patients did not start with the treatment and only the data of the 
32 patients who started with CBT after baseline assessment were used for further analysis.  
 
Design All patients were assessed at baseline and post-treatment. Patients were divided in a 
recovered and non-recovered group based on their post-treatment score on the CIS subscale 
fatigue severity. The definition of recovery in adult CFS patients was based on a previous 
randomised controlled trial that tested the effectiveness of CBT for adult CFS patients.18 In 
this study, adult patients were considered recovered if their score on the CIS subscale 
fatigue was lower than 36. This score is within two standard deviations of the mean of a 
healthy adult control group.2 19 Using this criterion created a potential overlap with the cut-
off score that was used for including patients in the adult study (scoring 35 or higher on the 
CIS subscale fatigue).16  However, as no patient in this latter study actually scored lower 
than 36, we could use scoring lower than 36 as a criterion for recovery for adult patients. 
The original CBT study with adolescent CFS patients used a criterion of scoring lower than 
35.7 on the CIS subscale fatigue.11 This is a more strict criterion than the one used in adult 
patients, as a score of 35.7 represents the mean plus one standard deviation of a healthy 
adolescent control group.11 We used this cut-off score as a criterion for recovery for 
adolescent patients.    
Sixty three adult patients (66%) had a CIS score lower than 36 at post-treatment and were 
considered recovered; the remaining 33 patients formed the non-recovered adult group. Of 
the 32 adolescents, 21 (66%) scored lower than 35.7 and were considered recovered, 11 did 
not recover. In the analysis, the effect of CBT on pain for recovered and non-recovered 
patients was compared. For the adolescent study, there were also data available from a 
waiting list control group. We did an additional analysis in which the effect of CBT on pain 
symptoms was compared with the waiting list condition.  
 
Assessment  
Fatigue The CIS subscale fatigue severity indicates the level of fatigue experienced over 
the past two weeks. The CIS consists of eight items on a 7-point scale. The score can range 
between 8 and 56. The CIS has been validated and is reliable.2 11 19  
Pain Adolescent and adult patients rated their pain on a daily self-observation list four 
times a day during a period of 12 days, on a scale ranging from 0 (no pain) to 4 (very severe 
pain). The daily pain score could range between 0 and 16, and the total 12 daily pain scores 
were averaged into one daily observed pain (DOP) score. The DOP score was compared 
with the scores of a reference group of 90 healthy people, consisting of 35 men and 55 
women (mean age= 37.1, SD= 10.9) who participated as healthy controls in previous 
studies. Their mean DOP score is 1.0 (SD= 1.3).  
Adult patients also completed the McGill Pain Questionnaire (MPQ).20 21 The MPQ 
included a whole body outline to indicate the distribution of pain.    
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To determine the frequency of CDC pain symptoms at baseline, both adolescent and adult 
patients filled in a questionnaire where they had to report on a four-point scale how often 
during the last 6 months they had experienced muscle pain, headache, multi-joint pain and 
sore throat. Scores on each of the four items ranged from 1 to 4 (1= never, 2= several times 
a month, 3= several times a week, 4= every day).   
Physical activity Physical activity level was measured in adolescent and adult patients at 
baseline with an actometer, a motion-sensing device worn at the ankle that quantifies 
physical activity. The actometer detects movements of the leg (e.g. during walking or 
climbing stairs). The actometer was worn 12 consecutive days and nights. A general 
physical activity score that expressed the mean activity level over this period in the mean 
number of accelerations per 5-min interval was calculated.22 Research has shown that the 
actometer yields highly reliable data and is a valid instrument for measuring physical 
activity.23   
Negative affectivity Negative affectivity was operationalised as the level of depressive 
symptoms. This was assessed only in adults with the subscale depression of the SCL90.24   
Body consciousness The subscale private body consciousness of the Body Consciousness 
Questionnaire was used to measure the tendency of adolescent and adult patients to focus 
on bodily symptoms. This subscale has five items that can be answered on a scale from 0 
(extremely uncharacteristic) to 4 (extremely characteristic). It has been used before in 
studies of CFS patients.25 
There were two assessments, one at baseline and one directly following termination of the 
treatment. At each assessment the patient visited the hospital twice in a period of 2 weeks. 
During the first visit, the patient completed all the questionnaires and received the 
actometer and daily self-observation list. After 2 weeks, the patient brought the daily self-
observation list and actometer back.  
 
Intervention Adult patients received CBT for CFS according to the protocol described by 
Bleijenberg et al.26 The treatment consisted of 16 sessions over a period of 6 months and 
was aimed at changing fatigue-related cognitions and a gradual increase of activities. For 
adolescents, a protocol was designed that consisted of 10 sessions over a period of 5 
months.11 Adolescents received fewer sessions because experience has found that a positive 
outcome can be reached quicker.   
 
Statistics T-tests were used to analyse the effect of CBT on pain severity. The change in 
DOP score from baseline to post-treatment of the recovered groups was compared with the 
change in DOP score of the non-recovered groups. The differences in the percentage of 
recovered and non-recovered patients who had a DOP score within normal limits (when 
compared to healthy controls) were tested with a chi-square test. Within normal limits was 
defined as having a DOP score of 2.3 or lower (i.e. within the range of the mean plus one 
standard deviation of the controls). The same analyses with the DOP score were done when 
the total group of adolescents who received CBT was compared with the group of patients 
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from the waiting list. The differences in the percentages of recovered and non-recovered 
adult patients who report pain at the locations identified with the MPQ at baseline and post-
treatment were tested with a chi-square test. To determine the possible mechanisms of a 
change in pain, a stepwise multiple regression was performed with change in DOP score as 
dependent factor, the change in fatigue severity score, activity level, negative affectivity 
and body consciousness as predictors and the DOP score at baseline as covariate. For the 
adolescent group, the same regression was done but without the variable negative 
affectivity (no data available). For all the predictors, the differences between baseline and 
post-treatment were first tested with a pairwise t-test. To determine the predictive value of 
pain symptoms, a multiple regression analysis was performed with the change in CIS-
fatigue as dependent variable and the mean DOP score, mean activity level and CIS score at 
baseline as predictors. Finally, all regression analyses were repeated with residualised 
instead of raw change scores. Significance in all analyses was assumed at p< 0.05. 
Statistical analysis was performed using SPSS version 12.0.    
 
RESULTS 
Pain symptoms at baseline All but one of the adult patients had one or more of the four 
CDC pain symptoms. All adolescent patients had one or more CDC pain symptoms. Table 
1 shows the percentage of patients who reported at baseline that daily or several times a 
week they experienced muscle pain, headache, multi-joint pain or a sore throat.  
The percentage of adult patients with pain at a location identified with the bodily outline of 
the MPQ is shown in Table 2. Seventy-three patients (78%) reported pain in two or more 
locations. The MPQ also assesses the duration of pain complaints in five categories: <1 
year, 1–2 years, 2–3 years, 3–4 years or >4 years. In 53% of the patients, the pain 
complaints were present for more than 3 years. At baseline, 37% reported on the MPQ that 
they used pain medication. 
    
Table 1. Percentage (and number) of CFS patients with pain symptoms daily or several 
times a week 
Symptom   Adults (n=95
a) with pain Adolescents (n=32) with pain 
Muscle pain 72 %  (n=68) 60 %  (n=19) 
Headache 50 %  (n=48) 75 %  (n=24) 
Multi-joint pain 58 %  (n=55) 60 %  (n=19) 
Sore throat 17 %  (n=16) 19 %  (n=  6) 
a for one adult patient there were no data of the pain assessment available 
 
The effect of CBT on pain: comparison of recovered with non-recovered patients In 
both the adult and the adolescent CFS patients the DOP score decreased from baseline to 
post-treatment (Fig. 1). The difference in the mean change in DOP score of the recovered 
adult group (-2.01; 95% CI -2.62 to -1.39) and the non-recovered adults (-0.22; 95% CI -
0.85 to 0.41) was statistically significant (t= 3.74, d.f.= 93, p< 0.001). In the adolescent 
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study, the mean change in DOP score of recovered patients (-3.76; 95% CI -5.69 to -1.84) 
was also significantly larger than that of non-recovered patients (0.14; 95% CI –0.77 to 
1.04; t= 2.96, d.f.= 30, p= 0.006). 
0
1
2
3
4
5
6
7
baseline post-treatment
D
O
P-
sc
or
e recovered adults
non-recovered adults
recovered adolescents
non-recovered adolescents
 
Fig. 1:  Mean DOP score of adult and adolescent CFS patients before and after treatment 
  
Fourteen out of the 21 recovered adolescent CFS patients (67%) had a pain level within the 
range of healthy controls after CBT. In the non-recovered adolescent group, four out of 11 
reached this level (36%, χ2= 2.694, d.f.= 1, p= 0.10). Significantly more recovered adults 
(36/63; 57%) than non-recovered adults (3/33; 9%) reached a normal pain level (χ2= 20.73, 
d.f.=  1, p< 0.001).   
 
Table 2. Percentage (number) of adult patients at baseline with pain on locations 
identified with the MPQ 
Localisation 
 
 
Adults (n=94a) with pain 
Head 64%  (n=60) 
Neck and/or shoulders 61%  (n=57) 
Legs 56%  (n=53) 
Arms 48%  (n=45) 
Low back 34%  (n=32)    
Stomach 22%  (n=21) 
Chest 11%  (n=10) 
a for two adult patients there were no data of the MPQ at baseline available 
 
The percentage of adult CFS patients with pain in locations identified with the MPQ at 
baseline did not differ significantly between recovered and non-recovered adults. 
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Following treatment, recovered patients reported significantly less pain in neck and/or 
shoulders, legs, arms and chest compared to non-recovered patients (see Table 3). 
   
Table 3. Percentage of adult patients with pain on a specific location following CBT   
Localisation    
Recovered adults (%)  
(n=63)   
Non-recovered adults (%) 
(n=33)  χ²-value
a p-value  
Head  29% 46%   2.74  0.098 
Neck and/or shoulders 22% 55% 10.18  0.001 
Legs  22% 52%   8.50  0.004 
Arms   16% 46%   9.84  0.002 
Low back  22% 30%   0.75  0.385 
Stomach  10% 12%   0.16  0.692 
Chest    0% 18%  12.22 <0.001 
a χ²-test   
 
The effect of CBT on pain compared to a waiting list in the original adolescent study 
The original adolescent study was a randomised controlled trial in which CBT for CFS was 
compared with a waiting list condition.11 We also calculated the DOP scores for all patients 
of the original study. In case of missing data, the last observation was carried forward. The  
difference in DOP score in the CBT group (n= 35) between baseline and second assessment 
was significantly greater than in the waiting list (n= 34) condition  (-2.21, SD= 3.85 versus 
-0.36, SD= 2.19; t= -2.44, d.f.= 67, p= 0.017). Furthermore, at the second assessment there 
were significantly fewer patients in the waiting list with a pain level within the range of 
healthy controls (29%) than in the CBT condition (56%; χ2= 4.38, d.f.= 1, p= 0.04). 
 
Table 4. Change scores in scores of predictors after treatment   
 
 Adults t-value
a(d.f.)  p-value  
Δ Fatigue (CIS)   -19.7 (14.1) -13.6 (95) <0.001 
Δ Physical activity (actometer)    10.4 (21.3)    4.7 (94) <0.001 
Δ Body consciousness (BCS) -0.7 (1.8)  -4.0  (95) <0.001 
Δ Negative affectivity (SCL-90b) -6.2 (8.4)  -7.5  (95)  <0.001 
 
 Adolescents  t-value
a (d.f.)  p-value 
Δ Fatigue (CIS)   -24.3 (15.7) - 8.7 (31) <0.001 
Δ Physical activity (actometer)     10.3 (21.7)    2.5 (27)   0.019 
Δ Body consciousness (BCS)  -0.1 (1.8)       -0.5 (28)   0.780 
apairwise t-test bno data on the SCL90 available in adolescents 
 
The mechanism of  changes in pain In both adults and adolescents there was a significant 
decrease in fatigue and a significant increase in physical activity following treatment (see 
Table 4). In adults, body consciousness and negative affectivity decreased significantly. In 
adolescents, the decrease in body consciousness was not significant. A stepwise multiple 
regression with the baseline DOP score as covariate showed that the change in fatigue 
severity between baseline and post-treatment was significantly related to the decrease in the 
DOP score (see Table 5) of both adults and adolescents. The other change scores were not 
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related to the change in DOP score. We repeated the stepwise multiple regression but now 
used residualised change scores. This gave the same pattern of results. In adults the residual 
change score in fatigue was the only significant predictor of the change in pain (β= 0.61, p< 
0.001; R2 adjusted= 0.36). The residual change score in fatigue was also the only significant 
predictor of the change in pain in adolescents (β= 0.55, p= 0.002; R2 adjusted= 0.28). 
 
Table 5. Stepwise multiple regression with change in DOP score as dependent variable 
and baseline DOP score as covariate 
 
 Adults (n=95
a) Adolescents (n=28a) 
 B β B β 
Constant -2.59  -4.83  
Baseline DOP score  0.43 0.53**  0.72 0.69** 
Δ Fatigue (CIS)   0.07 0.54**  0.13 0.45** 
Not in equation     
Δ Physical activity (actometer)       
Δ Negative affectivity (SCL90)b       
Δ Body consciousness (BCS)     
R2 Adjusted 0.46   0.54  
a data of one adult and four adolescents missing b no data on the SCL90 available in adolescents ** p<0.01 
 
The predictive value of pain symptoms for treatment outcome Multiple regression 
showed that the DOP score at baseline was a significant predictor of the change in fatigue 
in adult patients (see Table 6). The regression with the residualised change in fatigue gave 
the same result (β DOP= –0.26, p= 0.011; R2= 0.06). In adolescent CFS patients, DOP did 
not predict outcome (Table 6). This was also true when the residualised change in fatigue 
was used (β DOP = -0.09, p= 0.612).  In all analyses the level of physical activity at 
baseline was not a predictor of the change in fatigue in both groups. 
 
Table 6. Prediction of change in CIS-fatigue with  DOP, CIS-fatigue and physical activity 
score at baseline   
Predictora 
 
 
Adults (n=95b) Adolescents (n=31b) 
 B   β B β 
Constant -17.64  11.62  
DOP  -1.35 -0.28** -0.34 -0.08 
CIS fatigue   0.81  0.30** 0.21  0.05 
Physical activity score   0.06  0.09 0.05  0.08 
R² adjusted 0.09  -0.09  
a multiple regression, method enter b in both groups the data of one person was missing ** P<0.01 
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DISCUSSION 
The first objective of this study was to determine if an effective treatment of CFS with CBT  
leads to a reduction of pain symptoms. It was remarkable to find that a treatment aimed at 
reducing fatigue also had an effect on pain. Patients who recovered following CBT for CFS  
reported a  reduction of pain severity. Furthermore, more recovered than non-recovered 
adults had a level of pain following treatment that is comparable to healthy controls. The 
results also showed that most adults report widespread pain before treatment and that after 
CBT the number of pain locations decreased in the recovered patients.    
The second objective of the study was to look at possible mechanisms for the decrease in 
pain. Changes in physical activity, changes in negative affectivity or changes in body 
consciousness could not explain the decrease in pain severity. Only a relationship between 
the decrease in fatigue and the decrease in pain was found. This implies that pain in CFS is 
part of the syndrome and is directly related to chronic fatigue. It would be interesting to 
look at other variables that could explain the decrease in pain (and fatigue). Perhaps not 
focussing on bodily symptoms per se, but the negative labelling of those symptoms might 
be a more important factor. The role of catastrophising pain symptoms in the perception of 
pain has been extensively studied.27 The role of catastrophising fatigue in CFS is largely 
unknown. It would be interesting to study the relationship between changes in the 
catastrophising of fatigue and pain in CFS and the reduction of these symptoms following 
CBT.   
The third objective was to investigate the predictive value of pain severity for the outcome 
of CBT for CFS. Although the amount of variance explained was modest, pain severity at 
baseline was a significant predictor: a high pain severity at the start of the treatment was 
associated with a smaller decrease in fatigue. This was not the case in the group of 
adolescent patients, possibly because of the relatively small group size in the adolescent 
study, resulting in a lack of statistical power. Alternatively, pain symptoms in adolescents 
might be different from those in adults. However, the fact that the pattern of results after 
treatment was the same in both groups speaks against the latter explanation. 
How can we understand that pain in CFS can be successfully treated with CBT and closely 
follows the decrease in fatigue while at the same time recognising that pain is a negative 
predictor of treatment outcome? A review by Cho et al28 suggests that there is a possible 
distinction between CFS and chronic widespread pain (as in fibromyalgia) with only a 
partial overlap. One could assume that if pain in CFS patients becomes more severe, these 
patients become more comparable to patients with syndromes in which the chronic 
widespread pain is the central feature (like fibromyalgia). In those cases, interventions 
exclusively aimed at the fatigue do not seem sufficient to reach recovery. This would be in 
accordance with the finding of different alterations in hypothalamic-pituitary-adrenal axis 
(HPA axis) functioning between CFS, fibromyalgia and patients meeting criteria for both 
conditions.28        
The fact that pain severity predicted therapy outcome suggests that a subset of CFS patients 
could possible benefit from additional interventions aimed at pain symptoms. A gradual 
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increase of physical activity and the reformulation of pain-related beliefs into more 
adaptive beliefs can be considered important elements of CBT for chronic pain.29 Increasing 
physical activity is already an element of CBT for CFS. Additional interventions should be 
focused on the reformulation of pain-related cognitions, e.g., the catastrophising of pain or 
fear of pain.27 
In this study, we wanted to know if a successful CBT would have an effect on pain 
symptoms. We only looked at the effect of a successful treatment of fatigue because clinical 
experience suggested that only then pain symptoms decrease. To generalise our findings to 
CBT  for CFS in general (successful or not), we had to test whether the pain reduction in 
CBT for CFS is greater than in a control group in a randomised controlled trial. The 
original adolescent study was a randomised controlled trial and a comparison of the CBT 
group with the waiting list also showed that the decrease in pain severity following CBT for 
CFS was   larger than in a non-treated control group. This confirmed the positive effect of 
CBT for CFS on pain symptoms. For adults no data were available of a controlled study 
with a no-treatment control group.       
A weakness of our study is that the role of  medication on pain symptoms could not be 
properly analysed. In the adult study, information about the type of medication and the 
dosage was missing, and for adolescent CFS patients information about  pain medication 
was lacking entirely.  
A second weakness of the study is that we did not correct the significance level for the 
number of hypotheses tested and/or the number of statistical analyses used to test the 
hypotheses. This increases the risk for type I errors. We think this is justified, as our study 
is explorative and one of the first to investigate the effect of CBT for CFS on pain. 
However, our findings have to be replicated.     
The most clinical relevant finding of the present study is that pain symptoms improve 
following CBT for CFS. A possible clinical implication is that adding interventions aimed 
at the restructuring of pain-related cognitions, especially in adult CFS patients with higher 
pain scores, may increase the percentage of patients who benefit from CBT for CFS. Future 
research will have to show if this hypothesis is correct.  
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ABSTRACT  
Background: Patients with chronic fatigue syndrome (CFS) often have concentration and 
memory problems. Neuropsychological test performance is impaired in at least a subgroup 
of patients with CFS. Cognitive behaviour therapy (CBT) for CFS leads to a reduction in  
fatigue and disabilities. 
Aim: To test the hypothesis that CBT results in a reduction of self-reported cognitive 
impairment and in an improved neuropsychological test performance.  
Methods: Data of two previous randomised controlled trials were used. One study 
compared CBT for adult patients with CFS with two control conditions. The second study 
compared CBT for adolescent patients with a waiting list condition. Self-reported cognitive 
impairment was assessed with questionnaires. Information speed was measured with simple 
and choice reaction time tasks. Adults also completed the symbol digit modalities task, a 
measure of complex attentional function.   
Results: In both studies the level of self-reported cognitive impairment decreased 
significantly more after CBT than in the control conditions. Neuropsychological test 
performance did not improve.  
Conclusions: CBT leads to a reduction in self-reported cognitive impairment, but not to 
improved neuropsychological test performance. The findings of this study support the idea 
that the distorted perception of cognitive processes is more central to CFS than actual 
cognitive performance. 
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe fatigue, lasting longer than 6 
months and leading to functional impairment. The fatigue is not the result of a known 
organic disease or ongoing exertion, and not alleviated by rest. According to the Centre for 
Disease Control definition of CFS, impaired concentration and/or memory is an  additional 
symptom criterion.1 The level of self-reported cognitive impairments in CFS is high2 and 
contributes to the social and occupational dysfunctions of patients with CFS.3   
Studies evaluating neuropsychological functioning in patients with CFS with 
neuropsychological tests yielded conflicting results.4 Reduced speed of (complex) 
information processing is the most consistently found impairment.3 5 6 However, several 
studies found no cognitive impairments7 and other studies identified a subset of patients 
with defective performance.8 9 
Fatigue-related cognitions and behaviour can perpetuate CFS.10 Several controlled trials 
have shown that cognitive behaviour therapy (CBT) aimed at these perpetuating factors 
leads to a reduction of fatigue and disabilities.11  
The first hypothesis tested was that CBT for CFS also results in a reduction of self-reported 
cognitive impairments. The second hypothesis was that the neuropsychological test 
performance of patients with CFS improves after CBT. Data of two previous CBT trials12 13  
were used to test the hypotheses. 
 
METHODS 
Patients The first study from which data were used compared the effects of CBT for adults 
with CFS with natural course and support groups12 in a multi centre randomised controlled 
trial. Assessments were done at baseline, and at 8 and 14 months. An intention-to-treat 
analysis showed  a reduction in fatigue and functional impairment after CBT. In two of the 
three participating treatment centres, neuropsychological tests were part of the assessments. 
Consequently, data from neuropsychological test performance were available for a subset 
of 233 (78 CBT; 76 natural course; 79 support group) of the total group of 278 patients. 
The mean (SD) age of this group was 36.8 (10.2) years, 182 (78%) were female and median 
illness duration was 41 months. The second study was a randomised controlled trial 
comparing CBT for adolescents with CFS13 with a waiting list condition. A total of 69 
patients were randomly assigned to the conditions. Assessments were done at baseline and 
at 5 months. The results showed a greater decrease in fatigue and functional impairment in 
the CBT group. Neuropsychological data of 67 patients were available (33 CBT; 34 waiting 
list). The mean (SD) age of the group is 15.6 (1.3) years, 59 (88%) were female and  
median illness duration was 18 months.  
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Questionnaires assessing self-reported cognitive impairments 
Checklist individual strength-concentration (CIS-conc) In both studies, the severity of 
concentration problems over the past 2 weeks was assessed with the subscale concentration 
of the checklist individual strength that consists of five items on a seven-point scale. The 
score can range between 5 and 35.3 12 13    
Sickness Impact Profile-alertness behaviour (SIP-ab) In adults, the  self observed effect of 
cognitive impairments on daily functioning was assessed with the subscale alertness 
behaviour of the sickness impact profile.14 The subscale has 10 items, each item is weighed 
and the score can range between 0 and 777. No such instrument was available for 
adolescents.  
Self-observation of cognitive impairment (SOCI) In adolescents, the frequency of cognitive 
impairments  was determined with a structured diary. Patients rated both concentration and 
memory impairment separately on a daily self-observation list four times a day for 12 days 
(0= no impairment; 1=impaired). The percentage of concentration problems and  memory 
problems (both number of assessments with a problem divided by 48 times 100) were 
added and then divided by two to calculate the mean percentage of incidents of cognitive 
impairment.  
 
Neuropsychological tests  
Reaction time task The reaction time task consisted of two subtests, simple and choice 
reaction time tasks. Both are described in detail elsewhere.8 15  In a previous study, the 
reaction times of  patients with CFS were slower than of healthy controls on both tasks.8   
Symbol Digit Modalities Task (SDMT) The SDMT16 was used in the adult study as a 
measure of  complex attention. In previous studies CFS patients scored lower than a 
matched healthy control group.8 9   
 
Statistical analysis Statistical analysis was performed using SPSS V.12.01. Significance 
was assumed at p<0.05.  A multivariate analysis of variance was performed with self-
reported cognitive impairment and reaction time as dependent variables and treatment as 
fixed factor.  Univariate tests and post hoc analysis are reported if the multivariate test was 
significant. For the SDMT, a  univariate analysis was performed, as data were available for 
a subset of 174 patients as  the SDMT was added later to the test battery. In the adult study, 
the dependent variables were the change scores at 14 months from baseline and in the 
adolescent study, it was at 5 months from baseline. Reaction times were transformed by a 
logarithm transformation. For adults, if data at 14 months were missing and data 8-months 
post-treatment were available, the second were used. In all other cases, missing data were 
replaced with estimates derived by single imputation (missing variable analysis regression 
in SPSS with baseline value as predictor). For significant treatment effects, effect sizes 
were calculated.  
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RESULTS 
Nineteen adult patients (8%) had missing CIS-conc and SIP-ab post-treatment data. One 
patient had missing data on both reaction time tasks at baseline,  for 44 (19%) patients only 
baseline data were available and for 30 (17%) patients only a baseline SDMT score was 
available.  
Two  adolescent patients had no SOCI scores at baseline. For 4 (6%) patients the CIS-conc 
and SOCI at second assessment were missing. Two patients had no baseline reaction times  
and  for 13 (20%) adolescents the reaction times at the second assessment were missing.  
In both studies, there were more data missing from neuropsychological tests than from 
questionnaires because some patients were willing to mail the questionnaires, but refused to 
undergo a  second neuropsychological assessment.  
   
Self reported cognitive impairments 
Adults The multivariate test (Pillai’s trace) showed a significant change in self-reported 
cognitive impairments (F(4,460)= 4.76; p= 0.001). The univariate tests showed a significant 
effect of treatment on the change in CIS-conc and SIP-ab (F(2,230)= 8.94; p< 0.001 and 
F(2,230)= 4.42; p= 0.013). Following CBT, the decrease in CIS was significantly greater than 
in both the natural course (p< 0.001) and the support group (p= 0.001; see Table 1). There 
was a significantly greater decrease in SIP-ab score following CBT compared to natural 
course (p= 0.004). The difference between CBT and  support group failed to reach 
significance (p= 0.055).   
 
Table 1. Estimated treatment effect in change score (95% CI) on the dependent variables     
Self-reported cognitive impairments 
 
 
Adults CBT Natural course Support group  
CIS-conc  -7.4 (-9.1 to -5.7)† -2.7 (-4.4 to -1.0)** -3.4 (-5.1 to -1.8)** 
SIP-ab -116 (-156 to -76)‡ -31 (-72 to -10)** -61 (-100 to -21) 
Adolescents CBT Waiting list  
CIS-conc -6.8 (-10.5 to -3.5)‡ -0.9 (-4.2 to +2.5)*  
SOCI -7.9 (-12.8 to -2.9)§ 0.9 (-4.1 to +6.0)*  
Neuropsychological test performance 
 
 
 
Adults CBT Natural course Support group 
Simple reaction time (ms)  9 (-9 to 27) -5 (-23 to 14) 6 (-12 to 24) 
Choice reaction time (ms) -24 (-51  to 3) -27 (-54 to 1)    -26 (-53 to 1) 
SDMT 2.8 (0.8 to 4.8) 2.3 (0.2 to 4.4) 4 (2 to 6) 
Adolescents CBT Waiting list  
Simple reaction time  (ms) -30 (-53 to -8) -18 (-41 to 4)  
Choice reaction time  (ms) -12 ms (-29 to 6)   -10 (-28 to 8)  
CBT, cognitive behaviour therapy; CIS-conc, checklist individual strength-concentration; SDMT, symbol digit modalities task; 
SIP-ab, sickness impact profile-alertness behaviour; SOCI, self-observation of cognitive impairment. *  significantly different 
from the CBT condition, p<0.05. **significantly different from the CBT condition, p<0.01. † Cohen’s d based on change within 
treatment condition = 1.3. ‡Cohen’s d  = 0.6. § Cohen’s d =  0.4. 
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Adolescents The multivariate test showed a significant treatment effect on self-reported 
cognitive impairments (F(2,62)= 5.03; p= 0.009). Univariate tests showed that the decrease in 
the CIS-conc and SOCI score was significantly larger in the CBT group (F(1,63)= 6.4; p= 
0.014 and F(1,63)= 6.28; p= 0.015).  
 
Neuropsychological test performance    
Adults There was no significant effect of treatment on either reaction time task (F(4, 458)= 
0.44; p= 0.783). There was no significant treatment effect on the SDMT (F(2,171)=0.73; p= 
0.484).  
Adolescents Multivariate tests showed no significant treatment effect on either reaction time 
task  (F(2,62)= 0.34; p= 0.714).  
 
DISCUSSION 
The hypothesis that self-reported cognitive impairments decrease after CBT in patients with 
CFS was confirmed. Only one comparison in the adult study, measuring cognitive 
impairments more indirectly, showed an effect in the expected direction without reaching 
significance. The results of the original adolescent study13 already indicated that 
concentration problems decrease after CBT. In that study,  the concentration problems were 
assessed with a single item evaluating these problems retrospectively over a period of 6 
months. This assessment can be easily influenced by situational circumstances and memory 
biases, which can be prevented by the use of a diary as in the present study. No support 
could be found for the hypothesis that neuropsychological test performance improves after 
CBT.  
A methodological problem  is that in a substantial part of the patients the 
neuropsychological data of the second assessment were missing. Furthermore, in our 
analysis  we assumed that drop out occurred at random, whereas patients may drop out for 
non-random reasons. We repeated the analyses, but only on the patients who completed 
both assessments. Again, there was no significant treatment effect. Our interpretation is that 
this  indicates that improvement in self-reported cognitive impairments after CBT is 
independent of the change in neuropsychological test performance.   
A discrepancy between subjectively reported disabilities versus objectively measured 
performance is not limited to the current study. Mahurin et al17 found that the objective 
cognitive functioning of monozygotic twins discordant for CFS did not differ, whereas the 
twin with CFS reported more cognitive impairments. Metzger and Denney18 showed that 
patients with CFS  underestimated their cognitive performance. In the study of Vercoulen et 
al8 most patients with CFS reported concentration and memory problems, whereas only a 
small percentage showed an impaired performance. Given the fact that patients with CFS 
perceive their cognitive processes as impaired but underestimate their actual performance, 
one would expect that an effective treatment of CFS would lead to a more accurate 
perception of one’s performance. The results of the present study are consistent  with this 
prediction. CBT resulted in a decreased complaints about cognitive functioning, but not in a 
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change in performance. This is also in line with the hypothesis that a distorted perception of 
symptoms and performance is a crucial element of CFS.10 
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ABSTRACT  
Background: The primary objective was to develop an adjective checklist, the Fatigue 
Quality List (FQL), aimed at assessing different perceptions of fatigue. 
Methods: 961 participants filled out the FQL (28 adjectives). A component and 
confirmatory factor analyses were performed and psychometric properties were evaluated. 
Differences on factor scores between different patients’ groups were investigated and pre- 
and post treatment scores were compared in demonstrating change of perceptions after 
treatment of fatigue. 
Results: Four independent factors were found with adequate psychometric properties. 
Different perceptions were found between the patients’ groups. Patients who were 
recovered after treatment for fatigue showed similar scores on the factors as healthy 
controls. 
Conclusion: The FQL appears to be a promising tool in measuring different perceptions of 
fatigue, which can be especially interesting for clinical practice. 
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INTRODUCTION 
What is meant by fatigue? Most people are familiar with the experience of fatigue, but the 
meaning of this sensation can differ between people and even within one person the 
meaning of fatigue can change. Therefore, fatigue can be defined in different ways and 
there is no ‘gold standard’. Healthy people would characterise fatigue as a pleasant, acute, 
normal and regulating phenomenon after exercise or a busy day, disappearing after a good 
night’s sleep or a period of rest. However, fatigue can also have a more negative 
connotation as in fatigue experienced by patients with a health problem. To them fatigue 
can be a chronic, disabling and life- and activity-limiting experience.1-6  
There are also differences in the factors underlying fatigue severity between patients with 
different somatic conditions. Processes involved in the experience of fatigue in patients 
with chronic fatigue syndrome (CFS) are clearly different from processes related to the 
experience of fatigue in patients with multiple sclerosis (MS)2 and there are many 
differences between severely fatigued breast cancer survivors and females with CFS.7  
Because fatigue is not clearly defined, poor communication regarding fatigue exist in the 
clinical practice.8 Additionally, health care professionals find consultations on fatigue 
difficult and are often dissatisfied with or uncertain about the care they provide to patients 
with fatigue complaints.9 10 Without appropriate assessment, recognition and providing the 
proper management to patients with chronic fatigue is difficult. The first necessary step 
towards improving recognition and management is a thorough understanding of the 
symptom. 
Until now fatigue scales are mostly used to measure fatigue severity.11 However, fatigue 
severity does not reflect a persons’ perception and appraisal of the fatigue. Therefore, the 
quantitative way of assessing fatigue fails to capture the nuances and differences in the 
experience of fatigue. In pain research assessment methods already exists in determining 
the quality of pain in a patient by using adjectives.12 13 
In this study an adjective checklist, the Fatigue Quality List (FQL), was constructed aimed 
at assessing different perceptions of fatigue. The development of the FQL was described 
and additionally three research questions were investigated: 
1. Is the FQL a reliable and valid instrument to assess different perceptions of 
fatigue? 
2. Are perceptions of fatigue different between several patient groups with and 
without chronic fatigue complaints and healthy controls? 
3. Do perceptions of fatigue change in patients who recover after treatment for 
fatigue? 
 
METHODS 
Materials 
The Fatigue Quality List Researchers and clinicians working at the Expert Centre Chronic 
Fatigue of the Radboud University Nijmegen Medical Centre made a large list of all 
possible adjectives that can be used to characterize the feeling of fatigue. The FQL was 
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developed by asking researchers and health care professionals working with patients with 
unexplained fatigue complaints to indicate on this large list which of the adjectives best 
fitted with the experience of the fatigue described by their patients. The final list consisted 
of 28 adjectives most frequently mentioned by the raters.   
In filling out the FQL, subjects are instructed to mark with a cross which of the 28 
adjectives fit their experienced fatigue. Multiple answers are possible. In this study the 
Dutch version of the FQL was used. However, the adjectives were translated into English 
by a back-translation procedure. 
Fatigue severity was measured by a subscale of the checklist individual strength (CIS-
fatigue) consisting of 8 items.14  Each item was scored on a 7-point Likert scale. High 
scores indicated a high level of fatigue severity. Based on research with CFS patients, a 
score of 35 or higher on the subscale fatigue severity indicated severe feelings of fatigue. 
Furthermore, the CIS has excellent psychometric properties.1 11 
 
Patients Nine-hundred-sixty-one participants with a mean age of 43.6 years (SD= 10.2, 
range 18-79) predominantly female (65%) filled out the FQL. All were either patients or 
healthy controls participating in scientific studies conducted by the Expert Centre Chronic 
Fatigue. The total group consisted of: 
- 219 cancer survivors. Hundred-twenty-eight (mean age 44.8, SD= 8.9; female 72%) 
experienced severe chronic fatigue and 91 (mean age 46.5, SD= 6.3; female 100%) 
were not fatigued.3 Forty-one of these cancer survivors were participating in a 
randomised control trial about the effectiveness of cognitive behaviour therapy (CBT) 
especially designed to reduce chronic fatigue in cancer survivors.15 These patients filled 
out the FQL at pre- and post treatment. 
- 160 patients who were diagnosed with CFS, according to the CDC criteria (mean age 
38.0, SD= 10.7; female 69%).4 16 Eighty-two CFS patients who were included in this 
study were treated for their chronic fatigue complaints with CBT.4 These patients filled 
out the FQL two times, at pre- and post treatment.  
- 151 employees on sick leave with unexplained fatigue complaints (mean age 44.0, SD= 
8.4; female 55%).17 Sixty-six (44%) of these met research criteria for CFS (mean age 
42.9,  SD= 8.6;  female 61%). 
- 276 patients with various neuromuscular disorders. Hundred-sixty-five experienced 
severe fatigue (mean age 42.2, SD= 10.6; female 48%) and 120 experienced no fatigue 
complaints (mean age 42.2,  SD= 11.3; female 48%).5 18 
- 77 patients who were diagnosed with pancreatitis. Fifty-three experienced severe 
fatigue (mean age 49.3,  SD= 10.0; female 47%) and 24 were not fatigued (mean age 
50.2,  SD= 15.5; female 58%). 
- 78 healthy persons who experienced no fatigue complaints (mean age 48.2,  SD= 6.2; 
female 100%).3  
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Statistical analysis Data analysis was performed using SPSS (version 12.0.1). The total 
participant group was randomly divided into two groups. A principal component factor 
analysis was performed in the first group to identify independent factors. A varimax 
rotation was used to facilitate the interpretation. Furthermore, factor loadings had to be 
above .40 with a .10 or greater difference in loadings with the other factors. The scree test 
and the eigenvalues (above 1) were used to identify the number of factors. The factor model 
was then tested in the second group by using confirmatory factor analyses / AMOS 5.0 
(Comparative Fit Index, Goodness of Fit Index, Adjusted Goodness of Fit Index).19 20  
The internal consistency reliability for each factor was calculated using Cronbach’s alpha. 
Spearman’s rho correlations were used to evaluate psychometric properties of the FQL. To 
investigate the differences between the groups of patients Kruskal-Wallis tests were 
performed. When the Kruskal-Wallis test was significant, Mann-Whitney-U tests between 
the groups followed. The sensitivity to change of the FQL was demonstrated by comparing 
cancer survivors and CFS patients at pre- and post treatment assessment, using the 
Wilcoxon Signed Ranks Test of matched pairs. To correct for the multiple comparisons, p-
value was set on < 0.01. 
 
RESULTS 
Factor solution Three of the 28 adjectives were marked with a cross for less than 10% and 
therefore excluded from further analyses. Final analyses were done with the remaining 25 
adjectives. Table 1 presents the final factor solution in the first group (n= 476). Seven 
adjectives were excluded of factor analysis because factor loadings were < .40 and/or <.10 
difference in loadings with the other factors. Both the scree test and eigenvalues indicated a 
4-factor solution (Table 2). Factor 1 consisted of 5 adjectives, factor 2 of 4 adjectives, 
factor 3 of 5 adjectives and factor 4 of 4 adjectives, explaining respectively, 24%, 9%, 6%, 
5% of the variance prior to rotation. After rotation the four factors explained respectively, 
13%, 12%, 10% and 9% of the variance. Factor 1 was labelled as ‘Frustrating’, Factor 2 as 
‘Exhausting’, Factor 3 as ‘Pleasant’ and Factor 4 as ‘Frightening’. This four factor model 
was then tested in the second group (n=485) by using confirmatory factor analysis. The fit 
indices indicated an adequate fit. Chi-square (129, n= 485) = 364.5, p < 0.001; Comparative 
Fit Index = .87; Goodness of Fit Index = .92; Adjusted Goodness of Fit Index = .90.  
The four factors were recoded on a 0 to 100 scale, facilitating comparisons between the 
factors. Higher scores indicate a higher appraisal of the fatigue experience as frustrating, 
exhausting, pleasant and frightening. The final version of the FQL and the criteria for 
scoring are presented in appendix A.   
 
Is the FQL a reliable and valid instrument to assess different perceptions of fatigue? 
For each factor the internal consistency reliability was calculated in the entire sample of 
961 participants, which demonstrated moderate to adequate internal consistencies for all 
four factors, ranging from .57 to .79 (Table 1).  
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Table 1. Final factor solution: principal-components analysis with varimax-rotation in 
the first group. Cronbach’s Alpha of the four factors 
 
 
Frustrating Exhausting Pleasant Frightening 
Discouraging 0.735    
Incessant 0.585    
Annoying 0.680    
Persistent 0.559    
Frustrating  0.704    
     
Exhausting  0.690   
Wearisome   0.537   
Extreme   0.724   
Unbearable  0.509   
     
Temporary   0.400  
Relaxing   0.661  
Fulfilling   0.713  
Normal   0.522  
Pleasant    0.792  
     
Upsetting    0.727 
Frightening    0.618 
Inexplicable    0.490 
Insuperable     0.444 
     
Cronbach’s Alpha 0.79 0.68 0.61 0.57 
Three adjectives were excluded of factor analysis because they were marked with a cross for less than 10%: Protective, 
Soothing, Threatening. Seven adjectives were excluded of factor analysis because factor loadings <.40 and/or <.10 difference 
in loadings with the other factors: Demanding, Paralysing, Aggravating, Compelling, Treacherous, Insoluble, Acceptable 
 
Supporting convergent validity we found that all four factors were statistically significant 
related to fatigue severity (CIS-fatigue) (Table 3).  
In calculating general psychometric properties statistically significant intercorrelations 
between the four factors were found (Table 3). Additionally, low correlations were found 
between the four factors and age and gender, explaining less than 3% of the variance. 
 
Table 2. Principal-components analysis with varimax-rotation, initial eigenvalues 
Component Eigenvalues Component Eigenvalues 
 
 
1 4.788 10 0.664 
2 1.906 11 0.623 
3 1.285 12 0.593 
4 1.176 13 0.568 
5 0.984 14 0.514 
6 0.875 15 0.503 
7 0.813 16 0.445 
8 0.742 17 0.428 
9 0.714 18 0.380 
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Table 3. Convergent validity of the 4 factors. Spearman’s rho correlation in total group 
(N= 961) 
Factor  
 
 
Frustrating Exhausting Pleasant Frightening 
Fatigue Severity 0.66* 0.58* -0.54* 0.43* 
Exhausting 0.54*    
Pleasant -0.48* -0.35*   
Frightening 0.49* 0.42* -0.25*  
Age -0.16* -0.14* 0.05 -0.03 
Gender (1=M, 2=F) -0.09* 0.03 0.11* -0.10* 
* p < 0.01     
 
Are the perceptions of fatigue different between several patient groups with and 
without chronic fatigue complaints and healthy controls? The non-fatigued groups 
scored significantly lower on Frustrating, Exhausting and Frightening and significantly 
higher on Pleasant compared with the fatigued groups (Table 4). The following analyses 
were performed separately in the fatigued groups and the non-fatigued groups. 
Frustrating The non-fatigued groups were similar with respect to the mean scores on 
Frustrating (p= 0.757). Patients with CFS and employees with unexplained fatigue scored 
significantly higher on Frustrating with respect to the other fatigued groups. 
 
Table 4. Mean score on 4 factors: comparisons between fatigued disease-free cancer 
patients, CFS patients, employees with unexplained fatigue, fatigued patients with 
neuromuscular disease, fatigued patients with pancreatitis, non-fatigued disease-free 
cancer patients, non-fatigued patients with neuromuscular disease, non-fatigued patients 
with pancreatitis and healthy persons 
 
 
Frustrating Exhausting Pleasant Frightening 
A Fatigued disease-free cancer patients 48.6 (30.9)b,c 29.3 (28.6)b,d 11.7 (17.7)b,c 22.7 (24.2)d,e 
B CFS  58.5 (32.2)a,d,e 37.8 (31.5)a,c,d,e 6.6 (13.0)a,c,d 25.2 (25.9)d,e 
C Employees with unexplained fatigue 63.7 (29.2)a,d,e 29.5 (28.1)b,d 4.3 (11.2)a,b,d,e 26.0 (26.6)d,e 
D Fatigued patients with neuro-
muscular disease 
41.8 (32.6)b,c 17.8 (24.8)a,b,c 13.6 (18.5)b,c 13.8 (20.1)a,b,c 
E Fatigued patients with pancreatitis 41.1 (33.1)b,c 25.9 (29.8)b 9.1 (13.9)c 14.2 (22.7)a,b,c 
F Non-fatigued disease-free cancer 
patients 
8.1 (16.3) 6.6 (14.4)g 38.9 (28.3)g 7.7 (17.0) 
G Non fatigued patients with 
neuromuscular disease 
9.0 (16.2) 1.7 (7.1)f,h 24.7 (21.3)f,i 5.6 (13.9) 
H Non-fatigued patients with 
pancreatitis 
13.3 (28.1) 9.4 (17.8)g 29.2(23.6) 5.2 (12.7) 
I Healthy persons 7.7 (18.3) 3.9 (13.4) 36.2 (23.3)g 3.2 (10.2) 
a. significantly different from group A, Mann-Whitney test p<0.01 b. significantly different from group B, Mann-Whitney test 
p<0.01 c. significantly different from group C, Mann-Whitney test p<0.01 d. significantly different from group D, Mann-
Whitney test p<0.01 e. significantly different from group E, Mann-Whitney test p<0.01 f. significantly different from group F, 
Mann-Whitney test p<0.01 g. significantly different from group G, Mann-Whitney test p<0.01 h. significantly different from 
group H, Mann-Whitney test p<0.01 i. significantly different from group I, Mann-Whitney test p<0.01 
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Exhausting The non-fatigued patients with various neuromuscular disorders scored 
significantly lower on Exhausting than the non-fatigued cancer survivors and the non-
fatigued patients with pancreatitis. Between the fatigued groups, CFS patients scored 
significantly higher on Exhausting than the other groups. Furthermore, fatigued patients 
with pancreatitis scored significantly lower with respect to fatigued cancer survivors and 
employees with unexplained fatigue. Additionally, patients with neuromuscular disorders 
scored significantly lower than employees with unexplained fatigue. 
Pleasant In the non-fatigued group patients with various neuromuscular disorders scored 
significantly lower on Pleasant than non-fatigued cancer survivors and healthy persons. In 
the fatigued group employees with unexplained fatigue scored significantly lower on 
Pleasant than the other groups. CFS patients scored significantly lower than cancer 
survivors and patients with neuromuscular disorders. 
Frightening The scores on Frightening in the non-fatigued groups were similar. In the 
fatigued groups a dichotomy was found between the patients with unexplained fatigue with 
and without a chronic disease. Fatigued patients without a chronic disease (cancer 
survivors, CFS patients and employees) scored significantly higher on Frightening than 
fatigued patients with a chronic disease (patients with a neuromuscular disorder or 
pancreatitis). 
 
Do perceptions of fatigue change in patients who recover after treatment for fatigue? 
Forty-one fatigued cancer survivors and eighty-two CFS patients were treated for their 
fatigue complaints with CBT at our department and filled out the FQL at pre- and post 
Table 5. Comparison of pre- and post treatment scores on the four factors. Comparison 
of the post treatment scores with those of healthy individuals 
   Frustrating Exhausting Pleasant Frightening 
 Cancer survivors 
pre 52.6 (27.8) 27.8 (24.4) 11.1 (14.0) 22.2 (23.3) 
A Non fatigued after CBT (n=27) 
post 11.9 (23.0)* 5.6 (20.0)* 36.3 (25.4)* 6.5 (11.2)* 
pre 67.1 (27.9) 46.4 (30.8) 8.6 (17.0) 19.6 (24.4) 
B Still fatigued after CBT (n=14) 
post 58.6 (34.6) 33.9 (38.7) 7.1 (12.7) 12.5 (19.0) 
 Chronic Fatigue Syndrome Patients 
pre 60.4 (26.5) 42.0 (31.8) 4.7 (8.6) 20.2 (22.5) 
C Non fatigued after CBT (n=47) 
post 11.1 (18.1)* 3.2 ( 8.4)* 32.3 (30.5)* 5.9 (11.9)* 
pre 57.7 (30.6) 44.3 (35.9) 5.1 (11.2) 24.3 (24.6) 
D Still fatigued after CBT (n=35) 
post 45.1 (31.2) 30.0 (33.1) 9.1 (17.0) 12.9 (15.3)* 
 Healthy individuals   7.7 (18.3)b,d 3.9 (13.4)b,d 36.2 (23.3)b,d 3.2 (10.2)b,d 
CBT = cognitive behaviour therapy * significant difference between pre- and post treatment scores, Wilcoxon signed rank test 
p<0.01 a. significantly different from post treatment scores of group A, Mann-Whitney-U test p<0.01 b. significantly different 
from post treatment scores of group B, Mann-Whitney-U test p< 0.01 c. significantly different from post treatment scores of 
group C, Mann-Whitney-U test p< 0.01 d. significantly different from post treatment scores of group D, Mann-Whitney-U test 
p< 0.01  
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treatment. Sensitivity to change of the FQL was demonstrated by dividing the CFS patients 
and the cancer survivors into two groups: patients who were completely recovered after 
CBT (CIS-fatigue < 35) and patients who remained fatigued after CBT (CIS-fatigue >=35). 
Baseline scores on the four factors were not significantly different between patients who 
recovered and patients who remained fatigued. The scores on the four factors at pre- and 
post treatment were compared. Additionally, we compared the post treatment scores on the 
four factors with the scores of healthy individuals (Table 5). Cancer survivors who were 
completely recovered after CBT (n= 27) showed a significant decrease on the factors 
Frustrating, Exhausting and Frightening and a significant increase on the factor Pleasant. 
The post-treatment scores were not significantly different from those of healthy individuals. 
In contrast, the cancer survivors who still remained fatigued after CBT (n=14) did not show 
a change in the scores on the four factors from pre- to post treatment. Furthermore, their 
scores at post treatment were significantly different from the scores of healthy individuals. 
In investigating CFS patients who recovered after CBT (n= 47) the same pattern was found. 
They also decreased significantly on the factors Frustrating, Exhausting and Frightening 
and increased significantly on the factor Pleasant. The scores at post treatment were not 
significantly different from those of healthy individuals. CFS patients who were not 
recovered after CBT (n= 35) showed no change between pre- and post treatment scores on 
the factors Frustrating, Exhausting and Pleasant. Although a significant decrease was seen 
on the factor Frightening, the post treatment scores of the four factors were significantly 
different form those of healthy individuals. 
 
DISCUSSION 
The present study shows that the FQL provides a self report instrument that assesses the 
perceptions of fatigue. The FQL consists of four coherent factors, namely Frustrating, 
Exhausting, Pleasant and Frightening. The stable pattern of these factors was indicated with 
a confirmatory factor analyses, revealing an invariant internal structure in a second group of 
patients. Furthermore, the data of this study show that the FQL has adequate psychometric 
properties. Both the intercorrelations and the correlations of the four factors with the 
subscale CIS-fatigue were not to the extent that the factors could be seen as a parallel test, 
thus supporting the relative uniqueness of each factor. 
The assumption that fatigue is experienced differently by everybody is confirmed with the 
data of this study. Severely fatigued patients had different perceptions of fatigue compared 
to healthy individuals. The healthy persons described fatigue as temporary, relaxing, 
fulfilling, normal and pleasant. None of these adjectives were chosen by 70% of the 
severely fatigued patients. Even patients with similar fatigue severity, appreciated fatigued 
differently. Different patterns were seen on the four factors of the FQL between the 
different populations of patients experiencing fatigue. CFS patients and severely fatigued 
employees had the highest score on the factors Frustrating, Exhausting and Frightening and 
also the lowest score on the factor Pleasant in contrast with the other fatigued groups. Until 
now the underlying aetiology of CFS still remains unclear.21 22 Because the patients can not 
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attribute their fatigue to a distinct cause, it’s possible that they are more focussed on their 
fatigue and perceive their fatigue in a more negative way than the other groups. In 
agreement with this finding, Moss-Morris et al23 found that CFS patients had a more 
negative view about their symptoms than patients with Rheumatoid arthritis (RA). 
Additionally, Taillefer et al24 found higher levels of illness worry in CFS patients than MS 
patients who were fatigued. Results of the FQL also showed that patients with a current 
chronic disease experience their fatigue as less frightening than patients with no current or a 
past disease. It is possible that these patients attribute their fatigue to their illness and 
therefore perceive it as less frightening. Cancer survivors may experience fatigue as highly 
anxiety provoking because they can see fatigue as a symptom for disease-recurrence. 
Therefore fatigue can be labelled as frightening.25 Future research is necessary to examine 
if the FQL is applicable for individual assessment and furthermore investigate what the 
effect of these different perceptions is on the management of fatigue complaints in the 
clinical practice. 
To reach recovery not only a decrease in fatigue severity is important, it is also important 
that a change in the evaluation of fatigue in the patient occurs. As fatigue is also a part of 
normal health, being recovered also includes feeling tired sometimes. This makes it 
difficult to decide where experiencing fatigue as a sign of illness ends and the experience of 
normal health surfaces. During CBT patients learn that fatigue may occur as part of normal 
healthy life. When a decrease is seen in the fatigue severity of a patient and the evaluation 
of the fatigue stays negative, it implicates that a patients still suffers and is disabled due to 
the fatigue. The patient cannot be seen as fully recovered.26 The results of this study 
showed that the FQL can demonstrate change in fatigue perceptions following treatment of 
fatigue. Patients who were recovered after CBT had the same scores on all four factors 
compared to healthy persons. So, not only the fatigue severity changed after therapy but 
also the evaluation of fatigue. The FQL can therefore be a helpful tool to define full 
recovery in the clinical practice. 
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Appendix A 
 
FATIGUE QUALITY LIST - FQL 
 
Fatigue can be described in different ways. The adjectives below can be seen as descriptions of fatigue.  
 
Please indicate which adjectives accurately describe the fatigue you experienced during the last two weeks by 
marking them with a cross.   
 
Upsetting Persistent 
Discouraging Frustrating 
Temporary Relaxing 
Exhausting Inexplicable 
Incessant Fulfilling 
Wearisome insuperable 
Frightening Unbearable 
Annoying Normal 
Extreme Pleasant 
  
Scoring FQL 
The scoring for the adjectives is:  
 20 25   
Discouraging  Upsetting 
Temporary  Exhausting 
Incessant Wearisome 
Annoying Frightening 
Persistent Extreme 
Frustrating Inexplicable 
Relaxing  Insuperable 
Fulfilling Unbearable 
Normal 
Pleasant 
 
 
Subsequently the four factors are calculated by summing the respective items (0-100): 
 
Factor 1: Frustrating adjectives: discouraging, incessant, annoying, persistent, frustrating 
Factor 2: Exhausting adjectives: exhausting, wearisome, extreme, unbearable  
Factor 3: Pleasant adjectives: temporary, relaxing, fulfilling, normal, pleasant 
Factor 4: Frightening adjectives: upsetting, frightening, inexplicable, insuperable 
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Is a full recovery possible after cognitive behavioural therapy for 
chronic fatigue syndrome?  
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ABSTRACT  
Background: Cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) 
leads to a decrease in symptoms and disabilities. There is controversy about the nature of 
the change following treatment; some suggest that patients improve by learning to adapt to 
a chronic condition, others think that recovery is possible. The objective of this study was 
to find out whether recovery from CFS is possible after CBT.  
Methods: The outcome of a cohort of 96 patients treated for CFS with CBT was studied. 
The definition of recovery was based on the absence of the criteria for CFS set up by the 
Center for Disease Control (CDC), but also took into account the perception of the patients’ 
fatigue and their own health. Data from healthy population norms were used in calculating 
conservative thresholds for recovery.  
Results: After treatment, 69% of the patients no longer met the CDC criteria for CFS. The 
percentage of recovered patients depended on the criteria used for recovery. Using the most 
comprehensive definition of recovery, 23% of the patients fully recovered. Fewer patients 
with a co-morbid medical condition recovered.  
Conclusion: Significant improvement following CBT is probable and a full recovery is 
possible. Sharing this information with patients can raise the expectations of the treatment, 
which may enhance outcomes without raising false hopes. 
 
 
Recovery after CBT for CFS 
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INTRODUCTION 
Between 50 and 70% of the patients show a significant reduction of symptoms and 
disabilities after cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS).1 2 
The nature of this improvement is uncertain. Some suggest that patients improve by 
adapting better to a chronic condition, while others think that recovery is possible.3 This 
debate shows some similarities to the issue of recovery from mood disorders.4 5 
The attitude of the therapist towards the treatment goals will affect the expectations and 
perceptions of the patient. If learning to cope with CFS is the jointly agreed maximal goal 
of treatment, patients will engage with treatment accordingly. If the therapist suggests that 
recovery is possible, the patient expectations are raised, which in turn may lead to a change 
in the perception of symptoms as well as disability. This is also the essence of the placebo 
response. The placebo response of CFS patients to psychological interventions is lower than 
that related to biomedical interventions and lower than that expected in other medical 
conditions6, suggesting that CFS patients are sceptical of psychological interventions. Since 
the communication of the aim of a treatment is an intervention that can facilitate change7, 
the controversy about the nature of improvement is clinically important. 
To find out the tenable goal of therapy –  adaptation or recovery – a definition of recovery 
is needed that can be operationalized and measured. We propose that a definition is used 
that closely follows the Center for Disease Control (CDC) criteria for CFS.8 Two key 
elements of the CDC criteria are that a patient is severely fatigued and disabled. Recovery 
then implies that the patient’s level of fatigue is within the range of healthy controls. We 
propose operationalizing this criterion as scoring within the range of the mean plus (or 
minus) 1 standard deviation (SD) of the healthy population. 
A second aspect of recovery is that a patient will no longer be disabled. This means that 
patients have no physical disabilities – an often used criterion in CFS – and no disabilities 
in any other domains of functioning. Again, we propose scoring within the range of the 
mean plus 1 SD of the healthy population as the criterion for recovery. Although patients 
who are no longer abnormally fatigued or disabled do not meet the CDC criteria for CFS, 
having a ‘normal’ level of fatigue and not being disabled is a more satisfactory definition of 
recovery. 
For complete recovery the perception of the patient also has to change. The patient has to 
perceive his fatigue and functioning as both normal and comparable to healthy people. 
Finally, a comprehensive definition combines changes in fatigue, disability and perception. 
The objective of this study was to find out whether recovery is possible after CBT. For this, 
we collected data from a cohort of patients treated with CBT. For comparison we used 
healthy population norms. By doing this, we assumed that CFS was the only health problem 
of the patients. However, it is possible that the patient had another medical condition beside 
CFS, causing disability. Therefore, we measured the confounding effect of co-morbid 
medical conditions on the outcome. 
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METHODS 
Subjects All consecutive patients with CFS that were treated with CBT at the Radboud 
University Nijmegen Medical Centre between September 2003 and May 2005 were eligible 
for the study if they met the following inclusion criteria: 
1. CDC criteria for CFS8; 
2. severely fatigued and functionally impaired, defined by a cut-off score of 35 or 
higher on the fatigue severity subscale of the Checklist Individual Strength (CIS-
fatigue)9 and a weighted score of 700 or higher on the Sickness Impact Profile 
(SIP) scale10; 
3. completed the pre- and post-treatment assessment. 
If a medical co-morbidity was present which could not explain the fatigue, it was registered 
for further analyses. 
 
Intervention All patients received CBT for CFS according to a protocol described 
elsewhere.11 
 
Assessment The assessment was part of the clinical routine and performed by research 
assistants not involved in the treatment. 
Self-Reported Improvement Self-rated improvement was measured after treatment by one 
question: patients indicated whether they had no symptoms, significantly fewer symptoms, 
the same complaints or whether the symptoms had become worse.12 
Fatigue The different definitions of recovery are summarized in Table 1. The CIS-fatigue 
indicates the level of experienced fatigue over the past 2-week period and consists of 8 
items on a 7-point scale. The score can range between 8 and 56.9 A normal group of 53 
healthy adults with a mean age of 37.1 (SD= 11.5) has a mean score on the CIS-fatigue of 
17.3 (SD= 10.1). Using this as a reference for the CBT group, there resulted a threshold 
score of 27, the mean plus 1 SD.13 
Disabilities Physical disabilities were measured with the ‘physical functioning’ subscale of 
the Medical Outcomes Survey Short Form-36 (SF-36).14 15 The scores range from 0 
(maximum physical limitations) to 100 (ability to do vigorous activity). Healthy adults 
without a chronic condition16 were used as a norm group, with a mean score of 93.1 (SD= 
11.7). A patient had to score 80 or higher to be considered as recovered. 
Social functioning was measured with the subscale ‘social functioning’ of the SF-36, 
ranging between 0 (no social activities) and 100 (normal participation in social activities). 
Using the same criterion and reference group as above resulted in a threshold score for 
recovery of 75 or higher. 
The SIP measures functional disability in ambulation, home management, mobility, 
alertness behaviour, sleep/rest, work limitations, social interactions, recreation and 
pastimes. The eight subscales were added to provide one weighted score of disability (SIP8 
total). The mean SIP8 total score of a healthy group of 78 women is 65.5 (SD= 137.8).17 
Recovery after CBT for CFS 
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Recovery was defined as scoring the same or lower than the mean plus 1 SD of this 
reference group, i.e. scoring 203 or lower. 
Combining Fatigue and Disabilities This definition of recovery was operationalized by 
combining cut-off scores on SF-36 physical functioning and the CIS-fatigue. 
Perception of Health and Fatigue Health perception was assessed with the scale ‘general 
health perception’ of the SF-36. This scale measures the evaluation of the health status by a 
patient, with scores ranging between 0 and 100. The mean in the reference group was 80 
(SD= 14.5) resulting in a cut-off score of 65.16 
The perception of fatigue was assessed with the Fatigue Quality List (FQL). The FQL 
consists of 18 adjectives and patients pick which adjectives best fit their experience of 
fatigue. Factor analysis showed a 4-factor solution; 3 of the 4 factors have negative 
connotations of fatigue: ‘frustrating’, ‘exhausting’ and ‘frightening’. About 97% of the 
untreated CFS patients scored on 1 or more of the 3 factors [Gielissen et al, unpubl. data]. 
Recovery was defined as no longer scoring on any of the 3 negative factors. 
Combining Fatigue, Disabilities and Perception This comprehensive definition of recovery 
was operationalized by combining the cut-off scores on the CIS-fatigue, the SF-36 scales of 
physical functioning and social disabilities, the general health perception and the FQL. 
 
 
Table 1. Operationalization of the different definitions of recovery 
Definition of recovery Measure Criterion used Cut-off  
Level of fatigue comparable to healthy people CIS-fatigue Mean + 1 SD ≤27 
No physical disability SF-36 physical Mean – 1 SD  ≥80 
No social disability SF-36 social Mean – 1 SD ≥75 
No disabilities in all domains SIP8 total Mean + 1 SD ≤203 
Normal fatigue and no physical disability CIS-fatigue/SF-36 physical Mean + 1 SD/– 1 SD ≤27, ≥80 
Normal health perception SF-36 general health Mean – 1 SD ≥65 
No negative perception of fatigue FQL Factor score neg.= 0  
Combining criteria of 
Fatigue CIS-fatigue Mean + 1 SD ≤27 
Physical and social disabilities SF-36 physical and social Mean – 1 SD ≥80, ≥75 
Perception of health SF-36 general health Mean – 1 SD ≥65 
Perception of fatigue FQL Factor score neg.= 0  
Mean = Mean of healthy norm group. 
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RESULTS 
Baseline data Of the 112 CFS patients with a pre-treatment assessment, 3 (3%) did not 
start with CBT. There were 13 drop-outs (11% of the patients starting with therapy) during 
treatment, so 96 patients completed the pre- and post-treatment assessment. The mean age 
of this group was 37.0 years (SD= 11.5). Seventy-three patients were women (76%). The 
mean duration of the illness was 70.8 months (range= 12–276 months, SD= 52.8). 
 
Treatment results Table 2 shows the scores of the patients before and after treatment. 
Following treatment, 73 (77%) of the 95 patients, who rated their improvement (data were 
missing for 1 patient), reported that they had no or significantly fewer symptoms. There 
was a significant decrease in CIS-fatigue and patients also reported significantly fewer 
disabilities on the SF-36 subscale physical functioning and the SIP8. In total, 66 patients 
(69%) no longer met the inclusion criteria for fatigue severity and the level of disabilities 
(SIP8 ≥700). 
 
Table 2. Pre- and post-treatment scores of CIS-fatigue, SF-36 physical and SIP8 (n= 96) 
 Pre-treatment 
mean 
Post-treatment 
mean 
Treatment 
effect 
95% CI t value d.f. p-value 
Self-rated improvement  77%    
CIS-fatigue 50.0  ± 5.2 30.3 ± 14.0 –19.7 –16.8 to –22.6 –13.6 95 <0.001 
SF-36 physical 51.8  ± 19.1 76.3 ± 23.0   24.5   19.1 to   29.8     9.1 94 <0.001 
SIP8 total 1,448 ± 510 682  ± 619 –766 –631  to – 900 –11.3 95 <0.001 
t values assessed  by  pairwise t test. 
 
Full recovery as outcome The percentage of recovered patients was determined for all 
criteria and ranged between 23 and 59% (Table 3). 
 
Table 3. Percentage of patients (n= 96) who meet the definitions of recovery following 
CBT 
Definition of recovery Criterion reached, % 
Level of fatigue comparable to healthy people 48 
No physical disability 59 
No social disability 55 
No disabilities in all domains 26 
Normal level of fatigue and no physical disability 44 
Normal health perception 54 
No negative perception of fatigue 37 
Combining criteria of fatigue, disabilities and 
perception of health and fatigue 
 
23 
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The effect of medical co-morbidity Twenty-two of the 96 patients (23%) had a medical 
co-morbid condition beside CFS. Fifteen patients had one medical co-morbidity: treated 
hyperthyroidism, gonadal dysgenesis with normal karyotype, menorrhagia, controlled 
diabetes mellitus, quiescent ulcerative colitis, nephrotic syndrome, controlled asthma, 
allergy (2), recurrent sinusitis, epilepsy, migraine, periodic leg movement disorder, multiple 
traumas, intramedullary haemangioma on medication. Seven patients had two co-
morbidities: treated hyperthyroidism and epilepsy, controlled diabetes mellitus and 
Forestier’s disease, controlled asthma and chronic low back pain (2), allergy and treated 
sleep apnoea, single transient ischaemic attack and cervical arthrosis, chronic headache and 
treated high blood pressure. After CBT, patients with medical co-morbidity had a mean 
CIS-fatigue score of 35.8 (SD= 13.7) compared to a mean CIS-fatigue score of 28.6 (SD= 
14.0) for the group without (t= 2.15, d.f.= 94, p= 0.034). The group with medical co-
morbidity also had more SIP disabilities following CBT, compared to the group without co-
morbidity (t= 2.22, d.f.= 94, p= 0.029). The SIP8 total mean scores were 934 (SD= 563) 
and 607 (SD= 739), respectively. The SF-36 physical functioning following treatment was 
lower in the group with co-morbidity (mean of 66 (SD= 27.9) and 80 (SD= 20.4), 
respectively; t= 2.46, d.f.= 94, p= 0.016). Fewer patients with medical co-morbidity 
recovered (Table 4). For social disability, the perception of fatigue, and the combination of 
all criteria for recovery, the difference in the proportions of recovered patients failed to 
reach statistical significance. 
 
 
Table 4. Percentage of recovered patients following CBT with (n= 22) and without (n= 74) 
medical co-morbidity 
Definition of recovery No co-morbidity % Co-morbidity % Z value p-value 
Level of fatigue comparable to healthy people 55 23 –2.68 0.007 
No physical disability 65 41 –2.00 0.046 
No social disability 59 50 –0.56 0.578 
No disabilities in all domains 31 19 –2.05 0.040 
Normal level of fatigue and no physical disability 50 23 –2.25 0.024 
Normal health perception 58 41 –1.41 0.157 
No negative perception of fatigue 41 23 –1.52 0.129 
Combining criteria of fatigue, disabilities and  
perception of health and fatigue 
 
29 
 
12 
 
–1.17 
 
0.241 
Z values determined by the Mann-Whitney U test. 
 
 
DISCUSSION 
More than 70% of the CFS patients reported significantly fewer symptoms following 
treatment with CBT and roughly 70% no longer met the CDC criteria for CFS. This 
favourable outcome is consistent with the results of earlier controlled studies.1 2 
Improvement and not meeting research criteria for an illness are different from 
recovering.18 19 To examine if recovery was possible we used different definitions of 
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recovery that encompassed three elements: no longer being severely fatigued, being able to 
resume all activities, and a perception of health and fatigue that is similar to the perception 
of healthy persons. Depending on the definition used, up to 59% of the patients recovered. 
Even if we used the most conservative definition of recovery, 23% fully recovered. We 
therefore conclude that recovery from CFS following CBT is possible. 
In the absence of a control treatment group, it is difficult to attribute this effect to treatment 
with certainty. A comparison with the natural course of CFS provides some useful 
information. In a review20 that used less stringent criteria for recovery, the median recovery 
rate without treatment was 5% of the patients meeting operational criteria for CFS. As 
expected, the recovery rates following CBT found in this study were substantially higher. 
Our study was only concerned with the short-term effects of treatment. The only controlled 
study investigating the long-term efficacy of CBT for CFS showed lasting benefits 5 years 
after treatment.21 
Some may argue that it is not possible to recover from CFS and that our recovered patients 
were misdiagnosed. We found no evidence to support this, with all patients meeting CDC 
criteria for CFS. Ninety-one of our 96 patients complained of post-exertional malaise, 
which some suggest is the main characteristic feature of CFS.22 
The criteria for recovery were based on healthy norms. Patients had to score within the 
range of the mean plus or minus 1 SD. The norm groups were selected for their good 
health. Assuming a normal distribution, this means that 15% of the healthy subjects 
(scoring between 1 and 2 SD beyond the mean) had a score that would be considered as 
deviant from the norm in the present study. One could say that a patient meeting these 
criteria not only recovered from CFS, but is also more healthy than a substantial part of the 
healthy general public. Thus, the effect of CBT may be underestimated. 
In determining the threshold scores for recovery we assumed a normal distribution of 
scores. However, in the healthy population the SIP and SF-36 scores were not normally 
distributed. Therefore one could argue that recovery according to the SIP8 has to be defined 
as scoring the same or lower than the 85th percentile of the healthy reference group. In that 
case, the recovery rate using the definition of having no disabilities in all domains (i.e. 
scoring the same or lower than the 85th percentile on the SIP8) would decrease from 26 to 
20%. As we do not know the exact distribution of the SF-36 scores, we cannot control for 
the effects of violation of the assumption of normality. 
Patients with medical co-morbidities had significantly higher levels of disabilities after 
treatment. This implies that less stringent criteria for recovery should be used that 
incorporate the effect of the co-morbidity. Using healthy adults as a reference group will 
lead to an underestimation of the effect of CBT in those with medical co-morbid conditions. 
The fact that fatigue, disability and health can return to a ‘normal’ level following treatment 
is a promising finding. Keeping in mind that most patients suffered several years of ill 
health, it is remarkable that such a change in perception can take place. These results 
suggest that recovery after CBT may be possible when it is applied to other related 
disorders for which CBT has been found to be helpful, such as fibromyalgia.23 
Recovery after CBT for CFS 
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The first clinical implication of the present study is that a therapist delivering CBT can tell 
the patient that substantial improvement is likely to occur and that full recovery is possible. 
By communicating this, the therapist can counterbalance factors that lower the expectations 
of the patient. Examples of such factors are a negative attitude of certain patient advocacy 
groups towards behavioural interventions or an oversolicitous attitude of significant others 
in response to CFS.24 There is empirical evidence that lower expectations of patients have a 
negative influence on therapy outcome.25 
The second clinical implication of the present study is that recovery is a construction. The 
percentage of recovered patients differed depending on the definition of recovery used. It is 
possible that a patient has another concept of recovery than the therapist. It is important that 
they jointly (re)formulate a definition which forms the objective of the treatment. 
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ABSTRACT 
Objectives: The purpose of this work was to assess the long-term outcome of adolescents 
with chronic fatigue syndrome who received cognitive behavioral therapy and to determine 
the predictive value of fatigue severity and physical impairments of the adolescent and the 
fatigue severity of the mother at baseline for the outcome of the treatment at follow-up. 
Patients and methods: Sixty-six adolescent patients with chronic fatigue syndrome who 
previously participated in a randomized, controlled trial that showed that cognitive 
behavioral therapy was more effective than a waiting-list condition in reducing fatigue and 
improving physical functioning were contacted for a follow-up assessment. Fifty 
participants of the follow-up study had received cognitive behavioural therapy for chronic 
fatigue syndrome (32 formed the cognitive behavioral therapy group in the original trial, 
and 18 patients received cognitive behavioral therapy after the waiting period). The 
remaining 16 patients had refused cognitive behavioural therapy after the waiting period. 
The main outcome measures were fatigue severity (Checklist Individual Strength), physical 
functioning (Short-Form General Health Survey), and school attendance. 
Results: Data were complete for 61 patients at follow-up (cognitive behavioral therapy 
group: 47 patients; no-treatment group: 14 patients). The mean follow-up time was 2.1 
years. There was no significant change in fatigue severity between posttreatment and 
follow-up in the cognitive behavioral therapy group. There was a significant further 
increase in physical functioning and school attendance (10% increase). The adolescents in 
the cognitive behavioral therapy group were significantly less fatigued and significantly 
less functionally impaired and had higher school attendance at follow-up than those in the 
no-treatment group. Fatigue severity of the mother was a significant predictor of treatment 
outcome. 
Conclusions: The positive effects of cognitive behavioral therapy in adolescents with 
chronic fatigue syndrome are sustained after cognitive behavioral therapy. Higher fatigue 
severity of the mother predicts lower treatment outcome. 
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterized by severe fatigue, lasting > 6 months, and 
leading to functional impairments. CFS is not the result of an organic disease or ongoing 
exertion and is not alleviated by rest.1 Several controlled trials have shown that cognitive 
behaviour therapy (CBT) leads to a reduction of fatigue and disabilities in adults with CFS.2 
CBT is aimed at changing fatigue related cognitions and a gradual resumption of activities. 
We published the first and until now only randomized, controlled trial that tested the 
effectiveness of CBT for adolescent patients with CFS.3 The effects of CBT (10 sessions 
over a period of 5 months) were compared with a waiting-list condition. The adolescent 
patients who received CBT reported a greater reduction in fatigue and a larger improvement 
in physical functioning directly after treatment than patients from the waiting list. The 
school attendance of the CBT group also increased more than in the waiting list. The main 
objective of the present study to determine whether the positive effects of CBT of the 
previous study were sustained over a longer period. Secondly, using an explorative 
analysis, we determined the predictive value of fatigue severity and physical functioning of 
the adolescent at baseline for the outcome of the treatment at the time of follow-up. In 
addition, we also looked at the predictive value of the fatigue severity of the mother of the 
adolescent patient with CFS for treatment outcome at follow-up. The parents of the 
adolescent patient with CFS are involved in the treatment.3 This is most often the mother, 
because she is generally more involved in the daily care of the child. During the treatment, 
she acts as a coach for younger adolescents. The parent supports older adolescent patients 
with CFS as they try to increase activity and change fatigue-related cognitions. We presume 
on the basis of our clinical experience that the ability of the mother to be effectively 
involved in the treatment is, to some extent, dependent on her own fatigue-related 
cognitions and level of fatigue. A recent study4 showed that the level of fatigue of the 
mother and that of the adolescent with CFS are related. In the current study, we wanted to 
determine whether such a relationship also existed between the level of fatigue of the 
mother and the treatment outcome of the adolescent patient with CFS. 
 
PATIENTS AND METHODS 
Patients Sixty-nine consecutively referred adolescent patients were included in the original 
trial. They were randomly assigned to the CBT condition (n= 35) or waiting-list condition 
(n= 34).3 All of the patients met the CFS criteria of the US Centers for Disease Control and 
Prevention1 and were between 10.0 and 17.2 years of age. 
Following the guidelines of the human ethics committee of the Radboud University 
Nijmegen Medical Centre evaluating the original research protocol, patients who were 
assigned to the waiting list were offered CBT directly after the postwaiting-list assessment. 
Of the 34 patients, 16 did not want CBT and 18 were treated according to the same protocol 
as in the original study.3  
At the start of the study, patients were informed that they could be contacted for a follow-
up assessment. In total, 66 patients were contacted for the follow-up. Fifty of them had 
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received CBT (32 patients from the original CBT condition and 18 patients who received 
CBT after the waiting-list period). Because the main objective of the present study was to 
determine whether the positive effects of CBT are sustained over time, the 3 patients from 
the original CBT condition who never started with therapy were not contacted for the 
follow-up. 
 
Design and procedures The 18 patients who received CBT after the waiting period were 
assessed 5 months later, immediately after CBT, for a posttreatment assessment. Most 
patients were contacted by mail for the follow-up assessment. Some were contacted by 
telephone, and if they agreed to cooperate, a set of questionnaires was sent to them. If 
patients did not send the questionnaires back within 2 weeks, a reminder was sent to them 
by mail. This was repeated if the patient did not respond to the reminder within 3 weeks. 
The time interval between follow-up and the posttreatment or post–waiting-list assessment 
varied. This was because patients entered the study and started treatment at different times, 
whereas the follow-up moments were fixed because of the limited availability of the 
participating researchers. 
 
Outcome variables Fatigue was measured in the same way as in the original trial, with the 
subscale “fatigue severity” of the Checklist Individual Strength (CIS). It consists of 8 items 
on a 7-point scale, with scores ranging from 8 (no fatigue) to 56 (severely fatigued). The 
CIS is a reliable and valid instrument.3 5 Functional impairment was measured with the 
subscale “physical functioning” of the Short-Form General Health Survey (SF-36).6 Scores 
range between 0 (maximal physical limitation) to 100 (ability to do vigorous activity). The 
SF-36 is reliable and valid6 and was also used in the previous study.3 Patients had to score 
>= 40 on the fatigue severity scale of the CIS and <= 65 on the SF-36 physical functioning 
subscale to participate in the original trial. School attendance was established as the 
percentage of regular school hours attended in the previous week.3 If a patient worked at 
the time of follow-up, the percentage of work attendance was calculated in the same way. 
 
Predictors of treatment outcome We determined the predictive value of fatigue severity 
and physical functioning at baseline for treatment outcome at follow-up. The mother of the 
adolescent patient completed the fatigue severity subscale of the CIS at baseline. 
 
Analysis Statistical analysis was performed using SPSS 12.01 (SPSS Inc, Chicago, IL). 
Significance was assumed at a P value of  < 0.05. The effect of CBT for the patients from 
the 
waiting list was determined with a pairwise t test comparing pretreatment with the 
posttreatment assessment. In case of missing observations, the last value was carried 
forward. With a t test for independent groups, it was tested if the posttreatment scores of the 
patients treated after the waiting period were different from the scores of the CBT group 
from the original study. If data at follow-up were missing, they were replaced with 
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estimates derived from single imputation (missing variable analysis, regression with 
baseline value as predictor). The relationship between time to follow-up (varied) and 
change in the outcome measures was determined with a Pearson correlation. Comparing the 
scores at follow-up with those at posttreatment with pairwise t tests helped to determine 
whether the effects of CBT were sustained. This was also done for the no-treatment group 
to get an indication of the course of CFS without CBT. We defined patients as showing 
clinical significant improvement3 at follow-up if they had a reliable change index of  > 1.96 
and a score of < 35.7 (1 SD above the mean for 420 healthy adolescents) on the fatigue 
severity subscale, had an increase of > 50 or an end score of >= 75 for on the physical 
functioning subscale of the SF-36,7 and were fully attending work and/or school at follow-
up. A χ2 test was used to assess the difference between the percentage of clinical significant 
improvement between the last assessment and follow-up. Furthermore, the scores on the 
outcome measures and the percentages of clinical significant change at follow-up of the 
CBT group were compared, using t tests and χ2 tests with the group who did not receive 
treatment. The predictive value of the selected variables on treatment outcome (fatigue) was 
determined with the use of multiple regression. 
 
RESULTS 
Effect of CBT after the waiting list condition Of the patients who received CBT after the 
waiting-list condition, 15 completed the treatment and the posttreatment assessment, and 3 
patients (16%) withdrew from therapy. Their posttreatment data were missing. In those 
cases, the last observation was carried forward.    
 
Patients showed a significant decrease in fatigue severity and an increase in physical 
functioning (Table 1). School attendance was already high at the start of the treatment and 
was not significantly different at posttreatment assessment. The posttreatment scores of the 
patients who received CBT after the waiting-list condition were compared with the 
posttreatment scores of the 32 patients from the treatment condition in the original study. 
The posttreatment fatigue score of the treated patients from the original study was 28.2 
(SD: 16.1) and was not significantly different from the posttreatment score of the patients 
who received CBT after the waiting list (mean= 29.6, SD= 15.0; t= -0.3; d.f.= 48; P= 
0.765). The level of physical functioning (72.0, SD=  28.9) and the school attendance (75%, 
Table 1. Effect of CBT for patients (n=18) who received treatment after the waiting list 
condition  
 Post-waiting list Post-treatment Treatment effect  
(95% CI)  
t –value 
(d.f.= 17) 
p-value 
 Mean score (sd)    
Fatigue severity1  46.2 (12.8) 29.6 (15.0) 16.6 ( 8.3 to 24.8) 4.2 0.001 
Physical 
functioning2 
54.2 (18.1) 72.2 (20.5) 18.1 ( 8.5 to 27.6)  4.0 0.001 
% School attendance  72.6 (34.0) 80.6 (28.7)  7.9 (-13.5 to 29.4) 0.8 0.447 
1 CIS fatigue severity subscale.2 SF-36 physical functioning subscale 
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SD= 38.9%) of the patients treated with CBT in the original study were also not 
significantly different from those of the patients treated after the waiting list (mean physical 
functioning= 72.2, SD= 20.5; t= -0.03; d.f.= 48; P = 0.979; mean school attendance= 
81.0%,  SD= 28.7%; t= 0.6; d.f. 48; P= 0.581). 
 
Change in outcome variables between final assessment and follow-up Five patients did 
not complete the follow-up assessment. Three of them were from the CBT group (6%): 2 
did not send the questionnaires back and 1 patient had moved without leaving an address. 
All 3 of the patients had withdrawn from therapy without completing posttreatment 
assessments. Of the 16 patients on the waiting list who did not want treatment, 2 (12.5%) 
did not send the follow-up questionnaires back. The 5 patients who did not complete the 
follow-up assessment did not significantly differ in fatigue severity, physical functioning, 
and school attendance at baseline from the other patients. The mean time passed between 
the last assessment and follow-up was 2.1 years (range: 3 months to 6 years and  8 months). 
There was no significant correlation between time elapsed since the final assessment and 
the changein fatigue severity (r= -.02; P= 0.892), physical functioning (r= -.15; P= 0.240), 
and school and/or work attendance (r= -.05; P=  0.739) between follow-up and 
posttreatment or postwaiting-list assessment. The mean age at follow-up was 18.6 years 
(SD= 1.7 years; range= 14.8–22.7 years). 
 
Table 2. Change in mean fatigue severity, physical functioning and school attendance 
between final assessment and follow-up   
Group1 Final  
assessment 
Follow-up Change score  
(95% CI) 
t-value5 p-value 
 Mean score (sd)    
Fatigue severity 2 
CBT 28.7 (15.6) 27.9 (14.4) -0.8 (-4.5 to 6.1) -0.3 0.764 
No treatment 41.6 (14.0) 39.2 (15.3) -2.4 (-10.7 to 5.8) -0.6 0.539 
Physical functioning3 
CBT 72.1 (24.5) 83.3 (20.6)  11.2 (4.8 to 17.7)  3.5 0.001 
No treatment 57.8 (23.7) 69.8 (26.7)  12.0 (1.3 to 22.6)  2.4 0.030 
% School/work attendance4 
CBT 79.0 (33.7) 92.2 (14.2) 13.2 (1.1 to 25.3)  2.2 0.033 
No treatment 64.9 (33.3) 68.8 (38.8)  3.9 (-27.9 to 35.7)  0.3 0.793 
1CBT n=50; no treatment=16; 2 CIS fatigue severity subscale; 3SF-36 physical functioning subscale; 4Number of patients 
reporting that they worked or attended school: n=42 for CBT, n=12 no treatment; 5Fatigue severity/physical functioning d.f. 
CBT=49, no treatment=15; schoolwork attendance d.f. CBT=41, no treatment=11 
 
Follow-up of patients treated with CBT After CBT there was no significant difference in 
fatigue between posttreatment assessment and follow-up. There was a significant further 
increase in physical functioning. At follow-up, 34 patients attended school and 8 worked. 
The school and/or work attendance was significantly higher at follow-up (see Table 2). 
The percentages of patients who had received CBT and who showed clinical significant 
improvement in fatigue severity and physical functioning did not significantly change 
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between posttreatment and follow-up. The percentage of patients with a full school and/or 
work attendance had significantly increased at the time of follow-up (Table 3). 
 
Table 3: Change in the number of patients (%) with a clinical significant improvement 
between final assessment and follow-up 
Group1 Final assessment Follow-up Change score  
(95% CI) 
χ2 
(d.f.=1) 
p-value 
 No (%) improved2    
Fatigue severity 
CBT 30/50 (60) 32/50 (64) 0.04 (-0.14 to 0.22) 1.2 0.279 
No treatment 5/16  (31) 5/16 (31) 0.0 (-0.28 to 0.28) 2.8 0.094 
Physical functioning 
CBT 31/50 (62) 37/50 (74) 0.12 (-0.05 to 0.29) 1.9 0.171 
No treatment 5/16 (31) 8/16  (50) 0.19 (-0.03 tot 0.40) 7.3 0.007 
School/work attendance3 
CBT 29/50 (58) 29/42 (69) 0.10 (-0.15 to 0.34) 4.9 0.027 
No treatment 4/16  (25) 5/12 (42) 0.17 (-0.29 to 0.62) 0.1 0.735 
1 CBT n=50; no treatment=16; 2 Definition of clinical significant improvement: a reliable change index of >1.96 and a score of  
<35.7 on the CIS fatigue severity;  increase of >50 or an end score of >= 75 on the SF-36 physical functioning;  full work/school 
attendance; 3 number of patients reporting that they worked or attended school: n=42 for CBT n=12 no treatment. 
 
Follow-up of patients who did not receive CBT In the group who did not receive CBT, 
there was an improvement in physical functioning at follow-up. There was no significant 
change in fatigue severity. At the time of follow-up, 9 patients attended school and 3 
worked. Their school and/or work attendance did not significantly change between post–
waiting-list assessment and follow-up (Table 2). 
Significantly more patients had a clinically significant change in physical functioning at 
follow-up assessment when compared with the post–waiting-list assessment. There was no 
difference in the number of patients a clinically significant improvement in fatigue and a 
full school and/or work attendance at the time of follow-up (Table 3). 
 
Difference in outcome at follow-up between CBT group and the group who did not 
receive CBT Patients from the CBT group were significantly less fatigued (mean 
difference in fatigue severity= -11.3; 95% confidence interval (CI) of the difference: -2.9 to 
-19.7; t= -2.7; d.f.= 64; P=  0.009), had a higher physical functioning score (mean 
difference physical functioning=  13.5; 95% CI: 0.8 to 26.2; t= 2.1; d.f.= 64; P=  0.037), 
and a higher school and/or work attendance (mean difference attendance= 23%; 95% CI: 
9.1% to 37.8%; t=  3.3; d.f.= 52; P= 0.002) at the time of the follow-up assessment than the 
patients who had not received treatment. 
More patients from the CBT group showed a clinically significant change in fatigue 
severity (mean difference= 33%; 95% CI: 5% to 60%; χ2= 5.3; d.f.= 1; P= 0.02). The 
difference between the percentage of clinically significant improvement in physical 
functioning (mean difference= 24%: 95% CI: -6% to 54%; χ2= 3.2; d.f.= 1; P= 0.073) and 
school/work attendance (mean difference= 27%; 95% CI: -4% to 58%; χ2= 3.0; d.f.= 1: P= 
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0.083) between the patients from the CBT group and the patients who did not receive 
treatment failed to reach statistical significance. 
 
Prediction of treatment outcome Fatigue severity and the level of physical functioning of 
the adolescents at baseline did not predict fatigue severity at follow-up for the patients who 
received CBT (Table 4). The more fatigued the mother of the adolescent patient was, the 
more negative the treatment outcome of the adolescent. Twenty-eight percent of the 
mothers who filled the fatigue severity subscale of the CIS in at baseline (11 of 40) were 
extremely fatigued (score of > 358). 
 
Table 4. Prediction of the level of fatigue at follow-up of patients who received CBT    
Predictor at baseline1 
 
 Unstandardized coefficients Standardized coefficients 
Constant  6.32  
Fatigue severity   0.38  0.10 
Physical functioning  -0.16 -0.17 
Fatigue severity Mother   0.40  0.35* 
R² adjusted 0.15  
* p<0.05 1 n=40, for 10 patients data on the fatigue severity of mother were lacking 
  
DISCUSSION 
The positive effects of CBT for adolescent patients with CFS were sustained over a period 
of about 2 years after termination of the treatment. The level of fatigue did not change, 
whereas the physical functioning and the school and/or work attendance of patients who 
had received CBT improved further over time. The percentage of patients with a clinically 
significant improvement in fatigue and physical functioning after CBT remained high at 
follow-up. The percentage of  patients with full school and/or work attendance after CBT 
showed a further increase from posttreatment to follow-up. These favorable results are 
comparable or superior to the known long-term effects of CBT for adult patients with CFS. 
Several randomized, controlled trials confirm that the positive effects of CBT in adult 
patients with CFS are sustained over a period of 6 to 8 months after the treatment.9 10 One 
study that investigated the efficacy of CBT over a 5-year follow-up period also showed that 
CBT for CFS produced lasting benefits in adults.10 
In the original trial, 2 treatment protocols were used: 1 for patients with a passive physical 
activity pattern and 1 for relatively active patients.3 The physical activity pattern of the 
adolescent patient with CFS was measured with an actometer, a motion-sensing device 
attached to the ankle. Directly after treatment, passive and active patients showed equal 
improvements on all of the primary outcome variables.3 We also compared the change 
scores between the postintervention assessment and follow-up for passive and relative 
active patients. The results of this analysis (data not shown) showed that there were no 
significant differences in the changes in fatigue severity, physical functioning, and 
school/work attendance between passive and active patients with CFS. 
Follow-up of CBT for adolescent CFS patients 
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The level of fatigue of the mother was a significant predictor of the fatigue of the treated 
patient at follow-up. The finding that the level of symptoms of 1 of the parents and their 
children with CFS are related is not new.4 11 12 What is new is that the fatigue of the mother 
was also related to the response to CBT. Of the fathers, a high proportion (8 of 36 [22%]) 
was also severely fatigued at baseline. However, there was no significant correlation 
between the fatigue of the father at baseline and the fatigue of the adolescent at follow-up 
(r= -.05; P= 0.757). This is in correspondence with the study of van de Putte et al,4 who also 
found that the level of fatigue of the father was not related to that of the adolescent patient 
with CFS. The fact that the fatigue of the mother is related to treatment outcome of the 
adolescent patient with CFS could implicate that additional interventions aimed at the 
mother will facilitate the response of the adolescent to CBT, especially when the mother 
has a level of fatigue that is within the range of adult patients with CFS (28% in our 
sample8). Other research has shown that adults with CFS can also be effectively treated 
with CBT.2 Future research has to determine whether the outcome of adolescent patients 
with CFS after CBT can be improved by individually treating the severely fatigued mother 
simultaneous with individual treatment of the child. 
Existing literature indicates that the prognosis for CFS in adolescents (without and after 
treatment) is more favorable12–16 than in adults.17 A recent community study showed that 
chronic fatigue and CFS in adolescents has a relatively good prognosis.12 However, as the 
authors of this study point out, the prognosis of adolescent patients with CFS who are 
referred to tertiary care seems less favorable, and those adolescents remain disabled for 
long periods of time.13 Our results confirm this. The group of patients who did not receive 
treatment showed substantially less clinically significant change at follow-up (31%–50%) 
than patients who received CBT (64%–74%). A majority of the untreated adolescent 
patients with CFS remained severely fatigued and functionally impaired. The substantial 
differences between the untreated patients with CFS and the patients with CFS who did 
receive CBT suggest that the outcome of adolescents with CFS is more favorable after 
treatment with CBT. We recommend that future research pay close attention to the reasons 
of adolescent patients with CFS for declining the offered CBT. One could use this 
information to develop strategies to motivate patients for CBT. It is also important to 
investigate the possible determinants of the lack of a positive response to CBT in a 
subgroup of adolescent patients. 
One could argue that nonspecific effects, like having had regular contact with health care 
staff rather than the specific intervention, could explain the difference in outcome between 
the adolescents who received CBT and the patients in the waiting-list condition. There are 2 
studies with adult patients with CFS that compared the effect of CBT for CFS with a 
“placebo” or nonspecific condition. Both showed a superior effect of CBT on fatigue and 
the level of disabilities.9 18 Furthermore, a recent review showed that the placebo response 
of patients with CFS to psychological interventions is lower than in other medical 
conditions.19 
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To assess the long-term effects of CBT, we sent questionnaires to the patients by mail. A 
patient can be more easily influenced by others when filling in the questionnaire at home 
than at the treatment center, as was done in the earlier assessments. We cannot rule out that 
patients might have been influenced by others during the assessment and that this might 
have had an effect on the results of the follow-up assessment. 
The mean follow-up time was 2 years, with a wide variation between patients in the time 
period between the postintervention assessment and follow-up. One could argue that this 
introduced a bias in the study, because the long-term effect of the treatment could change 
over time. We think that this is unlikely, because the results showed no statistically 
significant relationship between time passed since the postintervention assessment and the 
change scores of the outcome measures. 
Data on the type of activities of patients at the time of the follow-up assessment were not 
available for all of the patients. Some patients only indicated on the questionnaires that they 
did not study and did not work. We decided not to impute these missing values, because 
more detailed information about their activities were lacking. This could have introduced a 
bias when determining the long-term effects of CBT on work and/or school attendance. An 
example of such a bias would be that these patients are less active and function at a lower 
level than the patients who indicated that they worked or attended school, which, in turn, 
might have led to an overestimation of the effect of CBT. 
In assessing the predictive value of the fatigue of the mother on treatment outcome, data on 
the fatigue severity of a substantial number of mothers were lacking. We can only conclude 
that the relationship between the fatigue of the mother and the treatment outcome of the 
adolescent patients existed in the subgroup of patients where the fatigue severity of the 
mother was assessed. Furthermore, an alternative explanation for the association between 
the fatigue of the mother and that of the adolescent could be the negative influence of a 
child being sick on the functioning of the mother. However, it is our clinical experience that 
if the mother of the adolescent patient with CFS is severely fatigued, her fatigue exists 
longer than (and, thus, precedes) that of the child. 
In comparing the long-term outcome of patients treated with CFS and the patients who did 
not want CBT, it must be noted that it is possible that the patients with untreated CFS form 
a subgroup of the total group of patients with CFS who were referred for treatment. This 
subgroup could have some specific characteristics. These characteristics and not the fact 
that they did not receive CBT could have negatively influenced their level of fatigue and 
disabilities at follow-up. Lastly, it must be noted that the group of untreated patients in this 
study was small, which limits the scope of the conclusions that can be drawn from this 
sample. We suggest that the results of the current study can only be generalized to those 
adolescent patients with CFS who do want to be treated with CBT. 
 
CONCLUSIONS 
The original trial showed that CBT significantly reduced the symptoms of CFS in 
adolescents in 10 sessions. The current study showed that these results were not only 
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sustained over a time span of 2 years but that some aspects of CFS symptoms and 
disabilities had decreased even further after CBT. It is important that this effective 
treatment becomes available to more adolescent patients with CFS. 
 
ACKNOWLEDGEMENTS 
This work was supported by the Foundation for Children’s Welfare Stamps Netherlands 
(Stichting Kinderpostzegels Nederland) and the ME Foundation (ME Stichting). 
We thank all of the participants and their parents, and we thank Maaike van Kuijk and Ester 
Meijer for carrying out the therapy of the patients from the waiting list.  
 
REFERENCES 
1. Fukuda K, Straus SE, Hickie I, Sharpe  MC, Dobbins JG,  Komaroff A. The chronic fatigue syndrome: a 
comprehensive approach to its definition and study. International chronic fatigue syndrome study group. 
Ann Intern Med 1994; 121: 953-9. 
2. Chambers D, Bagnall A, Hempel S, Forbes C. Interventions for the treatment, management and 
rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic 
review. J Roy Soc Med 2006; 99: 506-520.  
3. Stulemeijer M, de Jong LWAM,  Fiselier TJW, Hoogveld SWB, Bleijenberg G. Cognitive behaviour 
therapy for adolescents with chronic fatigue syndrome: randomized controlled trial. Brit Med J 2005; 330: 
7481-6. 
4. van de Putte EM, van Doornen LJP, Engelbert RHH, Kuis WM,  Kimpen JLL, Uiterwaal CSPM. Mirrored 
symptoms  in mother and child with chronic fatigue syndrome. Pediatrics 2006; 117: 2074-9.  
5. Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama, JMD, van der Meer JWM, Bleijenberg G. 
Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38: 383-92. 
6. Stewart AL, Hays RD, Ware JE. The MOS short form general health survey: reliability and validity in a 
patient population. Med Care 1988;  26: 724-732. 
7. Powell P, Bentall RP, Nye FJ, Edwards RH. Randomised controlled trial of patient education to encourage 
graded exercise in chronic fatigue syndrome. Brit Med J 2001; 322: 387-390. 
8. Knoop, H, Bleijenberg G, Gielissen MFM, van der Meer JWM, White PD. Is a full recovery possible after 
cognitive behavioural therapy for chronic fatigue syndrome? Psychother Psychosom 2007; 76:171-6. 
9. Prins JB, Bleijenberg G, Bazelmans E, Elving L, de Boo Th, Severens JL, et al. Cognitive behaviour therapy 
for chronic fatigue syndrome: A multicentre randomized controlled trial. Lancet 2001 357; 841-7. 
10. Deale A, Husain K, Chalder T, Wessely, S. Long-term outcome of cognitive behaviour therapy versus 
relaxation therapy for chronic fatigue syndrome: a 5-year follow up study. Am J Psychiatry 2001; 158: 
2038-2042. 
11. Rangel L, Garralda ME, Jeffs J, Rose G. Family health and characteristics in chronic fatigue syndrome, 
juvenile rheumatoid arthritis, and emotional disorders of childhood. J Am Acad Child Adolesc Psychiatry 
2005; 44:150-8.   
12. Rimes KA, Goodman R, Hotoph M, Wessely S. Incidence, prognosis, and risk factors for fatigue and 
chronic fatigue syndrome in adolescents: a prospective community study. Pediatrics 2007; 119:603-9. 
13. Rangel I, Garralda ME, Levin M, Roberts H. The course of severe chronic fatigue syndrome in childhood. J 
R Soc Med 2000; 93:129-134. 
14. Bell DS, Jordan K. Robinson M. Thirteen-year follow up of children and adolescents with chronic fatigue 
syndrome. Pediatrics 2001; 107: 994-8. 
15. Patel MX, Smith DG, Chalder T, Wessely S. Chronic fatigue syndrome in children: a cross sectional survey. 
Arch Dis Child 2003; 88: 884-898.  
16. Gill AC, Dosen A, Ziegler JB. Chronic fatigue syndrome in adolescents. Arch Pediatr Adolesc Med 2004; 
158: 225-9.  
 76
17. Cairns R, Hotoph M: A systematic review describing the prognosis of chronic fatigue syndrome. Occup 
Med-C 2005;  55: 20-31.  
18. Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a 
randomized controlled trial. Am J Psychiatry 1998; 155: 1461-2. 
19. Cho HJ, Hotopf M,  Wessely S. The placebo response in the treatment of chronic fatigue syndrome: a 
systematic review and meta-analysis. Psychosom Med 2005; 67: 301-313. 
   7 
Efficacy of guided self-instructions in the treatment of patients with 
chronic fatigue syndrome: a randomised controlled trial  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hans Knoop, Jos W.M. van der Meer, Gijs Bleijenberg, submitted 
 78
ABSTRACT  
Background: A minimal intervention for Chronic fatigue syndrome (CFS), consisting of 
self-instructions combined with email contact, was developed from the protocol for 
cognitive behavioural therapy.       
Aims: 1) test if guided self-instructions lead to a reduction of fatigue and disabilities; 2) 
predict for which patients this minimal intervention suffices.   
Method: In a randomised controlled trial the effects of the intervention were compared to a 
waiting list condition. Patients met CDC criteria for CFS. Main outcome measures (fatigue 
severity and disabilities) were determined at baseline and after the intervention or waiting 
period. 
Results: 85 patients were allocated to the treatment condition, 86 to the waiting list. An 
intention to treat analysis showed that fatigue and disabilities decreased significantly more 
after guided self-instructions. Fatigue severity and disabilities were negatively related with 
treatment outcome.  
Conclusion: Guided self-instructions are an effective treatment for relatively less severely 
disabled and fatigued CFS patients.  
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe fatigue, lasting longer than six 
months and leading to disabilities.1 Cognitive behaviour therapy (CBT), aimed at the 
cognitions and behaviours that perpetuate the fatigue leads to a decrease of fatigue and 
disabilities.2 3 CBT for CFS is an intensive treatment, requiring thirteen to sixteen sessions 
depending on the protocol used.4-6  It is likely that for a subgroup of patients a less intensive 
intervention suffices. We developed a minimal intervention based on the CBT  protocol for 
CFS7 consisting of self-instructions combined with email contact. The first objective of this 
study was to determine if self-instructions were an effective treatment for CFS. For this, the 
effects of the guided self-instructions on fatigue severity and level of disabilities were 
compared to a waiting list condition in a randomised controlled trial. Secondly, the 
predictive value of indices of severity of CFS and of the perpetuating factors of CFS for 
treatment outcome were investigated in an explorative analysis to determine which patients 
benefited from a minimal intervention.  Furthermore, cut-off scores on the predictors of 
treatment outcome were determined to be able in the future to select  those patients at 
baseline who have the largest  chance on a favourable outcome with the minimal 
intervention.    
 
METHOD 
Patients All consecutive patients referred for CBT to the Expert Centre Chronic Fatigue of 
the Radboud University Nijmegen Medical Centre were eligible to enter the study if they 
met the following inclusion criteria:  
- Being 18 years or older;  
- Being able to speak and read Dutch; 
- The 1994 research criteria for CFS as formulated by the US Center for 
Disease Control; 1 8 
- Being severely fatigued, operationalised as reaching a score of 35 or more on 
the subscale Fatigue Severity of the Checklist Individual Strength (CIS);9 
- Being severely disabled, operationalised as having a total score on the 
Sickness Impact Profile (SIP total score) of 700 or higher;10  
- Given written consent for participation in the study.  
Patients were excluded  if they were engaged in a legal procedure concerning disability 
related financial benefits. This was done because a previous intervention study had shown 
that being engaged in a legal procedure predicted a negative treatment outcome.11  Patients 
could still be included in the study after the legal procedure was ended. The local ethics 
committee approved the study.       
 
Design and procedures All referred patients received a baseline assessment as a part of 
clinical routine. Patients that met the inclusion criteria of the study were offered CBT and 
were told that they were placed on a waiting list for the treatment. The waiting period was 6 
to 12 months and was caused by a limited treatment capacity. If a patient had agreed with 
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placement on the waiting list for CBT he or she was given detailed information about the 
study. Patients were told that they could participate in a study that tested the efficacy of 
guided self-instructions while he or she  waited for individual therapy. Participation in the 
study would not lead to a longer waiting period than usual to the start of the individual 
CBT. If the patient had given  informed consent for participation in the study he or she was 
randomly assigned to either the intervention condition (guided self-instructions) or a 
waiting list condition. Allocation to group was carried out by the therapist using cards in 
consecutive numbered and sealed envelopes that were opened in the presence of the patient. 
A statistical advisor independent of the study prepared the envelopes by coding them 
according to a computer-generated list of random numbers. Randomisation was  performed 
in blocks of 8. Patients in both conditions were assessed two times, at baseline and directly 
following the waiting period or intervention. This period could vary between 6 to 12 
months depending on the available treatment capacity.  
 
Intervention The self-instructions were derived from the protocol for CBT that was  
developed on the basis of a model of perpetuating factors of CFS.12 It has been tested in 
several studies6 10 13 and is aimed at changing fatigue related cognitions and a gradual 
increase of activities. There are two treatment protocols, depending on the pattern of 
physical activity of the patient.7 This activity pattern is assessed with an actometer, a 
motion sensing device that can quantify physical activity. A relatively active and a passive 
pattern is distinguished. The relatively active physical activity pattern is characterised by 
bursts of activity followed by periods of rest. Relatively active patients first have to attain a 
base level of activity where they divide their activities more evenly during the day. 
Subsequently they gradually increase their activity level and resume work and other 
activities. Patients with a passive activity pattern are characterised by an extremely low 
physical activity level and start immediately with a graded activity program. The two 
treatment protocols were also used in the self-instructions.  Patients received a self-
instruction booklet that consisted of information about CFS and assignments. The 
assignments were given per week, the total program took at least 16 weeks, but would more 
often take more time in order for the patient to reach goals as resumption of work. The 
booklet was given to the patient by the therapist who also invited the patient to email once 
every two weeks to report on his or her progress and ask questions about the self-
instructions. If a patient did not use email, the therapist proposed that the patient phoned at 
least once every two weeks. Patients were told that they were free to email (or phone if they 
did not email) more often if they wanted. If patients did not email or phoned every two 
weeks a reminder was send by the therapists by mail or patients were contacted by 
telephone.  The intervention was carried out by 6 cognitive-behavioural therapists trained in 
the treatment of CFS patients with CBT. They received group supervision once a week over 
the interventions carried out in the guided self-instruction condition.  
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Primary outcome measures Primary outcome variables  were fatigue severity and level of 
disabilities. Fatigue severity was measured with the subscale ‘fatigue severity’ of the 
Checklist Individual Strength (CIS). It indicates the level of experienced fatigue over the 
past 2-week period and consists of eight items on a seven point scale. Scores range from 8 
(no fatigue) tot 56 (severely fatigued). The CIS is a reliable and valid instrument.9 The level 
of disabilities were measured in two ways. The Sickness Impact Profile was used to 
measure functional disability in ambulation, home management, mobility, alertness 
behaviour, sleep/rest, work limitations, social interactions, recreation and pastimes. The 
eight subscales were added to provide one weighted score of disability (SIP total score). 
The SIP was used in several intervention studies with CFS patients.6 10 Physical disabilities 
were measured with the ‘physical functioning’ subscale of the Medical Outcomes Survey 
Short Form-36. Scores range from 0 (maximum physical limitations) to 100 (ability to do 
vigorous activity).  The SF-36 is reliable and valid.14 
 
Secondary outcome measure Psychological distress was the secondary outcome measure. 
This was measured with the total score of the Symptom Checklist 90 (SCL90). The SCL90 
consists of 90 items scored on a 5-point scale. Scores range from 90 to 450. A low total 
score reflects high psychological well-being. The SCL-90 is a reliable and valid 
instrument.15  
 
Clinical significant improvement To determine if the changes in fatigue severity and level 
of disabilities were clinical meaningful, cut-off scores for a clinical significant 
improvement were used. Clinical significant improvement was defined in two ways. First, 
as a reliable change index of 1.9616 and scoring lower than 35 on the subscale fatigue 
severity of the CIS at the second assessment. This score is within two standard deviations 
of the mean of healthy adults.17 Secondly, improvement was defined as having a clinical 
significant improvement in fatigue and a total score of less than 700 on the SIP.    
 
Assessment of predictors of treatment outcome  The fatigue severity score on the CIS, 
the SIP total score and the number of CDC additional symptom criteria present at baseline 
were seen as indices of the severity of CFS. To determine the number of additional 
symptom criteria the patients filled in a questionnaire where they had to indicate if they 
experienced the symptoms muscle pain, headache, multi-joint pain, sore throat, post-
exertional malaise, unrefreshing sleep, concentration and/or memory impairment, and 
sensitive lymph nodes. Scores could range from 4 to 8.   
Vercoulen et al12 showed that there are several factors that perpetuate the CFS symptoms. 
These factors are physical inactivity, a low self-efficacy, strong somatic attributions of 
symptoms and a focus on bodily symptoms. All these factors were assessed at baseline in 
the present study. The physical activity level was measured with an actometer, a motion-
sensing device worn at the ankle that quantifies physical activity. The actometer was worn 
12 consecutive days and nights. A general physical activity score that expressed the mean 
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activity level over this period in the mean number of accelerations per 5-minute interval 
was calculated. Patients were classified in relative active and passive by comparing their 
activity pattern with reference scores.18 On the basis of this typology they received a 
different type of treatment. For the analysis of the predictive value of the physical activity 
for treatment outcome the mean activity level was used. 
The self-efficacy scale, consisting of seven questions, measured the sense of control in 
relation to CFS complaints. The seven items were scored on a 4-point Likert scale, scores 
ranged between 7 and 28.19   
Somatic attributions with respect to the CFS symptoms were measured by the causal 
attribution list consisting of five questions scored on a 5-point likert scale. Scores range 
from 5 to 20, a higher score indicating stronger somatic attributions.6  
Focusing on bodily symptoms  was measured with the subscale somatisation of the SCL90. 
This subscale consist of 12 items scored on a 5-point Likert scale, scores range from 12 to 
60.6 
  
Sample size and data analysis The sample size was determined on the basis of the change 
in the primary outcome measure fatigue severity. A score of lower than 35 on the CIS  
(scoring within two standard deviations of the mean of healthy controls) at second 
assessment would reflect an acceptable change in fatigue. We assumed that in the waiting 
list 10% of the patients would have a fatigue score of lower than 35. A power calculation 
showed that 98 patients in each condition were needed to detect a difference of 15% in the 
proportion of patients with a fatigue score within normal limits (10% in the waiting list 
versus 25% in the guided self-instructions condition)  assuming a significance of 5%, 
power of 90% and a drop-out rate of 20%. 
Data analyses were performed using SPSS, version 14.0. Significance was assumed at p< 
0.05  in all analyses.  Independent samples t-tests and χ2 tests were used to determine if 
there were differences at baseline between the two conditions in patient characteristics.  To 
test if there was a difference in scores between the two conditions  on the primary and 
secondary outcome measures ANCOVA was used20 with the score on the second 
assessment as dependent variable, the baseline score as covariate and condition as fixed 
factor (2 levels). Differences between the two conditions in the proportion of patients with a 
clinical significant improvement were tested with χ2  tests. All comparisons between the 
two conditions were performed on the basis of an intention to treat, in case of missing data 
the last observation was carried forward. For the patients in the guided self-instructions 
who completed the second assessment pearson correlations were calculated between  CIS 
fatigue severity at the second assessment and the scores on the (potential) predictors of 
treatment outcome at baseline. Fatigue severity at second assessment was chosen as a 
measure of treatment outcome and not the SIP total score and SF-36 physical functioning to 
reduce the risk on a type I error by calculating many different correlations. The variables 
that correlated significantly with fatigue severity were subsequently used as predictors in a 
multiple regression (method enter) with post-intervention fatigue severity  as dependent 
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variable.   For the predictors that were significant in the multiple regression, optimal cut-off 
scores were determined that correctly identified the largest proportion of  patients that did 
and did not profit from the minimal intervention.    
  
RESULTS 
In the course of the study it became clear that the number of patients lost at the second 
assessment was much lower than expected (about 5% instead of the expected 20%). The 
same power analysis was repeated but now using an estimated drop-out rate of 5%. The 
results indicated that a sample size of 85 in each condition sufficed and it was decided to 
stop with the inclusion of patients when this sample size was reached. There were 184 
consecutively referred CFS patients eligible to enter the study (Figure 1).  
 
Fig.  1: Trial profile  
 
Thirteen patients refused participation, 8 because they preferred a face to face contact with 
a therapist, of the remaining 5 the reasons for refusing were unknown. The remaining 171 
patients were randomly assigned to either the guided self-instructions condition or the 
Randomised (n= 171)
Waiting list condition (n= 86) 
 
Excluded from trial because of  medical 
explanation for fatigue  (n= 1) 
Intention to treat analysis (n= 85) 
Refused participation  (n= 13) 
Guided self-instructions (n= 85) 
 
Excluded from trial because of  medical 
explanation for fatigue  (n= 1) 
Intention to treat analysis (n= 84) 
Completed second assessment (n= 81) Completed second assessment (n= 78)
• Did not start with 
   self instructions (n= 13)
• Did not complete second 
   assessment (n= 6) 
 
Three patients both did 
not complete 2nd 
assessment and did not 
start treatment.
• Did not complete second 
   assessment (n= 4) 
Eligible to enter trial (n= 184) 
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waiting list. Of the total group of patients, 85 patients entered the self-instructions condition 
and 86 patients remained on the waiting list. Two patients were excluded from the study 
because another medical condition that could explain the fatigue was diagnosed after 
randomisation. In the treatment condition one patient was excluded after a constriction of 
the coronary arteries was diagnosed that subsequently was treated with surgery. In the 
waiting list one patient was excluded after Hashimoto's Thyroiditis was diagnosed. In the 
intention to treat analysis 84 patients of the self-instruction condition were compared with 
85 patients of the waiting list. Thirteen patients (15%) did not start with the self-
instructions, six patients (7%) did not complete the second assessment (three of them also 
had not started with the treatment). Of the 13 patients that did not start with the self-
instruction, 6 indicated that they preferred a face to face contact with a therapist, from the 
others the reasons for not starting were unknown.  In the waiting condition four patients 
(5%) did not complete the second assessment. There were 78 patients (93%) in the 
intervention condition with complete data,  in the waiting list condition 81 patients (95%) 
had complete data.     
 
Baseline characteristics In Table 1 the baseline characteristics of the patients from the two 
conditions are described. There were no significant differences between the self-
instructions condition and the waiting list in the scores on the outcomes measures at 
baseline.   
 
Table 1. Baseline characteristics of the patients from the two conditions
 
 Self-instructions (n=84) Waiting list (n=85) t-value
2 p-value 
 Mean score (SD)   
Demography 
Age (yrs) 37.6 (10.0) 38.5 (10.6)  -0.55 0.582 
Duration of complaints (months)1 72 (12,420) 96 (12,420) -1.22 0.225 
Male/Female 15/69 20/65 χ2=0.83 0.363 
     
Outcome measures     
CIS fatigue severity 49.1 (5.2) 49.9 (5.6) -0.96 0.336 
SIP total score 1659 (648) 1515(545)  1.56 0.120 
SF-36 physical functioning 52.3 (20.4) 54.1 (21.1) -0.56 0.575 
SCL-90 total score 167.3 (40.5) 168.6 (39.3) -0.21 0.834 
     
Indices of severity     
Number of CDC symptoms 7.1 (1.6) 7.3 (1.6) -0.58 0.566 
     
Perpetuating factors 
Activity pattern (passive/active) 24/60 20/65 χ2=0.56 0.455 
Self efficacy 17.4 (3.2) 17.9 (2.8) -0.99 0.326 
Somatic attributions 12.4 (2.9) 12.0 (3.2)   0.86 0.392 
Focusing on bodily symptoms 28.7 (8.1) 29.6 (8.3) -0.68 0.496 
1 median (min, max) 2 d.f.= 167 
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The effects of guided self-instructions  The mean time passed between baseline and 
second assessment was 10.5 months (SD= 4.0) for the guided self-instruction condition and 
9.7 (SD= 3.6) for the waiting list. This difference in time passed was not statistically 
significant  (t= 1.34, d.f.= 157, p= 0.182).  
Of the 84 patients in the self-instructions condition 55 (66%) emailed with the therapist, 5 
(6%) exclusively used the telephone and 10 (12%) used both email and telephone. The 
remaining 14 (17%) patients had not contacted the therapist, 13 of them did not start with 
the self-instructions and 1 completed the program without assistance of a therapist.  The 
mean number of  emails send by the patients was 11 (SD= 7.0) with a mean number of 285 
words (SD= 194). The mean time passed between the first and last mail send by the patients 
was 32 weeks (SD = 19). There were no reliable data collected on the number of telephone 
calls of the patients or the number of emails send by the patients who combined email and 
telephone.  
There was a statistically significant difference on all primary outcome measures between 
the guided self-instructions condition and the waiting list (Table 2). Patients from the 
intervention condition were significantly less fatigued, reported less disabilities on the SIP 
and scored significantly higher on the SF-36 physical functioning.  
 
After guided self-instructions patients also reported significantly less psychological distress 
at the second assessment than patients from the waiting list (Table 2).  
After guided self-instructions 27% of the patients showed a clinical significant 
improvement in fatigue which was significantly more than the 7% from the waiting list 
(Table 3).  More patients from the intervention condition also showed a clinical significant 
reduction of fatigue and disabilities at second assessment (21% versus 2%). 
Table 2. Change  in outcome measures between baseline and second assessment   
 
 Self-instruction (n=84)
1 Waiting list (n=85)1 F(1,166) p-value 
Primary outcome measures 
CIS fatigue severity  -10.1 (-12.7 to -7.6) -3.5 (-5.2 to -1.7) 20.61 <0.001 
SIP total score -579 (-690 to –469) -195 (-312 to -79) 19.77 <0.001 
SF-36 physical functioning 13.6 (9.4 to 17.8) 6.1 (2.3 to 9.9)  6.56   0.011 
     
Secondary outcome measures     
SCL-90 total score -20.4 (-27.9 to -12.9) -10.6 (-16.6 to -4.6) 5.86   0.017 
1  mean difference between second assessment and baseline (95% confidence interval) 
 
 
 86
Table 3. Proportion of patients with a clinical significant improvement at the second 
assessment 
 
 Self-instructions (n=84)
 Waiting list (n=85)  χ2 (d.f. =1) p-value 
 No  % (95% CI)  No % (95% CI)   
CIS fatigue severity < 351 23/61  27 (18 to 37)  6/79 7   (2 to 13) 12.27 <0.001 
CIS <351 and  
SIP total score <700 
18/66 21 (12 to 30)  2/83 2   (0 to  6) 14.73 <0.001 
1 and a reliable change index of 1.96  
 
The prediction of the response to guided self-instructions Of the variables that were 
selected as indices of the severity of CFS, fatigue and the level of disabilities on the SIP at 
baseline were significantly correlated with the treatment outcome of the patients who 
completed the second assessment. The pearson correlations with the fatigue severity at the 
second assessment were respectively .32 (p= 0.004) with baseline CIS fatigue severity  and 
0.37 (p=0.001) with the SIP total score. The number of CDC symptoms reported at baseline 
were not correlated with outcome (r = .19; p= 0.10).  
The perpetuating factors physical activity (r= -.20; p= 0.081),  somatic attributions (r= .19; 
p= 0.092) and self-efficacy (r= .11;  p=0.325) showed no statistical significant association 
with treatment outcome.  The correlation between focusing on bodily symptoms and the 
fatigue severity following the intervention  was significant (r= .35; p= 0.002). 
Table 4 shows the results of a multiple regression with the variables that correlated 
significantly with treatment outcome as predictors. This regression showed that fatigue 
severity and the level of disabilities at baseline predicted treatment outcome.  
 
Table 4. Prediction of the level of fatigue after guided self-instructions     
Predictor at baseline1 
 
 Unstandardized coefficients Standardized coefficients 
Constant -6.32  
CIS Fatigue severity  0.56  0.24* 
SIP total score  0.60  0.31** 
Focusing on bodily symptoms  0.27  0.18 
R2 adjusted 0.22  
* p<.05; **p<.01 1 n=78 patients from the treatment condition who completed the second assessment   
 
Cut-off points were calculated, using the SIP total score and CIS fatigue severity subscale 
score, that correctly predicted the largest proportion of patients who did not profit from the 
intervention. From the eleven patients that had a CIS fatigue severity score of 51 or higher 
and a SIP total score of 2250 or higher none reported a clinical significant change in fatigue 
at second assessment.  From the 73 patients that scored lower on the CIS and SIP, 23 
patients (32%) showed a clinical significant improvement. This difference in proportion 
(0% versus 32%) clinical significant improvement between the group who had an 
extremely high score on CIS and SIP and the group who scored lower on these measures 
was statistical significant (χ2= 4.77, d.f.= 1, p= 0.029). 
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DISCUSSION 
The main objective of this study was to test the efficacy of guided self-instructions for the  
treatment of CFS. The self-instructions were based on the protocol for CBT for CFS.  The 
results showed that the minimal intervention led to a significant decrease of  fatigue 
severity, disabilities and psychological distress compared to a waiting list condition. Also, 
after the self-instructions more patients showed a clinical significant improvement in 
fatigue and disabilities. It was already known that ‘face to face’ CBT is an effective 
treatment for CFS3, the current study showed that a less intensive intervention based on the 
same principles suffices for a subgroup of CFS patients. Although, as far as we know, this 
is the first randomised controlled trial testing the effects of a minimal intervention  based on 
CBT in CFS patients, the present findings are in line with previous research. A randomised 
controlled study with patients with chronic fatigue showed that a self-help manual based on 
CBT combined with support from a nurse was more effective than no treatment.21 
However, in this study only a small minority of the included  patients suffered from CFS.  
Burgess and Chalder22  found in an uncontrolled study with nine CFS patients that a self-
help manual based on CBT combined with telephone contact with a therapist had a positive 
effect on fatigue and disabilities.  
Powell et al23 also performed a randomised controlled trial with a minimal intervention for 
CFS patients but this intervention was based on graded exercise therapy, another evidenced 
based behavioural intervention for CFS.2 3 In this study psycho-education and a graded 
activity program in the form of a  self-help manual were combined  with telephone contact 
with a therapist. It was found that the fatigue and disabilities of patients in the treatment 
condition decreased more than in a control  condition and that these positive effects were 
maintained at follow-up.24 Direct comparisons of the magnitude of the effects from the two 
studies is difficult,  but the results of the trial of Powell et al23 are impressive and seem 
larger than the effects of the minimal intervention reported here. It could be that graded 
exercise therapy lends itself better for adaptation to a minimal intervention than CBT as it 
focuses more on behaviour change and less on the restructuring of cognitions. An 
alternative explanation would be that the therapist that delivered the intervention (there was 
only one therapist in the study of Powell et al23) was highly effective, thereby limiting the 
possibility to generalize the findings of this study. In our study six therapists delivered the 
intervention and although the number of patients is too small to statistically analyse the 
effect of the therapist, the percentages of patients with a clinical significant improvement 
vary from therapist to therapist. We suggest that in the future more attention is paid to the 
role of therapist characteristics on the outcome, not only in this minimal intervention but 
also in ‘face to face’ CBT for CFS.    
All patients in the current study were severely fatigued and disabled. A subgroup of patients 
who reported extremely high levels of fatigue and disabilities profited less from the 
minimal intervention. This indicates that guided self-instructions should preferably be 
offered to those CFS patients who, although being severely fatigued and disabled,  do not 
report extremely high levels of fatigue and disabilities. This group of patients has a better 
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chance on a favourable response to this minimal intervention. For these patients, guided 
self-instructions could form a first step in a model of stepped care for CFS. If they do not 
profit from the minimal intervention, they could subsequently be offered individual CBT. 
Patients with the most severe fatigue and an extremely high level of disabilities could 
perhaps best directly be referred for individual ‘face to face’ CBT. By using the self-
instructions in this way, the available treatment capacity for CFS  can be used more 
effectively and probably also more economically. Furthermore, a substantial subset of 
patients will not be required to visit a treatment facility regularly to effectively reduce their 
complaints.  
We assumed that self-instructions would be an effective treatment for a subgroup of 
patients but on the whole would be less effective than the individual ‘face tot face’ CBT. 
This assumption was confirmed in a comparison of the outcome of patients receiving self-
instructions  with the outcome of a cohort of 96 CFS patients receiving individual CBT in 
the same treatment facility and delivered by the same therapists.10 After the self-instructions 
21% of the patients had a clinical significant improvement  in fatigue and disabilities. In the 
group receiving individual CBT, 53% of the patients reached this criterion using the same 
instruments and definition of clinical significant improvement. The fact that individual 
CBT is more effective does not form a problem in using self-instructions as long as 
individual CBT is available for those patients who do not profit from the minimal 
intervention. The difference in effectiveness would become problematic if the chances on a 
favourable response to CBT for CFS are lessened if it is preceded by a minimal intervention 
that was unsuccessful. If this would be the case, one withholds a CFS patient a possible 
more favourable outcome by first offering a less effective treatment. Data about the 
outcome of patients treated with CBT after an unsuccessful minimal intervention are 
needed to rule out this potential negative effect of the minimal intervention. These data are 
not yet available.  
 
Limitations of this study As we did not use a placebo or non-specific intervention as 
control condition but a waiting list we can not be sure that the specific elements in the 
minimal intervention condition were responsible for the reduction in fatigue and disabilities 
in the CFS patients. There are two randomised controlled trials that compared the effect of 
CBT for CFS with a ‘placebo’ or non-specific condition. Both showed a superior effect of 
CBT on fatigue and the level of disabilities.6 25 Furthermore, a review of Cho et al26 
investigating the placebo response of CFS patients, showed that the placebo response of 
CFS patients to psychological interventions is lower than in other medical conditions.   
In the intention to treat analysis we carried the last observation forward in the case of 
missing data. By doing this we assumed that the symptoms and disabilities would not 
increase from baseline to second assessment. This does not have to be the case and by 
assuming this we could have introduced a bias in our analysis. We tried to correct this by 
repeating the analysis but now missing data on the outcome measures were replaced with 
estimates derived by single imputation (missing variable analysis regression with the 
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baseline value as predictor). The pattern of results on the main outcome measured stayed 
the same.  
With the design used in the study we do not know if a combination of self-instructions and 
contact with a therapist by email or telephone is necessary for the positive effect on fatigue 
and disabilities. We found no significant correlations between the number of emails sent by 
the patients, number of words of the emails, time passed between first and last email, or 
number of emails sent by the therapist and the fatigue severity or level of disabilities at 
second assessment. Those aspects of the contact with the therapist do not seem related to 
treatment outcome. However, we did not analyse the content of emails which perhaps 
shows a relation with the outcome of the intervention.  
In this trial we also did not study differences in the effects of email alone, email combined 
with telephone contact, or contact by telephone. This was mainly because of the small 
number of patients who did not use email contact but we also failed to collect data about the 
number and durations of phone calls. It could be that having a telephone conversation with 
a therapist has a different effect on the patient than receiving an email often a couple of 
days after the patient had sent a message. The two previous studies testing the effectiveness 
of forms of self-help for CFS  used the telephone as only mean of communication between 
patient and therapist.22 23 It would be worthwhile to investigate possible differences in effect 
of the self-help intervention using email or the telephone. It could be that contact by phone 
is more effective that an email contact. The two intervention modes also differ in their use 
of therapist time. Email can be used more flexible by the therapist than the telephone, but it 
could be that a telephone consult is less time consuming. It is important to look more 
closely at these aspects of the intervention because they determine the time a therapist has 
to invest in the treatment. This will have an effect on the treatment capacity for CFS and the 
cost-effectiveness of the minimal intervention. 
In the study of Chalder et al21 the self-help manual was combined with a consult with a 
research nurse. In our study qualified cognitive-behavioural therapists, all psychologists, 
delivered the intervention.  If other health care professionals, e.g. psychiatric nurses with 
less psychotherapeutic qualifications would be able to effectively guide CFS patients in 
using the self-instructions, this would probably further add to the cost-effectiveness of the 
intervention.  
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In this final chapter the results of the studies reported on in this dissertation will be 
discussed in light of the literature on cognitive behaviour therapy (CBT) for chronic fatigue 
syndrome (CFS). Furthermore, implications of our findings for the treatment of CFS 
patients will be formulated as well as possible directions for future research. This chapter is 
divided into three parts; the effects of CBT for CFS, the development of a model of stepped 
care for CFS, and future directions for research of CBT for CFS. 
 
The effects of CBT for CFS  
There is agreement in the scientific literature that the existing evidence shows that CBT 
leads to a reduction of self-reported symptoms and disabilities.1 Yet uncertainty exists 
about the nature and scope of the changes brought on by CBT. Here, it will be discussed 
what the studies described in this dissertation have added to our knowledge about the 
effects of CBT for CFS. First, the possibility to recover from CFS after CBT will be 
discussed; then what the effects of CBT are on symptoms other than fatigue; how CBT can 
change the experience of fatigue and lastly; what the long-term effects of CBT are. The 
clinical implications of these findings and unresolved issues surrounding these effects of 
CBT will also be mentioned.   
 
Recovery of CFS     
In chapter 5, the possibility to recover from CFS after CBT was investigated. The literature 
shows different views on this matter. Some authors state that the goal of CBT for CFS is to 
help patients improve activity levels and quality of life, rather than to overcome symptoms.2 
They find empirical support for this point of view in the fact that CFS patients continue to 
experience more fatigue than healthy controls after successful treatment with CBT, that 
only a minority of treated patients meet the criteria of full recovery and that some patients 
with a positive outcome directly following treatment relapse in the long term.2 Others think 
that recovery following CBT is not possible because CBT does not treat the causes of the 
syndrome. They often entail hypothetical pathophysiological models of CFS which are not 
easy to combine with the cognitive-behavioural model of CFS used in CBT.3-5 There are 
also authors that think that recovery from CFS is possible.6 In chapter 5, we empirically 
tested the controversy about the nature of change following treatment by defining recovery 
in constructs that can be assessed more or less objectively and that closely follow the CDC 
criteria for CFS. This seemed to us more fruitful than discussing hypothetical models of 
CFS or exchanging ideological viewpoints. It is important to note that the question was 
(and is) whether recovery is possible, not how many patients actually recover. Therefore, 
the aforementioned findings, e.g. that CFS patients as a group are more fatigued than 
healthy people after treatment, are not essential to answer this question. We think, on the 
basis of the study reported in chapter 5, that full recovery of CFS following CBT is 
possible.  However, full recovery is only achieved by a subgroup of patients. The 
characteristics of this group of patients are unknown, aside from the finding reported in 
chapter 5 that patients without a co-morbid medical illness have a better chance of 
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recovery. For the further development of CBT, it is crucial that our findings are replicated 
and that more is known about which patients do and which do not recover following 
treatment. Knowing the characteristics of these categories of patients could help in the 
development of new interventions that may increase the proportion of patients that recover. 
It could also lead to the conclusion that there is a subgroup of patients for whom recovery is 
not a tenable goal. For them, acceptance of a chronic condition should be seen as the aim of 
treatment.7 
In chapter 5, we reported that about half of the patients had a level of fatigue after CBT 
within the range of healthy controls. Only about one third of the patients no longer 
experienced fatigue as something negative. The fact that less patients reach the latter 
criterion of recovery, suggests that a ‘normalisation’ of the experience of fatigue is more 
difficult to establish in CFS patients with CBT than a reduction of the severity of the 
fatigue. It also seems that a return to normal physical functioning is more common than 
healthy functioning in other domains of living. This warrants further investigation and the 
development of strategies that better influence these aspects of CFS.  
In chapter 5, we did not look at the physical activity level of patients after CBT but mostly 
relied on self-reported change in symptoms and behaviour. As an increase of physical 
activity is seen as an important element of CBT, it would be interesting to look at the 
change in the scores on the actometer, a motion sensing device that reliably measures the 
actual level of physical activity of a patient.8 Re-examination of the available data of the 96 
patients in the recovery study (chapter 5) showed that after CBT and when measured with 
the actometer, 59 patients (62%) had a level of physical activity that was within the mean 
minus one standard deviation of healthy controls.8 At baseline, before treatment, 35% of the 
patients had an activity level within normal limits. The increase in the proportion of patients 
with an activity level within normal limits is statistically significant (χ2-test). Chapter 3 
showed that the level of physical activity measured with the actometer also significantly 
increased in adolescent CFS patients after a successful CBT. Is the increase in physical 
activity necessary to recover from CFS? The available data suggest that it is not. Again, we 
revisited the data of the cohort of patients from chapter 5. There was no significant 
correlation between the decrease of fatigue severity and increase of physical activity 
(pearson r= -.06, p= 0.552). After CBT, there was also no significant association between 
the level of fatigue and the physical activity level (pearson r= -.18). Thirteen of the 46 
patients that had a level of fatigue within the mean plus one standard deviation of healthy 
controls after CBT, being a very strict criterion for recovery, still had a physical activity 
level below that of healthy controls. The activity level of these 13 patients (13/46= 28%) 
was, even after CBT, more than one standard deviation below the mean of healthy controls. 
This means that it is possible to recover from CFS without reaching a physical activity level 
that is within normal limits. As most CBT protocols for CFS emphasize the importance of 
increasing the patient’s physical activity level to reduce fatigue and disabilities,6 it is 
remarkable to find that the relationship between an increase in physical activity and a 
decrease of fatigue is weak. We conclude from this, that rather than the increase in physical 
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activity, changes in cognitions play a crucial role in reaching recovery. Increasing activity 
levels is important because it facilitates the change in the cognitions about fatigue and 
disabilities, yet it is not the main mechanism of change in CBT for CFS.  The role of 
physical activity and cognitions (and their interplay) in reaching recovery needs further 
research. To this end, an analysis of the process of change that takes place in a successful 
CBT for CFS is needed (see further).     
The most important clinical implication of our outcome study is the need to communicate 
to patients that recovery is possible, but in no way a certain cure. Installing hope can 
motivate patients to change illness-related cognitions and behaviour and thus, increase the 
chance of a positive outcome of CBT for CFS.       
 
The effect of CBT on pain and cognitive impairments in CFS 
Most intervention studies use fatigue severity and level of disability as outcome measures. 
In this dissertation, we looked at the effects of CBT on pain and impairments in 
concentration and memory. Pain symptoms and cognitive impairments together form five 
of the eight additional CFS symptom criteria formulated by the Center for Disease Control 
(CDC). The majority of CFS patients report  these symptoms. We studied the effect of CBT 
on these symptoms and found that pain and self-reported cognitive impairments decrease 
after successful treatment. This suggests that both symptoms are part of the syndrome of 
chronic fatigue  and closely linked to the main symptom fatigue.  
It is important that these positive effects of CBT, which were not reported before by other 
research groups, are communicated to patients and clinicians who deliver care to CFS 
patients. There is no empirical support for often used alternative interventions for pain 
symptoms of CFS patients, like pain medication or physiotherapy. On the basis of existing 
evidence, CBT for CFS is the preferred treatment for pain symptoms of CFS patients. At 
the start of the treatment, the therapist asks the patients to stop all other treatments for CFS-
related symptoms. This is done to ensure that patients can attribute the reduction of 
symptoms and disabilities to changes in his or her cognitions and behaviour. This  will help 
to increase the self-efficacy of patients. The cessation of other treatments also includes the 
use of medication for CFS-related pain symptoms. The results of the study on pain 
symptoms in this thesis are in accordance with this intervention.  
Although pain severity decreases after CBT, patients with a very high pain level benefit less 
from CBT for CFS. We already suggested in chapter 2 that CFS patients with a high pain 
level are more like patients with syndromes in which the chronic widespread pain is a 
central feature (e.g. fibromyalgia). There is evidence that the biological correlates of CFS 
and these chronic pain syndromes differ.9 Furthermore, the subjective experience of severe 
pain is different from that of severe fatigue. Pain is an inherently negative sensation that is 
perceived as a possible signal of physical damage. Fatigue is a less alarming sensation that, 
for most healthy people, has, rather than negative, neutral or pleasant connotations (see 
chapter 4). In CFS patients, the fatigue gets negative connotations because of the negative 
consequences for the functioning of the person. Accordingly, one would expect that 
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patients with chronic fatigue have different symptom-related cognitions than patients with 
severe chronic pain. In chronic pain syndromes, catastrophising of pain symptoms plays a 
crucial role. It is an important predictor of the level of pain and disability of the patient, 
medication usage and psychological distress.10 Petrie et al11 found a tendency for 
catastrophising of fatigue in one third of the CFS patients. Those patients reported higher 
levels of fatigue and disabilities. There are several studies from one research group who 
also found a significant association between fatigue severity and catastrophising in patients 
receiving treatment for cancer and in cancer survivors.12-14 However, for these patients, 
fatigue is probably a far more threatening symptom than for CFS patients. In a large, 
multicentre study performed by our research group in cooperation with Belgium researchers 
from the university of Gent we found that catastrophising occurred less often in CFS 
patients compared to patients with severe chronic pain [Vermeer et al, unpublished data]. 
Furthermore, the relationship between catastrophising, fatigue severity and level of 
disabilities was weak. On the basis of this research we concluded that catastrophising is not 
a common clinical phenomenon in CFS. This could explain why CFS patients with severe 
pain (who perhaps do catastrophise) do not respond well to CBT. For this subgroup of 
patients, specific interventions aimed at the catastrophising of pain (and fatigue) could help 
to increase the effectiveness of CBT. Further research is necessary to test if these 
conclusions and assumptions are correct.  
 
The role of cognitive impairments in CFS 
In chapter 3, we found a decrease of self-reported cognitive impairments following CBT 
without a positive effect on neuropsychological test performance. This discrepancy between 
subjectively reported disabilities versus objectively measured performance is an important 
characteristic of CFS. With this in mind, one would expect that an effective treatment of 
CFS would lead to a more accurate perception by CFS patients of their performance. This is 
exactly what was found: CBT resulted in a decrease of complaints about cognitive 
functioning but not in a change in cognitive performance.  
One could argue against this interpretation that an improvement in neuropsychological test 
performance after treatment can only be expected for the sub-group of CFS patients with a 
defective performance at baseline. Recent research showed that the subgroup of CFS 
patients who report (retrospectively) a sudden onset of symptoms perform worse on 
neuropsychological tests compared to their monozygotic twin discordant for CFS.15 It is 
unclear how we must interpret these findings. Are the neuropsychological deficits just 
epiphenomena of some patients with CFS or is there an identifiable subgroup of CFS 
patients that differs from other patients on certain characteristics? And if so, what is the 
relevance of these characteristics for the treatment of CFS?  
In an attempt to find some preliminary answers to these questions we reanalysed the data of 
chapter 3 for those adult and adolescent CFS patients whose neuropsychological test 
performance at baseline is significantly worse than that of healthy controls. We compared 
the reaction times of CFS patients with the reaction times of healthy controls on the simple 
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and choice reaction time task. Reaction times were considered deviant if they were slower 
than the mean plus one standard deviation of healthy controls (21 males and 59 females 
with a mean age of 37.8, SD= 11.7). There were 94 adult (41%) and 20 adolescent patients 
(31%) with a deviant simple reaction time at baseline. In the choice reaction time task 126 
adults (54%) and 12 adolescents (18%) had a deviant performance. We tested the 
performance of both adolescents and adults with deviant baseline reaction times to see if 
their performance on the reaction time tasks improved after CBT. The results showed that 
patients with an ‘objective’ impairment in speed of information processing did not show an 
improvement in neuropsychological test performance following treatment. On the basis of 
these data, one could still conclude that the cognitive impairments remain after treatment 
but that patients learn to better cope with them, which results in a reduction of complaints. 
This would be an alternative explanation for the results of the study reported in chapter 3, 
namely for the sub-group of patients with a deviant neuropsychological test performance. 
We further examined this possibility by analysing the test performance on the reaction time 
tasks but now from the cohort of patients from the recovery study reported in chapter 5. We 
used this cohort and not the cohort from chapter 3 because the latter is much smaller, which 
lessens the statistical power.  In the cohort of 96 adult CFS patients, 44% had a ‘normal’ 
level of fatigue and no physical disabilities following treatment. The recovery rate of 
patients with a deviant simple reaction time at baseline (again mean plus one standard 
deviation of healthy controls) did not significantly differ from patients with a normal 
reaction time (46% versus 43%, χ2= 0.03, d.f. 1, p= 0.854). The recovery rate of patients 
with a deviant choice reaction time was also not significantly different from the recovery 
rate of patients without an impaired choice reaction time (64% versus 41%, χ2= 2.00, d.f. 1, 
p= 0.158). These results suggest that reaching recovery of CFS following CBT is 
independent of neuropsychological test performance.  This would implicate that having a 
deviant score or not is irrelevant for the treatment of CFS with CBT. We see an analogy: 
the lack of connection between neuropsychological test performance and complaints about 
mental functioning is very similar to the lack of connection between changes in physical 
activity and the reduction of fatigue. The improvement in fatigue severity or self-reported 
cognitive impairments is not related to changes in objective test performance or physical 
activity. We consider this evidence for the central role of perception and cognitions in CFS. 
During CBT, patients who complain about mental functioning follow a graded activity 
program where they systemically increase their mental activity (e.g. reading or surfing the 
internet). We assume that during this graded activity program they change their cognitions 
about their mental functioning (e.g. increase their self-efficacy), while no change occurs in 
their objective mental functioning.      
Smith and Sullivan16 showed that the beliefs of CFS patients about their cognitive 
functioning negatively influenced their actual test performance. In a study of Van der Werf 
et al17 more than 20 % of the CFS patients had a submaximal performance on a symptom 
validity test. We used the same symptom validity test in the study reported in chapter 3 but 
did not report the data in the final paper. As in previous studies, we found that a substantial 
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proportion of CFS patients (19% of the adult and 18% of the adolescent CFS patients) 
performed submaximally on a symptom validity task.17 18 Further analysis showed that this 
submaximal performance was associated with a significantly lower neuropsychological test 
performance on the reaction times tasks and the Symbol-Digit Modality Test. This implies 
that in order to be able to interpret the neuropsychological test performance of CFS patients 
in research and clinical practice, one needs a symptom validity test. The fact that most 
studies do not use symptom validity tests seriously hampers the interpretation of the 
findings of these studies.  We strongly feel that that without the use of symptom validity 
tests, it is not possible to come to valid conclusions about the reasons why a subgroup of 
CFS patients perform worse on neuropsychological tests than matched healthy controls.   
 
The experience of fatigue in CFS  
As far as we know, the studies described in chapter 4 and 5 were the first to show a change 
in the experience of fatigue following CBT for CFS. The fact that fatigue no longer has a 
negative connotation in a group of patients who have suffered several years from chronic 
fatigue is remarkable. Although this is a positive finding, only a subgroup of patients 
reaches this point, implying that it is not easy to change the experience of fatigue. The fact 
that more patients report a reduction of fatigue severity and disabilities than a change in the 
experience of fatigue suggests that there is room for improvement. How could the 
perception or experience of fatigue be addressed more successfully in therapy? One could 
try -more than is being done in the current protocol- to normalise the experience of fatigue 
after patients report that they are no longer chronically fatigued but still have moments of 
severe fatigue. Knowing that fatigue does not have to have negative consequences for the 
patient’s functioning (as was the case before), can reduce the negative connotations of 
fatigue. During therapy this is made explicit. Articulating this change in experience can 
further lessen the negative connotations of fatigue. These kinds of interventions can 
influence the attentional and attributional processes that are, in most likelihood, at the core 
of the perpetuation of CFS.19 
It would be interesting to see if, some time after the completion of CBT, the negative 
connotations surrounding fatigue decrease further in those patients who no longer are 
severely fatigued. Perhaps time is necessary to get rid of the negative associations with 
fatigue that were established over a long period of being disabled by the fatigue. It would 
also be worthwhile to test whether a change in the experience of fatigue after successful 
CBT, more specifically whether fatigue has once again become a normal or even pleasant 
experience,  protects a patient from future relapses in the future. Although the follow-up 
studies performed so far have shown that the treatment effects are sustained over time in 
both adult and adolescent CFS patients (see chapter 6), relapse does occur.2 One could 
assume that continuing to experience fatigue as something negative after (an otherwise 
successful) CBT will make patients more vulnerable for a recurrence of CFS.           
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Long-term outcome of CBT for CFS 
Several randomized controlled trials in adults confirmed that the positive effects of CBT in 
CFS patients are sustained over a period of 6 to 8 months following the treatment.2 20 One 
study investigating the efficacy of CBT over a 5 year follow-up period also showed that 
CBT for CFS produced lasting benefits in adults.2 On the basis of the follow-up study 
reported in chapter 6 of this thesis, the conclusion that the treatment effects sustain over 
time can be extended to adolescent CFS patients treated with CBT. However, relapses 
occur after CBT.2 In our study we found that the percentage of patients with a clinical 
significant improvement in fatigue slightly increased from post-treatment to follow up 
(from 60% to 64%). However, further analysis showed that from the 30 patients that 
improved at post-treatment, 9 patients relapsed at follow-up (31%). While this was 
compensated by the number of patients who improved after the treatment, it shows that 
relapse is also a clinically relevant problem in adolescent CFS patients. We think that more 
attention should be paid to relapse after CBT. This can be investigated by doing repeated 
assessments over a longer period after termination of CBT in cohorts of patients who were 
successfully treated. In this way the characteristics of patients that show a relapse can be 
studied, which can aid in the development of interventions that prevent the recurrence of 
CFS.  
 
Towards a model of stepped care for CFS 
Minimal intervention for CFS 
It is estimated that there are between 30.000 to 40.000 patients with CFS in the 
Netherlands.21 The capacity to treat these patients with CBT is lacking and it is unlikely 
that enough trained therapists will be available in the near future. We have developed a 
minimal intervention requiring less time of a therapist to deliver, and we have tested its 
effectiveness. The results reported in chapter 7 show that guided self-instructions based on 
the protocol for CBT for CFS is an effective treatment for a subgroup of patients. For this 
group, a minimal intervention suffices. This intervention could form a first step in a model 
of stepped care for CFS patients.   
How effective are self-instructions compared to individual CBT?  Scheeres et al22 
calculated the mean (within treatment) effect size for fatigue severity and disabilities of 
CBT for CFS derived from four randomised controlled trials testing the effectiveness of this 
treatment. The mean effect size (cohen’s d) for fatigue was 1.44 (95% CI:  0.97 tot 1.89) 
and for disabilities it was 1.04 (95% CI =0.63 tot 1.44). The effect sizes of the guided self-
instructions was for fatigue severity 1.1 and for the level of disabilities (which was 
measured with the Sickness Impact Profile; SIP) it was 0.8, both within the confidence 
interval of the statistical benchmark. For physical functioning, the effect size was 0.6, 
outside the confidence interval of the benchmark for disabilities.  On the basis of this 
comparison it can be concluded that, aside from the outcome with respect to physical 
functioning, the effect-sizes of self-instructions are not different from those of ‘face to face’ 
individual therapy. However, the patients in the trials were not always treated by 
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experienced therapists20 and the protocol of CBT has been improved on the basis of the 
outcome of the trials testing the effectiveness of CBT for CFS.23 We calculated the effect 
sizes of the cohort of 96 CFS patients from chapter 5 who received individual CBT in the 
same treatment facility as in the randomised controlled trial testing the effectiveness of 
guided self-instructions (see chapter 6). Nearly all patients were treated by therapists who 
also participated in the study reported in chapter 6. The effect sizes were 1.9 for fatigue 
severity, 1.4 for level of disabilities measured with the SIP and 1.2 for the increase in 
physical functioning. The effect size of CBT in this cohort treated by experienced therapists 
is higher for fatigue severity than the statistical benchmark and reached the upper limit of 
the confidence interval of the benchmark for the measures of the disabilities. We also 
calculated the effect sizes at follow-up of the ‘face to face’ CBT in adolescent CFS patients 
from chapter 6. For fatigue severity the effect size was 1.9, which is again higher than the 
statistical benchmark. For the increase in physical functioning the effect size was 1.4, again 
near the upper limit of the confidence interval. On the basis of these data we conclude that 
individual treatment has become more effective and is superior, providing it is delivered by 
experienced therapists in a specialized treatment facility, to guided self-instructions. This 
does not mean that there is no place for self-instructions in the care for CFS patients. As 
long as patients have access to individual treatment when the minimal intervention does not 
succeed, self-instructions are an efficient treatment form.  
Currently, our group is engaged in two studies that further investigate the effects of guided 
self-instructions. In the first study, psychiatric nurses deliver the treatment instead of fully 
trained cognitive behavioural therapists. A second difference is that the self-instructions are 
offered to CFS patients diagnosed in primary care instead of CFS patients referred to a 
tertiary, specialised CFS clinic. In this study, the effects of the guided self-instructions are 
also compared to a waiting list condition. If this trial can replicate the findings of the 
original study described in chapter 7, the treatment capacity for CFS can be increased 
rapidly because the training of psychiatric nurses for this specific intervention requires less 
time than the training program for cognitive-behavioural therapists. Furthermore, by 
offering self-instructions in primary care CFS patients can enter treatment earlier. This is 
important, as the mean symptom duration of patients in our specialised CFS clinic is more 
than 6 years. Reduction of the time passed before the start of CBT will reduce the suffering 
of patients and will also reduce the medical and societal costs of CFS.  The second study on 
self-instructions is a follow-up of the original trial reported in chapter 7.  The effectiveness 
of individual therapy for patients who still desire individual treatment after completion of 
the self-instructions, is compared with the effects of the same treatment that patients receive 
after the waiting list. This will help us determine whether the chance of a positive outcome 
after ‘face to face’ individual CBT is smaller if one has had an unsatisfactorily response to 
the self-instructions. Data on this issue are necessary to make an informed decision about 
implementation of self-instructions in a model of stepped care.  
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Future directions in the development of interventions for a model of stepped care 
In a model of stepped care, specific interventions should also be available for patients who 
do not profit from individual CBT for CFS. A substantial subgroup drops out from CBT or 
does not have a positive outcome. They remain severely fatigued and disabled.  Perhaps for 
this group a form of treatment has to be developed that learns patients to manage symptoms 
that are chronic and disabling. There are some exploratory studies that show promising 
results of such treatment forms. Surawy et al24 found that mindfulness training (which aims 
to facilitate non-judgmental attention to present moment experience through the practice of 
meditation) in CFS patients waiting for CBT resulted in a significant reduction of anxiety 
and fatigue and in an increase of quality of life and physical functioning. Treatment gains 
were modest compared to those following CBT but mindfulness training could be helpful 
for those patients who do not profit from CBT. 
Another subgroup where interventions have to be developed and tested with regard to their 
effectiveness, is that of patients that are too severely disabled for CBT delivered in an out-
patient clinic. Patients who are continuously bedridden, depend on a wheelchair or have 
extremely severe complaints, could perhaps best be treated in an in-patient setting. There 
have been some studies testing the effectiveness of behavioural interventions in an in-
patient setting.1 25 Two of them reported positive treatment effects.  However, it is not clear 
to what extent the patients in these studies were more severely disabled.  The studies also 
have methodological flaws and the interventions offered seem to differ from the CBT 
protocol. One uncontrolled case study found a positive effect of CBT for CFS in an 
outpatient setting for two patients who depended on a wheelchair.26 The patients had a large 
number of contacts (55-60) with the therapists, some face to face, some by telephone. It is 
probable that the protocol for CBT for CFS has to be adjusted in order to effectively treat 
the subgroup of patients who are homebound. They show a persistent low physical activity 
level, are at risk for developing physical deconditioning and more often have had 
depressive episodes in the past. Motivating these patients for behavioural intervention will 
probably be very difficult as they tend to have stronger somatic attributions of CFS 
symptoms.27 Controlled studies testing the effectiveness of interventions based on CBT for 
these groups of CFS patients (homebound, dependent on wheelchair) are lacking and badly 
needed, but will be difficult to perform.      
 
Future directions in the research of CBT for CFS 
Mechanisms of change in CBT for CFS: the role of physical activity and perception  
CBT is an effective treatment for CFS, but the mechanisms by which the changes in 
symptoms and disabilities are reached is unknown. Some postulate that CFS is associated 
with a physical deconditioning and that by systematically increasing the level of physical 
activity, this is reversed and followed by a reduction of symptoms.28 However, research has 
shown that physical deconditioning is not a perpetuating factor in CFS, at least not in the 
majority of CFS patients.29 Also, the improvement in symptoms and functioning in CFS 
patients is not associated with increased fitness after a graded exercise program but with a 
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change of illness-related cognitions.30 Furthermore, we did not find an association between 
a change in the level of physical activity and a reduction of fatigue severity after CBT. 
Recovery of CFS was possible, even if the physical activity level of the patient remained 
low. If there are no direct connections between the level of physical activity and/or fitness 
of CFS patients and the response to therapy what could be the role of graded physical 
activity in CFS? Some suggest that by gradually becoming more active, the fear and 
avoidance of activity decreases and activity impeding cognitions are restructured.31 The 
gradual increase of physical activity can then be seen as a form of exposure therapy. This 
could well apply to patients with an extremely low physical activity pattern where activity-
impeding cognitions play an important role.6 However, the majority of CFS patients have a 
fluctuating activity pattern, in which bursts of activity leading to an increase of symptoms 
are followed by periods of inactivity.8 They are not characterised by activity-impeding 
cognitions. For those patients, the gradual increase of physical activity could reinforce the 
belief that they can increase their activity, at a slower pace, without becoming extremely 
fatigued. This change in cognitions could, in turn, help to reduce disabilities. Seen in this 
way, the precise level of physical activity reached is less relevant. The graded activity has a 
function in changing the perception and to elicit positive feedback that patients receive 
when they increase their level of activity (from others and from the evaluation of one’s own 
behaviour). The change in perception and elicited feedback will also lead to an increased 
self-efficacy and a decreased focus on bodily symptoms, both factors that perpetuate the 
fatigue.5 This would explain how fatigue severity can decrease as a consequence of the 
graded activity program. Finally, being physically active could be an inherently positive 
experience to some CFS patients, as is regularly reported by patients during therapy. 
Examples of this are feelings of ‘healthy’ fatigue or of being less exhausted after the walks 
that are part of the graded activity program. This could add to the restructuring of 
dysfunctional cognitions about the negative consequences of activity on fatigue. This is in 
accordance with the evidence that physical activity of moderate intensity has positive 
effects on affect, activation and relaxation.32       
The aforementioned hypothetical mechanisms of change in CBT would imply that the 
central disorder in CFS is one of perception of bodily symptoms and one’s own 
performance and activity in relation to the symptoms. This would be in accordance with the 
already mentioned findings of others concerning the discrepancy between subjective 
complaints and objective performance of CFS patients.33-36 It would also be in line with 
recent research using F-MRI in which not the actual performance but the interpretation and 
affective labelling of the errors made during a task of CFS patients differ from healthy 
controls.37 A recent review describing a model of medically unexplained symptoms 
referring to different research findings also emphasized the role of attention and attribution 
in the maintaining of symptoms.19  
However, it must be noted that solid data about the possible mechanisms of change in CBT 
for CFS are still lacking. These data are crucial to better understand CFS and to further 
improve CBT for CFS. Our research group will start a study to find out which variables 
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during the therapy process contribute to recovery or predict an unsuccessful outcome of 
CBT for CFS. We chose variables that are related to the specific interventions in CBT and 
variables that are known perpetuating factors of CFS.5 6  Examples of the process variables 
of interest are self-efficacy,  pain,  social support, level of physical activity, expectations 
from the patients of the therapy, the focus on bodily symptoms and catastrophising of pain 
and fatigue. By studying the process of change in these variables and its relation to changes 
in fatigue and disabilities, more will be known about the specific mechanisms of change 
and how they interact in a successful treatment of CFS. This will also provide more insight 
into the role of physical activity and perception in reaching recovery.  
Another way of investigating the role of physical activity is to compare the difference in the 
effects of a graded activity program that is aimed at increasing mental activity (using the 
computer, doing work that requires mental effort, increasing social contacts) with a 
physical activity program (e.g. walking). If physical activity is crucial for the positive 
effects of CBT, one would expect that the patients who increase their physical activity will 
show a larger reduction in fatigue and disabilities. 
Currently, a study investigating the response of CFS patients to virtual physical activity is 
in preparation. The use of virtual reality in CBT is not new, especially as an alternative to 
exposure in vivo.38 With this technique patients can be exposed to virtual physical activity 
and assess the effects of the activity on cognitions and symptoms. Repeating this 
assessment in different phases of the therapy may facilitate a better understanding of the 
relationship between fatigue, cognitions and physical activity. 
Finally, evidence is mounting that CFS patients show neurobiological abnormalities.37 39 
Structural and functional MRI before and after therapy could help us to better understand  
the biological correlates of CFS and the mechanisms of change in CBT. Similar research in 
affective disorders has proven to be fruitful.40 41        
 
Prediction of the response to CBT  
Several studies have looked for variables that predict the response to CBT. Membership of 
a self-help group, being dysphoric, receiving sickness benefits, being involved in a legal 
procedure concerning a disability claim, having a low self-efficacy, being strongly focused 
on bodily symptoms and having an extremely low physical activity pattern were all 
predictors of a poor response to therapy.2 42 43 The fact that certain characteristics of a 
patient, his or her environment, or a symptom belonging to the syndrome predicts the 
response to treatment could be seen as an indication that during the treatment the influence 
of the specific predictor has not been adequately addressed. The finding that a low physical 
activity was a predictor of treatment outcome led to an adjustment of the protocol of CBT 
for CFS.44 After this adjustment, the activity pattern no longer predicted treatment 
outcome.23 The predictive value of certain patient characteristics for treatment outcome can 
also lead to the exclusion of patients because CBT is not effective in their situation. An 
example of this is being involved in a legal procedure concerning a disability claim what in 
the current protocol leads to (temporarily) exclusion from treatment.  In this way, 
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knowledge about what predicts the response to treatment can help to make CBT more 
effective and efficient.  
In this dissertation, some new predictors of the response to treatment were found. The role 
of pain as predictor of treatment outcome has already been discussed earlier in this chapter. 
The study discussed in chapter 5 showed that somatic co-morbidity is associated with a 
lower response to CBT. There are two possible explanations for this effect of co-morbidity. 
The first would be that the symptoms and disabilities that remain are caused by somatic co-
morbidity and do not reflect the effect of CFS. If this is true then other criteria for recovery 
from CFS have to be used that incorporate the effect of the co-morbidity on symptoms and 
disabilities. In other words, the treatment goal is different for this subgroup of patients.  An 
alternative explanation would be that having a somatic disorder hampers the treatment of 
CFS because it strengthens the perception of patients that they are ill and therefore cannot 
recover. When the latter is true, then it is important to direct more attention to the 
restructuring of the attributions of the fatigue in such a way that the patients can influence 
the fatigue and reduce the fatigue-related disabilities. Replication of our findings and 
further investigations into the difference between patients with and without somatic co-
morbidity with respect to their fatigue related cognitions is warranted. In chapter 5 only the 
effect of somatic co-morbidity was analysed. Prins et al45 diagnosed a current psychiatric 
disorder in 32% of the CFS patients participating in a randomised controlled study testing 
the effect of CBT for CFS. That percentage was significantly higher than the percentage of 
psychiatric illness in the general population. There was no difference in treatment outcome 
(fatigue severity and disabilities) between patients with and without a psychiatric diagnosis. 
In the adolescent study, an interesting finding was that the fatigue of the mother of the 
adolescent CFS patient was related to treatment outcome of the adolescent. The clinical 
implication of this finding was already discussed in chapter 6. The question is whether this 
relationship has a parallel in adult CFS patients. It would be interesting to look at the 
relationship between the response to CBT and the fatigue of the partner or other proxy. 
Perhaps if such a person is seriously fatigued, this also hampers, like in adolescents, the 
treatment of the adult with CFS. If so, this could also have clinical implications of the 
interventions carried out.   
For future research it is important to test the predictive value of variables for the treatment 
response in larger cohorts of patients because the studies performed so far were probably 
under-powered. 
 
Incorporating  new developments in CBT in the  treatment of CFS 
In studying CBT for CFS we can learn from the new developments in CBT, already applied 
to some other disorders. Three developments could be relevant for CFS.  The first is the 
concept of metacognitions in the perpetuation of dysfunctional beliefs that produce 
symptoms. Metacognitions can be seen as appraisals of the consequences of choosing to 
adopt a particular belief or style of thought.46  Matthews and Wells46 use the example of 
patients with health anxiety to illustrate the role of metacognition. A subgroup of patients 
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with health anxiety, believes that worrying is desirable because it is perceived to be a way 
to detect problems at an early stage, before it is too late. This metacognition will keep a 
patient worrying, even if it leads to negative consequences like anxiety or fatigue for which 
the patient seeks help. There have been a few uncontrolled studies in anxiety disorders 
testing the effectiveness of interventions aimed at the modification of metacognitions 
instead of the conventional treatment aimed at the restructuring of symptom related beliefs. 
The studies showed remarkable large positive effects of this intervention strategy.47 48 We 
consider it possible that metacognitions play an important role in the focusing on bodily 
symptoms which is a perpetuating cognitive process in CFS. If this is true, this could lead 
to alternative treatment strategies for this perpetuating factor.  
The focus on bodily symptoms is also an important characteristic of patients with social 
phobia with fear of blushing, trembling and sweating. Task concentration training aimed at 
redirecting the attention away from the bodily symptoms to the social task is an effective 
treatment.49 It would be worthwhile to test the effectiveness of this type of intervention 
incorporated in the protocol of CBT in CFS patients.  
According to some, a ‘third generation’ of cognitive behavioural therapies has emerged. 
These therapies see the modification of dysfunctional cognitions as unnecessary to induce 
change. Instead, the role of behavioural change, constructivism and attentional control is 
emphasized.50 Examples of such therapies are Acceptance and Commitment Therapy 
(ACT) and mindfulness based cognitive therapy. The study of Surawy25, investigating the 
effects of mindfulness training is an example of the use of these new therapies in CFS. 
There are two studies that investigated specifically the role of acceptance in CFS.7 51 
According to some, CBT for CFS focuses exclusively on gaining control over the fatigue, 
while acceptance of CFS could also have a positive effect on the symptoms. Acceptance is 
defined as a willingness to live with fatigue without reactance, disapproval or attempts to 
reduce or avoid it. In chronic pain patients’ acceptance is associated with less disabilities, 
symptom reduction (or less attention to symptoms) and less medical consumption. In an 
experimental study in CFS patients it was shown that that hostile rejection towards in 
contrast to acceptance of CFS or relaxation triggered more symptoms.51 The CBT protocol 
used in the studies reported in this dissertation also contains elements of acceptance: 
patients who are relatively active learn to accept the fact that they are currently severely 
fatigued in order to prevent bursts of activity that worsen symptoms. Given that CFS 
patients tend to perceive a lack of social support and a lack of acknowledgement of 
symptoms, we emphasize acceptance of the current situation and the social responses to this 
situation to be able to focus on reaching recovery in the future. However, it is conceivable 
that a more systematic use of elements from coping strategies aimed at the acceptance of 
CFS in those situations could help patients to deal better with their current situation. This 
seems especially true for the subgroup of patients who do not profit (enough) from CBT. 
We believe that the new developments in CBT could help to further improve the treatment 
of CFS patients and deserve to be tested on their effectiveness.          
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This dissertation reports on six studies that investigate different aspects of the treatment of 
patients with chronic fatigue syndrome (CFS). CFS is characterized by severe fatigue 
lasting longer than six months and leading to a substantial reduction of activities. A somatic 
explanation for the fatigue is lacking. Cognitive behaviour therapy (CBT) is an evidence 
based treatment for CFS that leads to a reduction of fatigue and disabilities. CBT is aimed 
at changing cognitions and behaviours that perpetuate the fatigue. Although there is 
substantial evidence that CBT leads to a decrease of symptoms, there are concerns about 
the effectiveness and scope of CBT. This thesis aims to not only address some of the 
unresolved issues surrounding CBT, but also to test the effectiveness of a minimal 
intervention based on the protocol of CBT for CFS.   
 
In chapter 1 the outline of this thesis is presented.  
 
Patients with CFS frequently report chronic pain symptoms. CBT for CFS is not aimed at 
pain symptoms. The study reported in chapter 2 had three objectives. First, to test the 
hypothesis that successful treatment of CFS can also lead to a reduction of pain. CBT was 
considered successful if a patient reached a post-treatment level of fatigue within normal 
range. The second objective was to explore the possible mechanisms of changes in pain. 
The third objective was to assess the predictive value of pain for treatment outcome. Data 
from two CBT studies were used, one of adult CFS patients and one of adolescent CFS 
patients. The results showed that adult and adolescent CFS patients reported a significant 
reduction of pain severity after a successful CBT. Adult patients also had fewer pain 
locations following successful treatment. The decrease in fatigue predicted the change in 
pain severity. In adult patients, a higher pain severity at baseline was associated with a 
negative treatment outcome. 
  
CFS patients often have concentration and memory problems. Neuropsychological test 
performance is impaired in at least a subgroup of patients with CFS. In the study, described 
in chapter 3 we tested the hypothesis that CBT results in a reduction of self-reported 
cognitive impairment and in an improved neuropsychological test performance. We used 
the data of two randomised controlled trials; one of adult CFS patients and one of 
adolescent patients.  In both studies the level of self-reported cognitive impairment 
decreased significantly more after CBT than in the control conditions. Neuropsychological 
test performance did not improve. The findings of this study support the idea that the 
distorted perception of cognitive processes is more central to CFS than actual cognitive 
performance. 
 
In chapter 4 the change in the experience of fatigue following CBT was investigated. For 
this, an adjective checklist, the Fatigue Quality List (FQL) was developed. The FQL aims 
to assess different perceptions of fatigue. The psychometric properties of the list were 
evaluated and component and confirmatory factor analyses were performed. Different 
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perceptions of fatigue were found in different patients’ groups. CFS patients were 
characterised by strong negative connotations of fatigue. CFS patients who recovered after 
CBT did no longer differ in their experience of the fatigue from healthy controls. 
 
There is controversy about the nature of the changes following treatment of CFS with CBT; 
some suggest that patients improve by learning to adapt to a chronic condition, others think 
that recovery is possible. The objective of the study presented in chapter 5 was to find out 
whether recovery from CFS is possible after CBT. The outcome of a cohort of 96 patients 
treated with CBT was studied. The definition of recovery was based on the absence of the 
criteria for CFS set up by the Center for Disease Control (CDC), but also took into account 
the perception of the patients’ fatigue and their own health. Data from healthy population 
norms were used in calculating conservative thresholds for recovery. After treatment, 69% 
of the patients no longer met the CDC criteria for CFS. The percentage of recovered 
patients depended on the criteria used for recovery. Using the most strict definition of 
recovery, 23% of the patients  fully recovered. Fewer patients with a co-morbid medical 
condition recovered. It was concluded that significant improvement following CBT is 
probable and that full recovery is possible. Sharing this information with patients can raise 
the expectations of the treatment, which may enhance outcomes.  
 
In chapter 6 the long term outcome of adolescents with CFS who received CBT was 
investigated. Also, the predictive value of fatigue severity and physical impairments of the 
adolescent, and the fatigue severity of the mother at baseline for the outcome of the 
treatment at follow-up was determined. Adolescent CFS patients who previously 
participated in a randomized controlled trial were contacted for a follow-up. The original 
study showed that CBT was more effective than a waiting list condition in reducing fatigue 
and improving physical functioning. In this particular study, the mean follow-up time was 
2.1 years. There was no significant change in fatigue severity between post treatment and 
follow-up in the patients who had received CBT. There was a significant further increase in 
physical functioning and school attendance. A group of patients who did not receive 
treatment were more fatigued, more functionally impaired, and had a lower school 
attendance at follow-up than patients treated with CBT. Higher fatigue severity of the 
mother predicted lower treatment outcome in adolescent patients. We concluded that the 
positive effects of CBT in adolescents with CFS are sustained after CBT.  
 
The capacity to treat CFS patients with CBT is lacking and it is unlikely that enough trained 
therapists will be available in the near future. We developed a minimal intervention for CFS 
consisting of self-instructions combined with email contact based on the protocol for CBT. 
We tested if the guided self-instructions led to reduction of fatigue and disabilities and tried 
to predict for which patients this minimal intervention suffices. In a randomised controlled 
trial the effects of the intervention were compared to a waiting list condition. The main 
outcome measures, fatigue severity and level of disabilities, were determined at baseline 
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and after the intervention or waiting period. The trial is described in chapter 7.  In total 85 
patients were allocated to the treatment condition, 86 to the waiting list. An intention to 
treat analysis showed that fatigue and disabilities decreased significantly after guided self-
instructions. Fatigue severity and disabilities were negatively related with treatment 
outcome. We concluded that guided self-instructions are an effective treatment for 
relatively less severely disabled and fatigued CFS patients.  
 
Finally, in chapter 8, the findings of the six studies were discussed in light of the literature 
on CBT for CFS. The implications of the findings for the treatment of CFS patients and 
possible directions for future research were formulated. The importance of further 
development of a model of stepped care for CFS was emphasized. It was concluded that it 
is likely that the central disorder in CFS is one of perception of bodily symptoms and one’s 
own performance and activity levels in relation to the symptoms. Future research should be 
aimed at investigating this disorder in perception and the possible mechanisms of change in 
CBT for CFS. This research is necessary to better understand CFS and to further improve 
CBT for CFS.  
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In dit proefschrift werden de resultaten van zes studies beschreven waarin verschillende 
aspecten van de behandeling van patiënten met het chronische vermoeidheidssyndroom 
(CVS) zijn onderzocht. CVS wordt gekenmerkt door ernstige vermoeidheid, die langer dan 
6 maanden aanhoudt en samengaat met aanzienlijke beperkingen in het dagelijkse 
functioneren. Er is geen lichamelijke verklaring voor de vermoeidheid. Cognitieve 
gedragstherapie (CGT) is een evidence based behandeling voor CVS die leidt tot een 
afname van de vermoeidheid en beperkingen. Hoewel het meeste onderzoek dat verricht is 
laat zien dat CGT een effectieve behandeling is,  bestaat er wel discussie over de aard en 
omvang van de behandeleffecten. In vijf verschillende studies, die zijn beschreven in de 
hoofdstukken 2 tot en met 6,  werden de effecten van CGT nader onderzocht. In de zesde 
studie, beschreven in hoofdstuk 7, werd een nieuwe behandelvorm, gebaseerd op het CGT 
protocol voor CVS,  op zijn werkzaamheid getoetst.   
 
In hoofdstuk 1 werd een  inleiding gegeven over CVS en werden de achtergronden van de 
studies die in het kader van dit proefschrift zijn verricht besproken.  
 
CVS patiënten zijn niet alleen ernstig moe, vaak rapporteren zij ook chronische 
pijnklachten. Binnen het CGT protocol  voor CVS zijn er geen specifieke interventies die 
gericht zijn op deze pijnklachten. In hoofdstuk 2  werd de studie beschreven waarin de  
hypothese werd getoetst dat succesvolle behandeling van CVS met CGT samengaat met 
een afname van pijnklachten. Een behandeling werd als succesvol beschouwd als de patiënt 
niet langer ernstig vermoeid was. Het tweede doel van het onderzoek was na te gaan welke 
mechanismen een rol spelen bij de (eventuele) afname van pijnklachten. Het derde doel was 
te bepalen of de ernst van de pijnklachten bij aanvang van de behandeling een 
voorspellende waarde had voor het behandeleffect. Om deze vragen te beantwoorden 
werden gegevens van twee eerdere studies gebruikt die de effectiviteit van CGT hadden 
onderzocht. Een van deze studies was bij volwassen CVS patiënten gedaan, de andere bij 
adolescenten met CVS. In beide patiëntgroepen was er een significante afname van 
pijnklachten na een succesvol verlopen CGT. Bij volwassen patiënten nam ook het aantal 
pijnlijke plekken op het lichaam af na behandeling. De afname in vermoeidheid tijdens de 
behandeling voorspelde de afname van de pijnklachten. Bij CVS patiënten met zeer  
ernstige pijnklachten bij aanvang van de therapie was het resultaat van de behandeling van 
vermoeidheid met CGT geringer. Dit gold overigens alleen voor de volwassen CVS 
patiënten. Geconcludeerd werd dat CGT voor CVS ook een effectieve behandeling is voor 
de pijnklachten van CVS patiënten.     
 
Patiënten met CVS klagen vaak over concentratiezwakte en vergeetachtigheid. Een deel 
van de patiënten heeft afwijkende prestaties op neuropsychologische tests. In hoofdstuk 3 
werd  de hypothese getoetst dat CGT leidt tot een afname van klachten over het mentaal 
functioneren en tot een verbetering van prestaties op neuropsychologische tests. Om deze 
hypothese te toetsen werden de gegevens gebruikt van twee gerandomiseerde en 
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gecontroleerde studies waarin de effectiviteit van CGT werd onderzocht. Een van deze 
studies was bij volwassen CVS patiënten gedaan, de andere bij adolescenten met CVS. In 
beide groepen namen de klachten met betrekking tot het mentaal functioneren significant 
af. De prestaties op neuropsychologische tests verbeterden niet na behandeling. De 
resultaten van deze studie zijn in overeenstemming met de hypothese dat niet zozeer de 
mentale prestaties verstoord zijn in CVS, maar dat veeleer de perceptie van het 
functioneren van mentale processen veranderd is.  
 
In hoofdstuk 4 werden de veranderingen in de ervaring van vermoeidheid na CGT 
beschreven. Voor dit doel werd de Fatigue Quality List (FQL) ontwikkeld. Dit is een 
checklist met bijvoeglijke naamwoorden waarmee wordt beoogd de verschillende 
percepties van vermoeidheid te meten.  De psychometrische eigenschappen van de FQL 
werden bepaald en er werd een componenten- en conformatorische factoranalyse 
uitgevoerd.  Er bleken verschillen te zijn in de perceptie van vermoeidheid tussen de 
verschillende ziektebeelden die werden onderzocht. CVS patiënten werden gekenmerkt 
door een zeer negatieve perceptie van de vermoeidheid. Als CVS patiënten herstelden na 
CGT en niet langer ernstig moe waren, veranderde ook hun perceptie van de vermoeidheid. 
Deze perceptie was na CGT hetzelfde als die van gezonde proefpersonen.  
 
Er bestaan verschillende opvattingen over de aard van de veranderingen die worden 
bewerkstelligd met CGT voor CVS. Sommigen zijn van mening dat patiënten beter leren 
omgaan met hun chronische aandoening. Dit leidt tot een verbetering van hun toestand 
zonder dat sprake is van herstel. Anderen daarentegen stellen dat een volledig herstel van 
CVS na CGT mogelijk is. In hoofdstuk 5 werd nagegaan of herstel van CVS na CGT 
mogelijk is. Van een cohort van 96 CVS patiënten die met CGT behandeld was, werd het 
behandelresultaat onderzocht. Er werden verschillende definities van herstel gehanteerd die 
onder andere waren gebaseerd op de  internationaal algemeen geaccepteerde criteria voor 
CVS van het Center for Disease Control (CDC). Er werd niet alleen gekeken naar het effect 
van de behandeling op vermoeidheid en de activiteiten van patiënten, maar ook naar de 
perceptie van vermoeidheid en de gezondheidsbeleving. Er werden zeer strikte criteria voor 
herstel bepaald waarbij gebruik gemaakt werd van normgegevens van de gezonde 
populatie. Na behandeling voldeed 69% van de patiënten niet langer aan de CDC criteria 
voor CVS. Afhankelijk van de definitie van herstel die werd gehanteerd varieerde het  
percentage herstelde patiënten. Patiënten met een lichamelijke aandoening naast CVS, 
hadden een minder grote kans op herstel. Geconcludeerd werd dat het zeer waarschijnlijk is 
dat volgend op CGT een aanzienlijke verbetering in klachten en functioneren optreedt en 
dat een volledig herstel van CVS mogelijk is. Het delen van deze informatie met patiënten 
kan maken dat patiënten meer gaan verwachten van therapie. Dit kan een positief effect 
hebben op het daadwerkelijke behandelresultaat.  
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In hoofdstuk 6  kwamen de lange termijn effecten van CGT bij adolescenten met CVS aan 
de orde. Ook werd onderzocht welke factoren het behandelresultaat op langere termijn 
voorspellen. Gekeken werd naar de voorspellende waarde van de ernst van de vermoeidheid 
en fysieke beperkingen van de adolescent gemeten  bij aanvang van de therapie. Ook werd 
de voorspellende waarde van de ernst van de vermoeidheid van de moeder van de 
adolescent voor het behandelresultaat bij follow-up bepaald. De patiënten die werden 
benaderd voor het follow-up onderzoek hadden meegedaan aan een gerandomiseerde en 
gecontroleerde studie waarin het effect van CGT direct na behandeling was onderzocht. 
Deze studie had aangetoond dat CGT ook bij adolescenten met CVS leidde tot een afname 
van vermoeidheid en beperkingen. In het huidige onderzoek was er gemiddeld meer dan 
twee jaar verstreken tussen afsluiting van de behandeling en de follow-up meting. In de 
groep patiënten die behandeld was met CGT was er geen verandering opgetreden in de 
ernst van de vermoeidheid; de bereikte verbetering was behouden gebleven. Het fysieke 
functioneren was verder verbeterd en het schoolverzuim was verder afgenomen.  De groep 
niet-behandelde patiënten was meer vermoeid, had meer fysieke beperkingen en had een 
hoger schoolverzuim bij de follow-up meting dan de groep patiënten die met CGT waren 
behandeld. Naarmate de moeder van de adolescent ernstiger vermoeid was bij aanvang van 
de therapie van haar kind, was het behandelresultaat op langere termijn minder gunstig.  
Op grond van dit onderzoek kan geconcludeerd worden dat de positieve effecten van CGT 
bij adolescenten met CVS ook op langere termijn aanhouden en dat zelfs sprake is een 
verdere verbetering.  
 
De behandelcapaciteit voor CGT voor patiënten met CVS is ontoereikend. Het is 
onwaarschijnlijk dat op korte termijn voldoende therapeuten getraind kunnen worden om 
deze behandeling op grotere schaal te geven. Er is behoefte aan minder intensieve 
interventies waarmee grotere groepen patiënten behandeld kunnen worden. Wij 
ontwikkelden een minimale interventie voor CVS die bestaat uit zelfbehandelingsinstructies 
(ZBI) gecombineerd met tweewekelijks email contact met een therapeut. De minimale 
interventie is gebaseerd op het CGT protocol voor CVS. In een gerandomiseerde en 
gecontroleerde studie die beschreven werd in hoofdstuk 7, hebben we de effectiviteit van 
ZBI onderzocht. Hierbij werd tevens nagegaan voor welke groep patiënten de minimale 
interventie toereikend is. De effecten van ZBI  werden vergeleken met een 
wachtlijstconditie. De primaire uitkomstmaten, ernst van de vermoeidheid en ernst van de 
beperkingen, werden gemeten voor en na de interventie of de wachtperiode. In totaal 
werden 85 patiënten toegewezen aan de ZBI conditie en 86 aan de wachtlijstconditie. De 
resultaten lieten zien dat de vermoeidheid en de beperkingen meer afnamen na ZBI. Hoe 
ernstiger vermoeid en hoe meer beperkt een patiënt was, hoe kleiner de kans was dat hij of 
zij profiteerde van behandeling. Dit bracht ons tot de conclusie dat ZBI een effectieve 
behandeling is voor relatief minder ernstig vermoeide en beperkte patiënten. Op deze wijze 
ingezet, zou ZBI de eerste stap kunnen vormen in een model van getrapte zorg voor CVS.  
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In hoofdstuk 8 werden de resultaten van de onderzoeken geplaatst in het kader van wat uit 
eerder onderzoek reeds bekend was over de effecten van CGT voor CVS. De implicaties 
van de resultaten van de studies uit dit proefschrift  voor de behandeling van CVS patiënten  
werden besproken en er werden suggesties gedaan voor vervolgonderzoek.  
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en steun van velen. Graag wil ik hen op deze plaats bedanken.  
 
Allereerst wil ik de patiënten bedanken die meededen aan de verschillende studies. Uw 
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ook in met deelname aan wetenschappelijk onderzoek. Ook degenen waarbij de 
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actometer te dragen. Ik wil u allen bedanken voor uw bijdrage.  
 
Gijs Bleijenberg en Jos van der Meer hebben mij de afgelopen jaren begeleid. Beste Gijs, ik 
wil je bedanken voor wat jij mij de afgelopen jaren geleerd hebt als onderzoeker en  
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behandeling en onderzoek vaak meer mogelijk is dan ik dacht, jij leerde mij ook dat ik meer 
kon dan ik voor mogelijk hield. Daar pluk ik nog elke dag de vruchten van, bedankt 
hiervoor.  Beste Jos, voor een dokter weet je ongelofelijk veel van gedragstherapie. Je was 
meer op afstand betrokken, maar ik weet dat je een belangrijke rol speelt in het faciliteren 
van ons werk. Ik wil je bedanken voor de bruikbare commentaren op mijn teksten en vooral 
de bemoedigende adviezen.  
 
Voor onderzoek zijn data nodig. Bij het verzamelen hiervan hebben de psychologisch 
medewerkers, Carel, Tiny, Harmen, Lianne en Judith vaak en veel geholpen. Op elke 
(bijna) onmogelijke vraag van mij hadden jullie een gevat antwoord, doken vervolgens in 
de bestanden en vonden de gegevens, bedankt hiervoor.  
 
Bij het merendeel van de studies werden de gegevens van eerdere projecten gebruikt. Ik wil 
Maja Stulemeijer en Judith Prins bedanken voor hun bereidwilligheid om zich opnieuw te 
verdiepen in hun (vaak al lang geleden afgesloten) projecten. Terwijl jullie zelf vaak al druk 
bezig waren met andere zaken, lukte het toch mijn vele vragen tussen de bedrijven door te 
beantwoorden. Ook de bijdragen van Lieke de Jong en Theo Fiselier aan het follow-up 
onderzoek van adolescenten heb ik zeer op prijs gesteld. Speciale dank gaat uit naar Ria te 
Winkel, die ook toen zij niet langer bij onze afdeling werkte altijd bereid was oude 
gegevens op te diepen en de data voor mij op een rijtje te zetten.  
 
Theo de Boo wil ik bedanken voor zijn hulp bij de statistische analyse.  
 
Hoewel ik de afgelopen jaren veel onderzoek heb gedaan, was ik het grootste deel van mijn 
tijd werkzaam als behandelaar. De samenwerking met de andere therapeuten (Agaat, Hein, 
Annemarie, Thea, Gerrie, Henriette, Hanneke, Sanny, Ines, Inge en Pauline) was niet alleen 
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goed en leuk (vooral de groep, Agaat!), jullie leverden ook een belangrijke bijdrage aan 
mijn onderzoek. Jullie behandelden niet alleen een deel van de patiënten die meededen aan 
de studies, voor het onderzoek naar de effecten van de zelfbehandelingsinstructies hebben 
jullie heel wat voor mij geregistreerd, uitgezocht en bijgehouden terwijl daar eigenlijk geen 
tijd voor was. Bedankt hiervoor!  
 
Liesbeth, zonder jou zou elke verjaardag op de afdeling vergeten worden en zou ik niet 
weten welke goede films ik allemaal mis! Laat je niet (al te) gek maken!  
 
De collega-onderzoekers (Marieke ‘de Koningin’; Martine; Dewey; Korine; Marcia; 
Gerard; Joke; Marjolein; Ingrid; Sanne) wil ik bedanken voor de wandelingen in het park, 
het gezellige kletsen, de confrontaties met mijn leeftijd en het ontbreken van enige 
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pak hijsen. Jacques, een betere vriend kan ik mij niet voorstellen, bedankt voor de 
broodnodige afleiding. Het kon niet anders dan dat jij je ermee ging bemoeien toen het op 
het eten en drinken aankwam. Lieve Mirjam, dank je wel voor alle hulp bij de finishing 
touch bij het proefschrift, jij ziet een lay-out fout van een kilometer afstand.   
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ook aan dit proefschrift. Ma, zolang ik maar doe wat ik graag wil vind jij het goed, wat het 
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David, jij kan dit nog niet lezen, maar jij was zonder twijfel de afgelopen jaren de beste en 
leukste reden om niet te werken.  
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leuke dingen. En toen kwam ook  deze klus nog voorbij. Soms was dit wat veel, maar altijd 
was je steunend, dacht en hielp je mee. Dank je wel, en ook voor al die, al die andere 
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